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Abstract
The main aim of this project was to define the neurotrophin survival 
requirements of sensory neurons during the early stages of their development 
both in vivo and in vitro. The in vitro survival of neural crest-derived but not 
placode-derived cranial sensory neurons is promoted by several different 
neurotrophins early in their development. Neural crest-derived neurons 
subsequently lose responsiveness to all neurotrophins except NGF. Loss of 
responsiveness of neural crest-derived sensory neurons to BDNF and NT3 is 
associated with a marked shift in the dose responses of these neurons to higher 
neurotrophin concentrations. Analysis of the timing of cell death in the 
trigeminal ganglia of mouse embryos that are homozygous for null mutations in 
the TrkA, TrkB and TrkC genes which encode high affinity receptors for NGF, 
BDNF and NT3 respectively, show that there is an early peak of apoptosis in 
TrkB and TrkC knockouts which is consistent with the early survival response 
of trigeminal neurons to BDNF and NT3 in vitro. The elevated peak of apoptosis 
in TrkA knockouts occurs at the same development stages as in wild type 
embryos which is consistent with the later response of trigeminal neurons to 
NGF in vitro. Furthermore, there is a high level of expression of TrkC mRNA in 
early trigeminal neurons which accords with the early survival response of these 
neurons to NT3. It is also shown that subsets of trigeminal neurons discriminate 
between neurotrophins at very high concentrations during the period of cell 
death, indicating that neurotrophin responses can be far more highly specific than 
previously thought. Taken together, these results show that neurotrophin 
switching is a physiologically relevant phenomenon in certain populations of 
developing sensory neurons.
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Chapter 1 
INTRODUCTION
1.1. OVERVIEW
In the developing vertebrate nervous system neurons are generated in 
excess. Once differentiated, the neurons extend processes to their target fields. 
During the period of target field innervation a substantial number of nemons die. 
This phenomenon is called naturally occurring neuronal death (Oppenheim, 
1991; Davies, 1994a for review). The purpose of this process is to match the 
number of neurons to the requirements of their target fields and eliminate 
superfluous and inappropriately connected neurons. The subsequent discovery of 
nerve growth factor (NGF), a protein which promotes the survival of certain 
kinds of neurons and is produced in the target fields of these neurons, led to our 
current understanding of how target fields regulate their innervation density. 
Several homologous proteins have been discovered subsequently, and constitute 
the NGF family of neurotrophins. The neurotrophins exert their biological 
activity by binding to cell surface receptors. Two kinds of receptors have been 
identified, namely, gp75 and members of the trk family of tyrosine kinases 
(Bothwell, 1995 for review). gp75 is a common receptor for all neurotrophins 
and binds them with low affinity. In contrast, the trk receptors are specific for 
different neurotrophins which they bind with high affinity. To understand how 
neurotrophins regulate the size and the connections of neuronal populations, it is 
essential to study neurons at successive stages of their development. Sensory 
neurons are particularly advantageous for these studies because these neurons
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and their progenitors cells can be easily obtained for in vitro studies at different 
stages throughout their development. Another advantage of sensory neurons is 
that a substantial amount of information is available concerning their 
developmental history (Davies and Lumsden, 1986). To ascertain the 
neurotrophin requirements of sensory neurons during the early stages of 
development, I have studied the responsiveness of various populations of cranial 
sensory neurons to neurotrophins in vitro during embryonic development. These 
studies have shown that some populations of cranial sensory neurons switch their 
survival requirements from one set of neurotrophins to another during the early 
stages of target field innervation. To determine the physiological relevance of my 
in vitro observations, I have studied the timing of neuronal death in mice with 
targeted null mutations in the TrkA, TrkB and TrkC genes. Subsequently, I have 
studied the specificity of binding of neurotrophins to their respective receptors in 
developing chicken cranial sensory neurons in vitro. Finally, to clarify the role 
of high affinity receptor expression in sensory neuron development, I have 
carried out a detailed investigation of the expression of TrkC mRNA, which is 
the preferred receptor for Neurotrophin-3 (NT3). The switch in neurotrophin 
dependence was correlated with changes in receptor mRNA expression. The 
General Background and the results of all these studies are presented in the next 
five chapters.
22
1.2. GENERAL BACKGROUND
1.2.1, Development of the Vertebrate Nervous System
The nervous system of vertebrates is derived from the ectoderm. In a 
process known as neurulation, a broad central region of the ectoderm thickens, 
rolls up into a tube, and pinches off from the rest of the ectoderm. This tube, the 
neural tube, forms the brain and the spinal cord. Along the line where the neural 
tube pinches off from the future epidermis, a number of ectodermal cells break 
loose from the epithelium and migrate through the mesoderm. These neural crest 
cells form almost all of the peripheral nervous system (PNS), including 
autonomic neurons, most sensory neurons, sympathetic ganglion neurons and all 
of the support cells of the PNS, the Schwann cells and satellite cells.
1.2.2. Sensory Neurons
Sensory neurons are extremely useful for studying neuronal 
differentiation and development in the vertebrate nervous system because these 
neurons and their progenitor cells aie accessible to experimental manipulation 
from the earliest stages of their development. Sensory neurons differentiate from 
progenitor cells that migrate from two regions of the embryonic ectoderm, the 
neural crest and neurogenic placodes (Le Douarin, 1986). The teim placode was 
used by Von Kuppfer (1894) to designate the epithelial thickenings appearing in 
the cephalic ectoderm of the early vertebrate embryo. Epithelial neuron 
progenitor cells detach from the "neurogenic" placodes and migrate to certain
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developing cranial sensory ganglia where they differentiate (D'Amico-Martel and 
Noden, 1983). The neural crest at the lateral margins of the neural plate gives rise 
to the sensory neurons associated with spinal and some cranial neiwes. Neuronal 
differentiation is recognised by the emergence of central and peripheral axonal 
processes and by the expression of neuron-specific proteins such as 
neurofilament proteins. In all but one case, the cell bodies lie in anatomically 
discrete aggregates termed sensory ganglia. Dorsal root ganglia (DRG) are 
located on the dorsal roots of spinal nerves and cranial sensory ganglia are found 
on 5 of the 12 pairs of cranial nerves. The exception is a population of neural 
crest-derived sensory neurons located in the midbrain that constitute the 
trigeminal mesencephalic nucleus (TMN).
The contributions to populations of cranial sensory neurons from neural 
crest and placodes in avian embryos have been mapped by grafting quail 
(LeDouarin, 1973) or radiolabelled chick primordia into unlabelled chick hosts 
(Weston, 1963). These findings are summaiised in Table 1.1. All of the ganglion 
supporting cells and Schwann cells are derived from the neural crest (D'Amico- 
Martel and Noden, 1983).
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Cranial Nerve Neuronal Origin
Populations Neural Crest Placodes
V Trigeminal (Dorsomedial) V
V Trigeminal (Ventrolateral) V
V Trigeminal Mesencephalic V
vn Geniculate V
vm Yestibulo-acoustic V
Distal IX Petrosal V
Proximal X Jugular V
Distal X Nodose V
Table 1.1. Origin of chicken cranial sensory neurons
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1.2.3. Naturally Occurring Neuronal Death
Once early sensory neurons differentiate in developing sensory ganglia 
their axons grow to their peripheral and central target fields. The peripheral target 
field of a population of sensory neurons comprises those tissues to which they 
extend their peripheral axons, whereas the central target field comprises those 
populations of second order neurons with which its central axons synapse. For 
example, the peripheral target fields of dorsal root ganglia comprise a 
heterogeneous collection of tissues including skin, muscle and viscera. The 
peripheral target fields of many populations of cranial sensory neurons, however, 
consist of just one kind of tissue.
During the phase of target field innervation appropriate connections are 
established. A remai'kable feature of this phase of development (establishment of 
connection with the target field) is the death of a substantial number of the 
innervating neurons. During the formation of the nervous system, nerve cells are 
produced in excess. The final number of cells is attained by a phase of cell death 
that occurs shortly after innervation of target fields (Oppenheim, 1991 for 
review). In the case of sensory neurons, the magnitude of cell death ranges from 
25% in the vestibular and cochlear ganglia (Ard and Morest, 1984) to over 75% 
in the TMN (Rogers and Cowen, 1974) and generally takes place over a period of 
3 to 6 days.
Neuroembryologists have understood for several decades that the number 
of neurons in developing vertebrates is influenced by cellular mechanisms that 
depend on feedback from neuronal targets. The currently accepted view of such
26
regulation is that targets elaborate trophic signals on which neurons are 
selectively dependent for their survival. There is also some evidence that 
afferents play a role in maintaining neuronal survival (Oppenheim, 1991 for 
review). Thus, the number of neurons that survive to maturity is governed by 
interactions with their targets and afferents.
Natural neuronal cell loss occurs by the process of programmed cell death 
or apoptosis. This differs in many respects from necrosis which is typical of 
pathological conditions (Kerr, Wyllie and Curie, 1972; Altman, 1992). General 
(though not universal) characteristics of apoptosis are well established (Wyllie et 
al, 1980). Distinctive morphological changes occur that include nuclear 
condensation and degradation of DNA to oligosomal fragments. In some cases 
this process is dependent on protein synthesis (a striking illustration of the active 
nature of the process). Apoptosis typically affects scattered single cells and is 
identified histologically by the presence of small, round or oval cytoplasmic 
fragments, some of which contain pyknotic nuclear remnants (Kerr et at, 1972).
Despite considerable progress, it has proven difficult to identify the 
molecules responsible for apoptosis by conventional biochemical and molecular 
approaches in mammalian systems. Fortunately, there is increasing evidence that 
apoptosis occurs by a mechanism that has been at least partially conserved 
thr oughout animal evolution. In the nematode Caenorhabditis elegans, 14 genes 
have been shown to function in programmed cell death. Three of these genes 
affect the execution of all somatic cell deaths: ced-3, ced-4 and ced-9 (ced 
stands for cell death defective). The activity of ced-3 and ced-4 is required for 
cell death to occur, and ced-9 protects cells that should survive from undergoing 
programme cell death (Hengartner et at, 1992 ).
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Overexpression of the vertebrate homologues of ced-3, ICE (interleukin 
IB converting enzyme), in mammalian cells causes apoptosis (Wang et al, 1994), 
suggesting that either ICE , or a related cysteine protease may function in 
mammalian cell death. Likewise, the vertebrate homologue of ced-9, bcl-2, has 
been shown to be a suppressor of apoptosis in the vertebrate nervous system. 
The human bcl-2 gene was identified at the breakpoint site of the t(14;18) 
chr omosomal translocation that is associated with follicular lymphoma (Cleary et 
al, 1986). Bcl-2 is thought to contribute to oncogenesis by suppressing signals 
that induce apoptotic cell death (Williams et al, 1990; Vaux et al, 1992). 
Overexpression of bcl-2 in vitro can prevent haematopoietic and neural apoptosis 
that has been induced by growth factor withdrawal (Nunez et al, 1990; Garcia et 
al, 1992; Allsopp et al, 1993).
Bcl-2 is the founder member of an expanding family of genes that 
regulate apoptosis, which now includes bclx-l, box, bad, bak, mcl-1 and AL Bax 
(Oltvai et al, 1993), bad (Yang et al, 1995) and bak (Farrow et al, 1995; 
Chittenden et al, 1995; Kiefer et al, 1995) have been identified as effector 
proteins in the cell death program, whereas bcl-2 (Garcia et al, 1992) and bclx-l 
(Boise et al, 1993) are putative repressors of neuronal death (for review Nunez 
and Clarke, 1994). Proteins of the bcl-2 family contain a stretch of hydrophobic 
amino acids at their C-termini which appear to be important for attachment to 
intracellular membranes (Nguyen et al, 1993; Tanaka et al, 1993), but not 
important for cell death preventing functions.
Genetic analysis of the process of naturally occurring cell death in 
Drosophila melanogaster has led to the isolation of a gene, reaper, that is 
capable of integrating information from different signalling pathways to activate 
the apoptotic program (White et al, 1994; White et al, 1996). The mechanism by
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which reaper induces apoptosis is not clear. The reaper gene encodes a small 
polypeptide of 65 amino acids with no significant similarity to other known 
proteins.
1.2.4. Importance of Neurotrophic Factors in the Regulation of Neuronal 
Survival
The discovery of NGF by Rita Levi-Montalcini 40 years ago led to the 
widely accepted hypothesis that neuronal target fields play an important role in 
regulating the number of neurons that survive by their production of limited 
quantities of NGF, or other so called neurotrophic factors, which the innervating 
neurons require for their survival. This hypothesis is based on two main 
assumptions. First, the survival of developing vertebrate neurons depends on 
specific neurotrophic factors secreted by the target cells that the neurons 
innervate. Second, many types of neurons are produced in excess, so that only a 
proportion gets enough neurotrophic support from their target cells to survive. 
Thus, the level of trophic factor production in the target field directly influences 
the size of the innervating populations of neurons (Thoenen and Barde, 1980; 
Davies, 1988; Barde, 1989).
The most important evidence for the neurotrophic hypothesis has come 
from the demonstration that developing neurons whose survival is promoted by 
NGF in vitro, namely sympathetic and certain sensory neurons, also depend on 
NGF in vivo. Anti-NGF antibodies eliminate these neurons during the early 
stages of target field innervation, whereas exogenous NGF rescues neurons that
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would otherwise die (Levi-Montalcini, 1987). Likewise, mice lacking a 
functional NGF gene have severely reduced numbers of sensoiy and sympathetic 
neurons and exhibit marked reductions in response to nociceptive stimuli 
(Crowley et al, 1994). NGF is synthesised in the tai'get fields of NGF-dependent 
neurons in proportion to their innervation density both in the adult (Korsching 
and Thoenen, 1983; Heumann et al, 1984; Shelton and Reichardt, 1984) and 
during development (Harper and Davies, 1990), and is conveyed from these 
tissues to the cell bodies of the innervating neurons by rapid axonal transport 
(Hendry etal, 1974\ Korshing and Thoenen, 1983).
Studies of the site and timing of NGF synthesis and NGF receptor 
expression during development gave further support to the neurotrophic 
hypothesis. The demonstration that NGF synthesis commences in the target 
fields of NGF-dependent sensory (Davies et al, 1987) and sympathetic 
(Korsching and Thoenen, 1988) neurons with the onset of target field 
innervation, and that NGF receptors aie not expressed until the neurons innervate 
their taigets (Davies et al, 1987) showed that NGF does not affect these neurons 
at earlier stages of development.
NGF is now known to be only one member of a family of homologous 
neurotrophic proteins, called neurotrophins, which includes brain derived 
neurotrophic factor (BDNF) (Barde et al, 1982), Neurotrophin-3 (NT3) (Hohn et 
al,l990\ Maisonpierre et al, 1990; Rosenthal et al,1990; Jones et al, 1990; 
Ernfors et al, 1990), Neurotrophin-4 (NT4) cloned in Xenopus, mammalian 
Neurotrophin 4/5 (Berkemeier et al„ 1991; Ip et al, 1992), and the recently 
cloned Neurotrophin 6  (NT6) (Gotz et al, 1994).
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Nerve Gro’wth Factor
For over four decades, NGF provided the only basis for the concept that 
trophic molecules are necessary for neuronal survival. An important source for 
the initial purification and characterisation of NGF was from the mouse 
submandibular salivary gland (Cohen, 1960). NGF isolated from this source is 
an acidic protein complex with a molecular weight of 130 kDa consisting of three 
subunits, alpha, beta and gamma, that aie present in the ratio 2 :1 :2 , respectively 
(Vai'on et al 1968). The biological activity of this molecular complex is due to a 
dimer consisting of two identical 118 amino acid chains. Therefore, NGF exists 
as a 26 kDa homodimer of 13 IcDa polypeptides, refened to as BNGF. Although 
the association of the chains of the dimer is non-covalent, the interaction is stable 
even at physiologically low NGF concentrations (Bothwell and Shooter, 1977).
Sequencing of the mouse submandibulai* gland NGF B subunit (Angeletti 
and Bradshaw (1971) provided invaluable information about its primary structure 
and led to the subsequent cloning of the mouse (Scott et al, 1983), human 
(Ullrich et al, 1983), bovine (Meier et aZ, 1986) and chick (Ebendal et at, 1986) 
NGF genes which exhibit a high degree of homology. The NGF gene codes for a 
precursor polypeptide of 307 amino acid residues which, upon cleavage, gives 
rise to the 118 amino acid mature NGF protein (Scott et al, 1983; Berger and 
Shooter, 1977; Edwards et al, 1988a, b). The mouse gene spans 45 kb and has 
several small 5' exons (Selby et al, 1987). At least four different mRNA 
transcripts can be produced by differential splicing, although the functional 
difference of these various transcripts is not yet fully understood. Most of the 
pre-pro NGF coding sequence, including the full sequence of the biologically 
active processed NGF, is located in one exon at the 3' end of the gene. Gene 
transfer studies in various cell lines have established that the two primary
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translation products (27 or 34 kDa corresponding to the two major NGF mRNA 
transcripts) give rise to the precursor protein (Edwards et al, 1988a, b). The 
trypsin-like enzymes necessary for the correct processing of NGF are found in 
many cells (Edwards et al, 1988). This is in agreement with in vivo data 
indicating that NGF is made by a variety of cells, such as epidermal cells, smooth 
muscle cells or hippocampal neurons. There are indications that, depending on 
the tissue or the cell transfected, NGF can be stored in vesicles and released 
either by calcium-dependent mechanism or via the ’constitutive’ pathway (Barth 
et al, 1984; Edwards et al, 1988b).
Although crystals of NGF have been available for some time, they have 
only recently been successfully analysed by X-ray diffraction methods to 
produce a three dimensional structure of the mature NGF molecule to 2.3 A° 
resolution. The stmcture is characterised by a new protein folding that is rich in 
6 -strands (McDonald et al, 1991).
The amino terminus of NGF is susceptible to proteolytic cleavage. A 
comparison of the bioactivity of highly purified full length (1-118) recombinant 
human NGF (rhNGF) and a NH2-terminal truncated (10-118) rhNGF revealed 
lower potency of the truncated rhNGF with regard to early NGF responses in 
neuron-like PC 12 cells. It was found that, whereas the truncated form of rhNGF 
(10-118) had a 300-fold less affinity for TrkA (the high affinity receptor for 
NGF) than the full length molecule (1-118). The amino-terminal truncation of 
NGF changed its affinity for the low affinity receptor (gp75) only slightly (5-10 
fold). These observations suggest that amino acids 1-9 of NGF are important for 
binding to the signal transducing receptor TrkA (Kahle et al, 1992).
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Mice that are homozygous for null mutations in NGF gene failed to 
respond to noxious mechanical stimuli, and histological analysis revealed 
profound cell loss in both sensory and sympathetic ganglia. Within dorsal root 
ganglia, effects of the mutation appeared to be restricted to small and medium 
peptidergic neurons. In contrast, within the central nervous system, basal 
forebrain cholinergic neurons differentiate and continue to express phenotypic 
markers for the life span of the null mutant mice. Thus, differentiation and initial 
survival of central NGF-responsive neurons can occur in the absence of NGF 
(Crowley et al, 1994)
Brain Derived Neurotrophic Factor
BDNF is a 12.3 kDa protein that was purified from pig brain using an 
assay based on sensory neuron survival (Barde et al, 1982). Using partial 
sequence data, a pig BDNF cDNA was isolated that has an open reading frame 
coding for a precursor protein of 252 amino acids (Leibrock et al, 1989). A 
striking feature of the primary structure of mature BDNF is its similarity to NGF. 
Fifty one amino acids are common to BDNF and NGF. However, most of the 
cleaved precursor sequence is unrelated to that of NGF. Subsequently, full 
length human (Jones and Reichardt, 1990; Maisonpierre et al, 1991), mouse 
(Hofer et al, 1990) and rat BDNF (Maisonpierre et al 1991) were isolated as 
well as partial cDNA clones for monkey, chicken and Xenopus BDNF (Isackson 
etal, 1991; Hallboke/<3/, 1993).
33
BDNF mRNA is predominantly expressed in the brain and spinal cord but 
is also found in a number of non-neuronal cell types like human platelets 
(Leibrock et al., 1989; Yamamoto and Gurney, 1990), fibroblasts and sciatic 
nerve Schwann cells (Acheson et al, 1991). BDNF mRNA expressing cells are 
widely distributed in the rat brain, with high levels in the hippocampus, the 
internal and external pyramidal layers of the cerebral cortex and the claustrum 
(Wetmore et al, 1990). In the peripheral nervous system, BDNF mRNA is 
expressed in rat dorsal root ganglion neurons (Ernfors et al, 1990), BDNF 
mRNA has also found in early chicken DRG neurons (Wright et al, 1992). Since 
early DRG neurons mature when grown in single cell culture and antisense 
BDNF oligonucleotides, but not sense oligonucleotides, inhibit maturation, it is 
possible that BDNF promotes maturation by an autocrine route at this stage of 
development (Wright et al, 1992).
Expression of BDNF mRNA in spinal cord and superior colliculus 
supports the idea that BDNF is a tai*get-derived neurotrophic factor, as these 
regions contain the target cells of neurons previously shown to respond to BDNF 
(Lindsay etal, 1985; Davies etal, 1986; Johnson etal, 1986).
Although the neurotrophic theory was formulated on the basis of work 
done on NGF, it holds true for other members of the neurotrophin family. In a 
similar way to NGF, BDNF promotes survival of certain neuronal populations 
during development. BDNF supports the survival in vivo of placode and neural- 
crest- derived sensory neurons (Lindsay etal, 1985; Hofer and Barde, 1988) and 
increases the survival and differentiated functions of rat septal cholinergic 
neurons in culture (Alderson et al, 1990), BDNF also promotes the survival and 
differentiated phenotype of both dopaminergic and GABAergic neurons of the 
forebrain and substantia nigra (Hyman et al,l99A\ Knusel et al, 1991).
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Embryonic retinal ganglion cells respond to BDNF in vitro from E ll  onwards, a 
time corresponding to target field innervation in vivo (Johnson et al, 1986; 
Rodriguez-Tebar et al, 1989). Although not required for the survival of adult 
retinal ganglion cells, BDNF stimulates re-elongation from these cells and can 
rescue them from degeneration (Thanos et al, 1989). Chicken sensory neurons 
like dorsal root, trigeminal mesencephalic, jugular and geniculate neurons, are 
responsive to BDNF in vitro (Lindsay et al, 1985; Davies et al, 1986). BDNF is 
also a neurotrophic factor for dopaminergic neurons of the substantia nigra, 
increasing their in vitro survival, including those cells that degenerate in 
Parkinson's disease (Hymann et al, 1991).
Homozygous mutant BDNF mice (-/-) are reduced in size as compared to 
their litter mates and most die within the first three postnatal weeks. However, 
the heterozygous animals (-/-!-) are viable but consistently intermediate in size 
(Carrol et al 1994 ). There is an increased level of cell death within DRG neurons 
in the mutant animals. In addition, BDNF (-/-) mutants were found to have 
reduced numbers of inner ear vestibular and nodose neurons (Ernfors et al, 1994, 
Jones etal, 1994).
Neurotrophin 3
Talcing advantage of sequence identities between NGF and BDNF, a third 
member of the neurotrophin family, NT3, was originally cloned from a mouse 
genomic template by PCR using degenerate oligonucleotides. Mature NT3 
consists of 119 amino-acids of 13.6 kDa (Relative molecular mass of 13.625, pi
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9.3). Like BDNF and NGF, recombinant human NT3, exists as a dimer at 
physiological relevant concentrations (Radziejewski et al, 1992).
In every respect, NT3 stincture resembles that of NGF and BDNF. The 
primary translation product of NT3 contains a putative signal sequence of 18 
amino-acids followed by a pro-sequence of 121 amino-acids. Such pro­
sequences, presumably involved in the folding and correct formation of the 
disulphide bridges of these proteins, have also been found in mouse NGF (103 
amino-acids) and mouse BDNF (112 amino-acids). Almost 50% of the structure 
is conserved among the three proteins. All six cysteine residues, which in NGF 
and BDNF are involved in the formation of disulphide bridges, are among the 
conserved residues.
The sequences of the mammalian NT3 species characterised so far are 
entirely identical within the region encoding the matuie biologically active NT3 
protein (Maisonpierre etal, 1991). The chicken NT3 sequence contains only one 
amino acid change from its mammalian counterparts (Hallbook et al, 1993).
In the brain. Northern blotting analysis has shown that the highest NT3 
mRNA level is present in the cerebellum and hippocampus (Ernfors et al, 1990) 
and the overall distribution of NT3 mRNA is veiy different from that of NGF 
and BDNF in adult mouse tissues (Hohn et al, 1990). It can be detected in many 
adult tissues such as brain, heart, skin and muscle (Hohn et al, 1990; 
Maisonpierre et al, 1990; Rosenthal et al, 1990; Maisonpierre et al, 1990b) 
suggesting that it may act as a target derived factor for central and peripheral 
projections. NT3 mRNA has also been found in adult rat peripheral tissues such 
as kidney, secretory cells in the male rat submandibular gland and epithelial cells
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in the ovary (Ernfors et al, 1990). The expression of NT3 in the central and 
peripheral nervous system is described in more detail in Chapter 5
Unlike BDNF, NT3 does not have neurotrophic activity on central 
cholinergic or dopaminergic neurons (Johnson et al, 1986; Knusel et al, 1991; 
Hohn et al, 1990; Maisonpierre et al, 1990). However, it prevents the 
degeneration of noradrenergic neurons of the locus coeruleus in vivo (Arenas 
and Persson, 1994). In addition to promoting survival, NT3 induces neurite 
outgrowth from a subset of neural crest and placode-derived neurons. NT3 has 
also been shown to induce a mitogenic response in neural crest cells grown as 
homogeneous cultures. This effect is larger when migrating neural crest cells 
were grown together with some somite cells (Kalcheim et al, 1992). Using an 
anti-NT3 antibody in early stages of development Gaese et al (1994) have 
demonstiated that NT3 plays an essential role during gangliogenesis. Further 
evidence that NT3 prevents the death of proliferating sensory precursors cells 
during neurogenesis has been obtained from NT3 knockout animals (ElShamy 
and Ernfors, 1996, a, b). Excessive cell death in DRG and trigeminal neurons of 
NT3-/- mice occurs in a period that precedes the programmed cell death period 
and results in the reduction in the number of proliferating precursors (El Shamy 
and Ernfors, 1996a, b). It has also been shown that NT3 stimulates the 
differentiation of motoneurons from avian neural tube progenitor cells but has no 
significant effect on the survival of differentiated avian motoneurons (Averbuch- 
Heller et al, 1994).
The mutant mice for NT3 have severe movement defects of the limbs, 
and most died shortly after birth. Substantial portions of peripheral sensory and 
sympathetic neurons are lost while motor neurons are not affected. Spinal 
proprioceptive afferents and their peripheral sense organs (muscle spindles and
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Golgi tendon organs) are completely absent in homozygous mutant mice. The 
number of muscle spindles in heterozygous mutant mice is half of that in control 
mice, indicating that NT3 is present at limiting concentrations in the embryo. No 
gross abnormalities are seen in sensory receptors such as Pacinian corpuscles, 
cutaneous afferents containing substance P and calcitonin-related peptide, and 
deep nerve fibers in the joint capsule and tendon. These mutants demonstrated 
that NT3 is required for the development and survival of subpopulations of 
dorsal root ganglia, trigeminal and nodose ganglia neurons in vivo, as well as 
mesencephalic trigeminal nucleus neurons. These observations also confirm 
tissue culture studies which have shown that NT3 promotes the survival of 
neurons from these ganglia in vitro (Ernfors et al, 1990; Hohn et al, 1990; 
Maisonpierre et al, 1990; Rosenthal et al, 1990; Avila et al, 1993; Ibanez et al,
1993).
Neurotrophin 4/S
NT4 was originally isolated from Xenopus and viper after an evolutionary 
conservation study of members of the NGF family. The NT4 gene encodes a 
precursor protein of 236 amino acids which is processed into a 123 amino acid 
mature NT4 protein with 50 to 60% amino acid identity to NGF, BDNF and NT3 
(Hallbook et al, 1991; Berkemeier et al, 1991 and Ip et al, 1992).
Northern analysis of different tissues from Xenopus has shown that NT4 
mRNA is present only in the ovary. In situ hybridisation has detected NT4 
mRNA in the developing whisker follicles and skin of embryonic rats, regions 
where the other neurotrophins are also present although in different cellular
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locations (Ibanez e ta l, 1993). NT4 has been shown to stimulate neurite 
outgrowth in cultured peripheral sensory neurons (Ibanez et al, 1993).
Using degenerated oligonucleotides derived from conserved regions 
between NGF, BDNF and NT3, a novel NGF-related protein has been cloned 
from human placental DNA by PCR and named NT5 (Berkemeier et al, 1991). 
From the screening of a human genomic library a full length precursor human 
NT5 protein (hNT5) has been isolated that is 22.4 kDa and contains 210 amino 
acids. The mature hNT5 protein is basic (pi 10.3) and has 123 amino acids. 
Similar to other neurotrophins, the hNT5 open reading frame possesses a 
consensus sequence for N-glycosylation just upstream of a dibasic cleavage site 
that could generate the mature polypeptide. The overall homology of hNT5 with 
other neurotrophins is 6 6 % with Xenopus NT4, 55% with hNT3, 56% with 
hBDNF and 50% with hNGF. NT5 mRNA has been detected in rat embryos 
from embryonic day 12. In adult rats, NT5 mRNA is expressed in thymus, lung, 
ovary, brain, heart, stomach and kidney (Berkemeier et al, 1991). It has been 
demonstrated that NT5 is well conserved between species and that NT5 is the 
mammalian homologue of Xenopus NT4 (Ip et al, 1992). Therefore they are 
currently considered the same molecule and named NT4/5.
NT4/5 is as potent as BDNF in supporting the survival of early mice 
trigeminal and nodose ganglion neurons, but does not have any survival effect 
on chicken trigeminal mesencephalic or ventrolateral trigeminal ganglia neurons, 
which are BDNF dependent (Davies et al, 1993).
NT4 deficient mice are long-lived and show no obvious neurological 
defects. Nodose and petrosal sensory neurons are dramatically reduced in the
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absence of NT4 gene. Motor neurons aie not affected in the absence of NT4 
(Conover et al, 1995).
Neurotrophin 6
NT6  is the most recently isolated neurotrophin. It was cloned from a 
genomic library of the teleost platyfish Xiphophorus maculatus (Gotz et al,
1994). So far it has not been found as a soluble protein in the medium 
surrounding cells that synthesised it. Analysis of NT6  gene expression by 
Northern blotting has shown that a 1.4 kilobase transcript is expressed from 
organogenesis onwaids in the embryonic vavulla cerebelli (a rostral protrusion of 
the teleostean cerebellum under the midbrain tectum). Expression persists in 
some adult tissues, such as gill, liver and eye, with a wealc expression in skin, 
spleen, heart and skeletal muscle (Gotz et al, 1994).
Recombinant purified NT6  has a spectrum of actions similar to NGF on 
chick sympathetic and sensory neurons like dorsal root ganglia, although with 
lower specific activity than NGF. It had no survival effect on ciliaiy and nodose 
neurons. Therefore, the spectmm of responsive neurons seems similar to that of 
NGF (Gotz etal, 1994).
40
1.2.5, Neurotrophic Factor Receptors
Binding studies using iodinated NGF or BDNF have revealed two kinds 
of receptor for each factor: low affinity receptors that have a dissociation 
constant of lO'^M and high affinity receptors that have a dissociation constant of 
1 0 ' * (Sutter et al 1979; Rodriguez-Tebar and Barde, 1988). A cDNA encoding 
a transmembrane glycoprotein with a relative molecular mass of 75000 (gp75) 
that binds NGF with low affinity has been cloned (Johnson et al, 1986; Radeke et 
al, 1987). Competition binding studies and gene transfection experiments have 
shown that gp 75 NGF receptor also binds BDNF and NT3 with low affinity 
(Rodriguez-Tébar et al, 1990). In contrast, high-affinity neurotiophin receptors 
display high ligand specificity (Rodriguez-Tebar et al, 1990). The finding that 
the survival-promoting effects of NGF and BDNF are observed at concentrations 
that result in preferential occupancy of their respective high affinity receptors 
(Greene, 1977; Rodriguez-Tebar and Barde, 1988) suggested that these receptors 
mediate the response of neurons to neurotrophic factors. The functional high 
affinity receptors for the NGF family of neurotrophins have been identified as the 
members of the trk family of tyrosine protein kinases (for review, Barb acid,
1993). The trk gene was first identified as an oncogene in a human colon 
carcinoma biopsy (Coulier et al, 1990). The oncogenic activity of trk resulted 
from a genomic rearrangement event in which non-muscle tropomyosin 
sequences were aberrantly fused onto the transmembrane and cytoplasmic 
domains of trk (hence the name "tropomyosin receptor kinase").
The demonstration that neurotrophic factors promote rapid 
autophosphoiylation of trk tyrosine kinases (Kaplan et al, 1991; Klein et al, 1991 
and Soppet et al, 1991) and elicit a response from oocytes and cell lines 
transfected with trk cDNAs (Nebreda et al, 1991; Loeb et al, 1991; Cordon
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Cardo et al, 1991; Squinto et al, 1991; Glass et al, 1991 and Lambaile et al, 
1991) shows that these tyrosine kinase receptors play a role in neurotrophic 
factor signal transduction. Three members of the trk family of receptor tyrosine 
kinase have been identified in vertebrates: TrlcA, TrkB and TrkC (for review see 
Lambaile et a/,1991). Expression studies in PC12 cells and fibroblast cell lines 
have shown that TrkA is a functional receptor for NGF (Klein et al, 1991a), 
TrkB is a functional receptor for BDNF and NT4/5 (Klein et al, 1991b), and 
TrkC is a functional receptor for NT3(Lamballe et a/,1991) (Fig. 1.1). All three 
of the Trk receptors aie expressed at highest levels in the nervous system (Klein 
6 /a/,1989; Martin-Zanca etal, 1990; Lambaile etal, 1991).
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Figure 1.1. Trk receptors and their ligands. The thick arrows denote the preferred 
ligand. The non-preferred interactions are indicated by the thin arrows.
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Low Affinity NGF Receptor (gp75)
There is still much controversy regarding the role that gp75 plays in 
mediating the neurotrophins effects. The introduction of a recombinant 
retrovirus containing gp75 cDNA in NGF receptor deficient PC 12 cells restores 
both high and low affinity NGF binding (Hempstead et al, 1989). This suggests 
that the common low affinity neurotrophic factor receptor is a component of the 
high affinity receptor (Hempstead et al 1991). In addition, transfection assays 
with different amounts of gp75 have shown that it enhances the affinity of NGF 
binding to TrlcA (Benedetti, 1993). However, other studies have shown that 
TrkA alone can directly bind and mediate responses to neurotrophins in the 
absence of gp75 (Cordon Cardo et al, 1991; Klein et al, 1991; Chao, 1991 for 
review).
gp75 is a single peptide chain of approximately 400 amino acid residues, 
with a single membrane spanning domain separating a longer extracellular 
domain from a shorter cytoplasmic domain. gp75 binds to all the known 
members of the neurotrophin family (reviewed in Davies, 1994). This has led to 
the hypothesis that gp75 serves as a common subunit for different neurotrophin 
receptors, the specificity of a receptor for a given ligand being conferred by the 
second component of the receptor complex (Bothwell, 1991; Thoenen, 1991). 
However, although all neurotrophins bind to gp75 with similar affinity, their 
dissociation rates are markedly different, with NGF and NT3 being the fastest 
and slowest, respectively (Rodriguez-Tebar et al, 1992). This difference raises 
the possibility that gp75 may play a role in discriminating among neurotrophins, 
thereby tuning the specificity of neurotrophin binding.
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gp75 is also expressed during development in a number of tissues not 
known to respond to NGF or other neurotrophins, including sldn mesenchyme, 
somites and muscle anlage, testis and kidney (Persson et al, 1990; Heuer et al, 
1990; Wyatt et al, 1990; Sariola et al, 1991). This widespread expression has 
raised the possibility that the receptor has a more general role in embryonic 
development (Bothwell, 1995 for review).
Dorsal root sensory and neonatal sympathetic neurons from mice carrying 
a null mutation in the gp75 locus have a decreased sensitivity to NGF during the 
period of naturally occumng cell death suggesting that gp75 does play a role in 
mediating neurotrophin function in some NGF dependent neurons (Lee et al,
1994).
TrkA
The TrkA proto-oncogene encodes two tyrosine protein kinase isofonns 
of 790 or 796 aminoacid residues. These isoforms, designated as TrkA, or 
gpMQT'^ ):^ , are transmembrane glycoproteins of 140 kDa (Martin Zanca et al, 
1989; Meakin et al, 1992; Barker et al, 1993; Horigome et al, 1993). Both 
isoforms have the canonical structure of tyrosine protein kinase cell surface 
receptors including; a signal peptide, an extracellular domain responsible for the 
interaction with NGF, a single transmembrane domain and a cytoplasmic 
catalytic domain. The two isoforms differ in the presence of six amino acid 
residues (VSFSPV) located in the extracellulai' domain near the transmembrane 
region. Whereas the 796 amino acid TrkA molecule is primarily expressed in 
neuronal cells, the 790 amino acid isoform has been found in cells of non­
neuronal origin (Barker et al, 1993; Horigome et al, 1993). Although no
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comparative studies have been carried out so fai', it appears that both isoforms 
have similar biological properties ( Klein et al, 1991b; Jing et al, 1992; Meakin 
etal, 1992).
The extracellular domain of the TrkA receptor exhibits two distinct 
subsets of cell adhesion-related motifs (Schneider and Schweiger, 1991). The 
amino-terminal moiety consists of an array of three tandem leucine-rich motifs 
(LRM) of 24 amino acids, flanked by two distinct cysteine clusters (CCI and 
CCII). This LRM motif has been found in a diverse superfamily of proteins 
thought to be involved in specific protein-protein interactions, such as the human 
platelet von Willebrand factor receptor and several cell adhesion proteins and 
extracellular matrix components. Next to the second cysteine cluster there are 
two imunoglobulin-like domains (Igl and Igll) of the C2 type similar to those 
found in the neural cell adhesion molecules N-CAM and in other tyrosine Idnase 
receptors such as the PDGF and FGF receptor subfamilies (Schneider and 
Shweiger, 1991). Deletion of 51 amino acid residues encompassing the carboxy- 
terminal half of the Igll motif (residues 322-372) or replacement of the single 
Cys^ "*^  residue in this sequence by Ser results in the constitutive activation of the 
TrkA receptor (Coulier et al, 1990).
The TrkA cytoplasmic domain has a set of structural features unique to 
this subfamily of receptors (Martin-Zanca et al, 1989; Klein et al 1989; Lambaile 
et al, 1991). They include; a Thr residue (position 647) instead of the conserved 
Ala in the highly conserved HRDLAARN kinase motif, a Trp residue (position 
722) instead of Tyr in the WEXyPY sequence and the replacement of the 
conserved Pro in the CWXgRP sequence located at the carboxy terminal end of 
the kinase domain.
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A common characteristic of the tyrosine kinase receptors for the 
neurotrophins of the NGF family is a very short carboxy-terminal tail of 15 
amino-acids which includes a conserved Tyr residue (Martin Zanca et al, 1989). 
Outside of this receptor subfamily, the TrkA cytoplasmic region is most closely 
related to that of several new receptors called orphan receptors. However, these 
receptors have rather distinct extracellular domains and aie likely to recognise 
ligands unrelated to the NGF neurotrophin family. The deletion of the 15 C- 
terminal amino-acids, including tyrosine 785 (Y-785), abrogates receptor and 
substrate phosphorylation activities (Obermeier etal, 1993). Therefore, the short 
C-terminal tail seems to be a crucial structural element of the TrkA cytoplasmic 
domain.
The identification of gpl40 TrkA as an NGF receptor was made after it 
was noted that its distribution was restricted to targets of NGF action in neural 
crest derived sensory neurons (Martin Zanca et al, 1989). It was later proved to 
be a receptor whose tyrosine kinase activity and autophosphorylation is 
stimulated by the binding of NGF (Kaplan et al, 1991b). Tyrosine 
phosphorylation of TrkA by NGF is rapid, specific and occurs with picomolar 
quantities of factor, indicating that the response is mediated by physiological 
amounts of NGF (Kaplan et al, 1991b).
In addition to the highly effective receptor-ligand interactions previously 
mentioned, there is evidence for indiscriminate receptor action. Expression 
studies in fibroblasts have shown that NT-3 is able to elicit a response via TrkA 
and TrkB, although it is much less potent than the preferred ligands of these 
receptors (Klein et a/,1991; Soppet et al, 1991;Squinto et al, 1991), and NT-4/5 
can elicit a response via TrkA in fibroblasts, although it is less potent than NGF 
acting at this receptor (Berkemeier et al, 1991). In neurons, however, there is
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some indirect evidence that the neurotrophin receptors have a higher degree of 
ligand specificity (Ip et al, 1993). The neurotrophin specificities of Tries are 
illustrated in Figure 1.1.
Detection of TrkA mRNA expression in sympathetic ganglia 
(Schecterson and Bothwell, 1992) and basal forebrain cholinergic neurons 
(Holtzman et al, 1992) has confirmed that TrkA expression is directly associated 
with classic targets of NGF. For example, cholinergic neurons of the basal 
forebrain and of the caudate-putamen are sensitive to NGF. Holtzman and 
collaborators (1992) have shown that TrkA mRNA expression is highly restricted 
in its distribution in the adult rat forebrain, that it is present in cholinergic 
neurons and that NGF up-regulates its receptor expression.
A null mutation in the TrkA gene results in mice with a phenotype very 
similar to that seen after developmental treatment with an activity-blocking NGF 
antibodies (Smeyne et al, 1994). Newborn animals are insensitive to pain and 
temperature stimuli and few animals survive for more than a month after birth. 
Ten days after birth, extensive neuronal cell loss was found in trigeminal and 
dorsal root ganglia. Presumably cells lost were those responsible for detecting 
pain and temperature (Smeyne et al, 1994). In addition, sympathetic neurons of 
the peripheral nervous system are virtually absent. In contrast TrkA and hence 
NGF, does not appear to be required for the survival of basal forebrain 
cholinergic neurons, although the rate-limiting enzyme for neurotransmitter 
production, choline acetyltransferase, is reduced in the absence of functional 
TrkA. This is especially interesting as these neurons normally express TrlcA and 
their tai'get fields express NGF during development (Lu et al, 1989). In addition, 
exogenous NGF can prevent the death of many of these cells following injury in 
the adult (Martinez et al, 1985). Curiously, a decrease in choline
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acetyltransferase staining is not observed in cholinergic cells of the striatum that 
normally also expresses TrkA (Mobley et al, 1986).
TrkB
TrkB was initially cloned from an adult mouse brain cDNA library using 
low stringency screening with a TrkA probe (Klein et al, 1989). Alignment of the 
deduced amino acid sequence of the mouse TrkB gene product with that of 
human TrlcA reveals an overall homology of 69%, a 57% homology in their 
extracellular regions and a 88% homology within their respective tyrosine kinase 
domains (Klein et al, 1989; Martin-Zanca et a/, 1989).
The TrkB locus exhibits a complex transcriptional pattern generating at 
least eight different transcripts ranging in size from 0.7 to 9 kb. The existence of 
transcripts that aie too small to encode the full length TrkB product led to the 
search for additional protein products and the isolation of novel cDNAs encoding 
two truncated receptors in rats (Middlemas et a/, 1991) and one tmncated receptor 
in mice (Klein et a/,1990). The full length receptor is called gpHS’^ ’^^  
(glycoprotein of 145 KDa) and is refened to as TrkBTK-f. The gpl45'TrkB is a 
heavily glycosylated molecule of 821 amino acid residues that contains all the 
canonical motifs of tyrosine kinase receptors. In the extracellular domain most 
of the residues that are homologous to TrlcA are located within the second and 
third leucine rich motifs and particularly within the second Ig-like domain 
(Schneider and Schweiger, 1991). The second class of TrkB receptors are 
referred to as TrkBTK- and have the same extracellular and transmembrane 
domain as TrkBTK+,. However, they have a very short cytoplasmic domain and 
lack the entire kinase catalytic region (Klein et al, 1990; Middlemas et al, 1991).
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So far, two isoforms of non-catalytic TrkBTK- receptor isoforms have been 
identified. gpPS^ r^ B or TrlcB.Tl has been isolated from mouse and rat cDNA 
libraries and has been shown to be expressed in adult mouse brain at levels 
comparable to those of the signalling TrkBTK+ receptor (Klein et al, 1990). The 
cytoplasmic sequences of TrkB .T1 or gp95'^ ''‘^  consist of 23 amino acid residues 
of which the last 11 are unrelated to the other known sequences (Klein et al,
1990). The second non-catalytic TrkBTK- receptor, TrlcB.T2, has a 21 amino 
acid-long cytoplasmic domain, of which the last 9 residues are unrelated to those 
present in TrlcB .Tl/gp9 5 TrkB (Middlemas et al, 1991). All the different receptor 
forms appear to be the products of the same gene locus and are derived by 
alternative mRNA splicing. Different variants which contain deletions in the 
extracellular domain of the TrkB receptor have been recently discovered 
(Ninldna et al, submitted).
Binding studies have shown that TrkB is the preferred receptor for BDNF 
and NT4/5 (Berkemeier, 1991; Ip er al, 1992) although NT3 also binds to TrkB 
(Soppet et al, 1991).
Northern blotting analysis in adult mouse tissues has shown that TrkB 
transcripts are most abundant in brain and the transcripts of 9.0 and 5.5 kb are 
specific for the brain. Other smaller transcripts have been found in lung, heart, 
kidney and muscle, albeit at lower levels (Klein et al, 1989). In situ 
hybridisation analysis of 14 and 18 day old embryos indicates that TrkB 
transcripts are localised in the central and peripheral nervous system including; 
brain, spinal cord, spinal and cranial ganglia, paravertebral trunk of the 
sympathetic nervous system and various innervation pathways (Klein 'et al, 
1989X
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The phenotypic characteristics of TrkB knockout mice include a 
significant decrease in the number of both cranial and spinal sensory neurons, as 
well as a loss of some cranial and spinal motoneurons (Klein et al, 1993). These 
animals die soon after birth. Comparisons of the TrkB knockouts with mice 
lacking either BDNF or NT4 supports the hypothesis that there are at least two 
endogenous ligands for the TrkB receptor. The reduction in trigeminal sensory 
neurons in BDNF knockouts (44% fewer than in wild type animals), is much less 
than that resulting from a null mutation of the TrkB receptor (60% fewer than 
wild type). More remarkable is the observation that the significant loss of 
motoneurons observed in the TrkB knockouts does not occur in either the BDNF 
(Emfors et al, 1994) or NT4 knockouts (Conover et al, 1995). In addition, the 
survival of many motoneurons in the TrlcB knockout mice suggests the 
involvement of still other trophic agents, that can compensate for the loss of 
signalling through TrkB (for review, see Snider, 1994).
TrkC
TrkC was initially cloned from a porcine brain cDNA library screened 
with a probe derived from the human TrkA proto-oncogene (Lamballe et al,
1991). The TrkC protein has 67% homology with human TrkA and 68% 
homology with mouse TrkB and has a molecular weight of 145 KDa. The 
extracellular domains of TrkA and TrkC are 54% homologous and the 
extracellular domains of TrkC and TrkB are 53% homologous. The catalytic 
domain is 87% homologous to that of human TrkA kinase and 88% homologous 
to that of mouse TrkB kinase. The catalytic kinase regions of TrkC exhibit the 
characteristic features of TrkA and TrkB tyrosine kinases (Klein et al, 1989;
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Martin-Zanca et al, 1989). In addition, TrkC possess the short carboxyl-terminal 
tail characteristic of TrkA and TrlcB (Barbacid etal, 1991).
Tyrosine phosphorylation, cross linking, and ligand binding assays 
indicate that TrkC receptors interact with NT3 and not with the related 
neurotrophins NGF, BDNF, NT4 or NT5 (Tsoulfas et al, 1993).
Screening an adult rat cDNA library has allowed novel forms of TrkC 
containing kinase inserts to be cloned (Valenzuela et al, 1993). The kinase 
inserts, either 14 amino acids or 39 amino acids, are located at the same position 
within the tyrosine kinase domain, between subdomains VII and VIII. The 14 
amino acid insert is included within the 39 amino acid insert. Tsoulfas et al 
(1993) also report the cloning of four different forms of rat TrkC; a full length 
one, two different isoforms with either a 14 or 25 amino acid insertion in the 
tyrosine kinase domain and a truncated receptor that lacks the cytoplasmic 
catalytic domain.
In transfected NIH3T3 fibroblast, both the full length TrkC isoform and 
the isoform containing the 14 amino acids insertion are phosphorylated on 
tyrosine residues upon binding NT3, but not BDNF or NGF. The time course of 
phosphorylation and the NT3 dose response are similar for both isoforms. 
Chemical cross-linking experiments show that the full length form of TrkC and 
the isoform with the 14 amino acids insertion both bind NT3 at physiologically 
relevant concentrations, but respond differently to NT3 when transfected into 
PC 12 cells. The 14 aminoacid insertion renders the TrkC receptor inactive in 
neurite outgrowth in PC 12 cells even though NT3 can stimulate tyrosine 
phosphorylation in these cells (Tsoulfas et al, 1993). The 39 amino acid form is 
also unable to transduce a signal leading to neurite outgrowth in PC 12 cells
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(Valenzuela, 1993). The binding of NT3 to full length TrkC results in 
proliferation of transfected NIH3T3 fibroblasts. However, neither the 14 or 39 
amino acids kinase insert forms of TrkC can mediate fibroblast proliferation in 
response to NT3 (Valenzuela etal, 1993; Tsoulfas et al, 1993).
Different isoforms of TrkC have also been found in mouse. Isoforms exist 
that contain insertions, of either 14 or 25 amino acid residues, in a similar 
position to those in rat TrkC (Lamballe et al, 1993). All three forms become 
rapidly phosphorylated on tyrosine residues upon interaction with the cognate 
ligand NT3, but, in the same way as rat TrkC, only the full length isoform 
without any insertion is able to induce neuronal differentiation in PC 12 cells and 
has mitogenic activity in NIH3T3 cells. These TrkC isoforms may act through 
different signalling pathways (Lamballe etal, 1993).
A full length and a truncated form of chicken TrkC, lacking the tyrosine 
kinase domain, have also been isolated by screening a cDNA library with a 
cDNA probe corresponding to the tyrosine kinase domain of porcine TrkC 
(Okazawa et al, 1993). More recently, Gamer and Large (1994) have isolated 
nine different isoforms of chicken TrkC generated by alternative splicing. They 
have identified TrkC receptors with two different extracellular and four different 
cytoplasmic domains. The different cytoplasmic domains are; a full length 
tyrosine kinase motif (PL), a kinase truncation (KT), kinase deletion (KD) and 
kinase insertion (KI) motif. Like the rat homologue, the avian KD motif replaces 
the kinase domain of the FL receptor with 39 amino acids, 36 of which are 
conserved between chicken and rat. In contrast with deletion of the entire kinase 
domain, a single clone exhibited a KT motif in conjunction with a full length 
extracellular motif. In contrast with the alternative splicing that deletes regions of 
the kinase domain, a KI motif adds 25 aminoacid after the double tyrosine
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residues (711 and 712) that have been shown to be important regulators of TrkA 
function (Mitra et al, 1991). Only 13 of these aminoacid residues are identical to 
the 25 amino acid insertion identified in rat (Tsoulfas et al, 1993) and mouse 
TrkC (Lamballe etal, 1993).
TrkC is widely expressed in the embryonic and adult central and 
peripheral nervous system (Lamballe et al, 1991; 1993; Ernfors et al, 1992; 
Merlio et al, 1992). TrkC is also expressed in certain ganglia of the autonomic 
enteric nervous system (Lamballe et al, 1993). During embryonic development, 
TrkC expression correlates, both temporally and spatially, with the outgrowth of 
axons towards their peripheral targets. In the adult mouse, TrkC mRNA is 
heterogeneously distributed throughout the brain, with highest levels of 
expression in limbic and diencephalic structures. TrkC mRNA is also expressed 
in certain non-neuronal tissues such as the mesenchymal cells of arterial walls, 
the multilocular adipose tissue and the acini of the submaxillary gland (Lamballe 
et al, 1993) In situ hybridisation studies have revealed TrkC transcripts in the 
hippocampus, cerebral cortex and the granular layer of the cerebellum of 
developing rats (Lamballe et al, 1991). TrkC mRNA is highly expressed in the 
embryonic neural tube in early stages of development (E2) and has its expression 
in the spinal cord restricted in later stages of development (E4-E5) (Averbuch- 
Hellerera/, 1994).
Almost all neural tissues express transcripts encoding for both full-length 
and truncated TrkC forms. The retina is the only neural region that expresses 
relatively high levels of transcripts encoding for the full length forms as 
compared with the truncated forms. The sciatic nerve is unique among neural 
tissues in that it only expresses transcripts encoding the truncated forms of TrkC. 
In this same study Valenzuela and colleagues (1993) reported that isolated
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neuronal cells from hippocampus express transcripts encoding both full length 
and truncated forms of TrkC, whereas astrocytes purified from the same region 
express transcripts only for the truncated forms of TrkC .The two different mouse 
TrkC isoforms (insertion of 14 or 25 amino acids) have been identified in various 
structures of the adult murine brain. This suggests that the trophic activities of 
NT3 might be mediated by different TrkC receptor isoforms (Lamballe, 1993).
When the chicken full length and the kinase insert isoforms of TrkC are 
transfected into PC 12 cells, they are able to stimulate process outgrowth in 
response to NT3 . However, unlike the full length TrkC isoform, the isoform 
with the 25 amino acid insertion is unable to support the survival of these cells 
after 4-5 days in culture.
A TrkC null mutation results in very specific sensory losses and death of 
the mice within several weeks after birth (Klein et al, 1994). Newborn animals 
exhibit proprioceptive (awareness of limb position) disorders and a significant 
reduction in spinal sensory cells innervating muscle spindles afferents, but no 
loss of motoneurons. These animals lack la muscle afferent projections to spinal 
motor neurons and have fewer large myelinated axons in the dorsal root and 
posterior columns of the spinal cord. This defect may be the cause of the 
behavioural deficits found in these homozygous mice. TrkC null mutants appear 
normal at birth but by postnatal day 4 they are reduced in size and most of them 
die by postnatal day 21 (Klein et al, 1994). In accordance with the observed 
deficits in proprioception, they have 19% neuronal loss in dorsal root ganglia that 
corresponds to the subpopulation of dorsal root ganglia known to express TrkC 
transcripts (Carrol etal, 1992; Mu etal, 1993).
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1,2.6, Other Neurotrophic Factors
Several proteins that are not structurally related to the neurotrophins are 
also able to support the survival of particular kinds of neurons in vitro. These 
include ciliary neurotrophic factor (CNTF) (Sendtner et al, 1994), basic 
fibroblast growth factor (bFGF) (Eckenstein, 1994), leukaemia inhibitory factor 
(LIF) (Murphy et al, 1993) and glial cell line derived neurotrophic factor 
(GDNF) (Lin etal, 1993).
CNTF, GPA, IL-6, FGF, LIF
CNTF was initially identified based on its ability to sustain the survival of 
embryonic chicken ciliary neurons (Adler et al, 1979; Manthorpe et al, 1985; 
Manthorpe and Varon, 1985; Barbin et al, 1984; Manthorpe et al, 1986, Lin et al, 
1989; Stockli et al, 1989). CNTF is an acidic protein with an estimated 
molecular mass of 20-24 kDa that acts as a survival factor for certain neurons 
like chicken sympathetic and sensory neurons at ElO (but not at E8) (Manthorpe 
et al, 1986). A physiological role for CNTF in maintaining the function of 
normal adult motor neurons is supported by recent observations of motor-neuron 
degeneration in mice where the expression of the CNTF gene was abolished by 
homologous recombination (Masu et al, 1993).
The receptor for CNTF seems to be a heterotrimer of one membrane- 
linked ligand-binding subunit and two transmembranous signal transducing 
subunits (Davis et al, 1991; Ip et al, 1992). Ciliary neurotrophic factor (CNTF), 
leukaemia inhibitory factor (LIF) and interleukin-6 (IL-6) compose a family of 
distantly related cytokines (Bazan, 1991; Rose and Bruce 1991) that initiate 
signalling by inducing either homodimerization of the 6 signal transducing
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receptor component gpl30 (in the case of IL6) or heterodimerization between 
gpl30 and the gpl30-related LIFR13 (in the case of CNTF, LIF and OSM) 
(Murakami et al, 1993; Davis and Yancopoulos, 1993). CNTF also requires a 
third receptor component (CNTFR alpha) that is mostly restricted to the neiwous 
system in its expression. In fact, CNTFR alpha is a required receptor component 
that uniquely characterises CNTF-responding cells (Ip et al, 1993)
An additional member of this cytokine group has been isolated. This 20 
kDa protein, termed GPA (growth promoting activity) is 50% homologous to 
mammalian CNTF and has similar biological activities (Leung et al, 1992).
Leukaemia inhibitory factor (LIF) is a pleiotropic molecule with a 
multitude of effects on neurons and non-neuronal cells. It can produce blockage 
or enhancement of differentiation or proliferation, depending on the responsive 
cell population (Smith et al, 1992). In addition to promoting sensory neuron 
survival, there is some evidence that LIF is able to influence neurotransmitter and 
neuropeptide expression in these neurons (Murphy et al, 1994).
Another important growth factor is fibroblast growth factor (FGF) which 
can promote axonal regeneration. FGFs have been characterised by vir tue of their 
mitogenic activities for a variety of cell types of mesodermal and ectodermal 
origin (Rifkin and Moscatelli, 1989; Vlodavsky etal, 1991). Basic FGF (bFGF) 
enhances differentiation of sympathoadrenal precursor cells and PCI2 cells (Ip et 
al, 1994) and is a potent mitogen for certain CNS populations (Gensburger et al, 
1987; Cattaneo and McKay, 1990; Ray et al, 1993; Ray and Gage, 1994; 
Kilpatrick and Bartlet, 1993). Four high-affinity receptors for the FGF family 
have been cloned, forming a family of transmembrane proteins with ligand-
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activated tyrosine kinase activity (Klagsbrun and Baird, 1991; Yarden and 
Kelman, 1991).
GDNF, TGFB
Glial cell line derived neurotrophic factor (GDNF) is a newly discovered 
distantly related member of the transforming growth factor B superfamily. It 
exhibits neurotrophic effects on midbrain dopaminergic neurons both in vivo and 
in vitro. GDNF was originally isolated from the B49 glial cell line (Lin et al 
1993). It was found to be expressed in the developing limb bud, suggesting that it 
has a target- derived role in motor neuron development (Henderson et al., 1994; 
Oppenheim et al.,1995; Yan et al., 1994). It also protects midbrain dopaminergic 
neurons from MPTP toxicity (Tomac et a l, 1994) and axotomy-induced 
degeneration (Beck et al., 1995). It has also been demonstrated that GDNF is 
able to support in vitro suiwival of sympathetic, parasympathetic, proprioceptive, 
enteroceptive and cutaneous sensory neurons of chicken embryos at different 
stages of their development (Buj-Bello et a l, 1995).
Transforming growth factor 6 (TGFB) is the prototype of a family of 
polypeptide growth factors which were originally isolated and purified from 
several transformed cell lines as well as non-neoplastic tissues. TGFB is a 25 kD 
homodimer with multiple activities including roles in embryogenesis and in 
wound-healing responses (reviewed by Roberts and Sporn, 1990). TGFB has 
been shown to have a neurotrophic effect on sensory neurons in vitro and to be 
synergistic with NGF (Chalazonitis et al, 1992). A balanced interaction between 
neuronal and accessory cells during repair might be maintained via TGF-6, since
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this cytokine promotes Schwann-cell growth and activity (Perry and Brown,
1992).
OBJECTIVES OF THIS STUDY
I) To investigate the responsiveness of various chicken sensory neurons (placode 
and neural-crest derived) to neurotrophins during embryonic development in 
vitro
n) To analyse cell death in developmental mouse trigeminal neurons in wild type 
embryos and in embryos that are homozygous for null mutations in the TrkA, 
TrkB and TrkC genes.
in) To study neurotrophin discrimination among chicken sensory neurons in 
vitro
IV) To study the mRNA expression and regulation of the full length high 
affinity receptor for NT3 (TrkC) in chicken sensory and sympathetic neurons 
during development both in vivo and in vitro
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Chapter 2
THE SURVIVAL OF CHICK NEURAL CREST DERIVED BUT NOT 
PLACODE DERIVED NEURONS IS PROMOTED BY SEVERAL 
DIFFERENT NEUROTROPHINS EARLY IN THEIR DEVELOPMENT.
2.1. INTRODUCTION
As mentioned in the previous chapter, the peripheral nervous system is 
derived from precursors in the neural crest and placodes. After precursor cell 
migration and aggregation to form primitive ganglia, a defined number of 
neurons is generated by proliferation and differentiation of these precursors. With 
the exception of factors controlling neuronal death, most of the signals involved 
in the interactions between developing precursors cells and their surrounding 
environment are still unknown (Snider, 1994). The differentiated neurons extend 
processes to their targets fields which are known to produce limited amounts of 
trophic factors. Only a proportion of the neurons are able to obtain enough of 
these factors to survive (Davies et al, 1994a)
A family of homologous proteins termed neurotrophins, which have been 
already described and characterised in Chapter 1, are well recognised for 
promoting the survival of neurons in the developing vertebrate nervous system. 
The available evidence suggests that each neurotrophin promotes the survival of 
a particular set of developing neurons. For example, whereas NGF supports
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sympathetic neurons (Greene, 1977), neural crest-derived cutaneous sensory 
neurons (Davies and Lindsay, 1985) and basal forebrain cholinergic neurons 
(Hatanaka et al , 1988), BDNF supports proprioceptive, enteroceptive and 
placode-derived cutaneous sensory neurons (Davies et al., 1986a, 1986b) and the 
dopaminergic neurons of the substantia nigra (Hyman et al., 1991). NT3 
promotes the survival of proprioceptive neurons (Hohn et al, 1990).
Cranial sensory neurons have been especially useful for studying the 
specificity and time-course of the survival-promoting effects of neurotrophins 
(Davies, 1987). These neurons can be obtained for experimental studies from the 
earliest stages of their development. In contrast to the functional heterogeneity of 
the sensory neurons of DRG, cranial sensory neurons are segregated into 
functionally distinct populations. Perhaps as a consequence of this functional 
segregation, different populations of cranial sensoiy neurons have distinct 
neurotrophin requirements when cultured during the period of naturally occurring 
cell death. For example, the small-diameter cutaneous sensoiy neurons of the 
jugular ganglion and the dorsomedial part of the trigeminal ganglion (DMTG) 
are neural crest derived and aie supported by NGF (Davies and Lumsden, 1983; 
Davies and Lindsay, 1985) but show little response to BDNF (Davies et al., 
1986b) or NT-3 (Hohn et al., 1990). The large-diameter cutaneous sensory 
neurons of the ventrolateral part of the trigeminal ganglion (VLTG) are placode 
derived and are supported by BDNF (Davies et al., 1986b) but show little 
response to NGF (Davies and Lumsden, 1983) or NT-3 (Hohn et al., 1990). The 
proprioceptive neurons of the trigeminal mesencephalic nucleus (TMN) are 
neural crest derived and are supported by BDNF or NT-3 (Davies et al., 1986a; 
Hohn et al., 1990) but are unresponsive to NGF (Davies et al., 1987). The 
enteroceptive neurons of the nodose ganglion are placode derived and contain a 
major subpopulation of BDNF-dependent neurons and a minor subpopulation of
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NT-3-dependent neurons (Lindsay et al., 1985; Davies et al., 1986b; Hohn et 
al., 1990) but are unresponsive to NGF (Lindsay and Rohier, 1985).
Developmental studies have shown that cranial sensory neurons suiwive 
independently of neurotrophins when their axons are growing to their tai'gets and 
acquire neurotrophin dependence close to the time when their axons reach their 
targets (Davies and Lumsden, 1984; Vogel and Davies, 1991). In the embryonic 
mouse trigeminal system, where NGF responsive neurons innervate the facial 
region (Davies and Lumsden, 1984), the onset of NGF production and NGF 
receptor expression (gp75, Wyatt et al, 1990 and TrkA, Wyatt and Davies, 1993) 
both appealed to be related to the arrival of sensory axons in the target field 
(Davies, 1987 a). Trigeminal neurons do not express detectable levels of NGF 
receptors and are not dependent on NGF for survival when peripheral axons are 
growing to their targets.
However, in a recent in vitro study of the survival-promoting effects of 
different neurotrophins on embryonic mouse trigeminal neurons, a survival 
response to BDNF and NT-3 switches to responsiveness to NGF during the early 
stages of target field innervation (Buchman and Davies, 1993). When trigeminal 
axons come into proximity with their peripheral targets, the neurons become 
responsive to BDNF and NT-3. Shortly afterwards, the neurons become 
additionally responsive to NGF. With the onset of cell death in the trigeminal 
ganglion, the neurons become refractory to BDNF and NT-3 but remain 
dependent on NGF for survival throughout the phase of naturally occurring cell 
death (Buchman and Davies, 1993). The present study was undertaken to 
ascertain if responsiveness to multiple neurotrophins is a universal feature of the 
early stages of neuronal development and to provide information on how early 
neurons selectively lose responsiveness to certain neurotrophins by studying the
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survival requirements of several different populations of chicken cranial sensory 
neurons at stages throughout their early development in vitro.
2.2. MATERIALS AND METHODS 
Chicken Cranial Sensory Neurons
To obtain chicken embryos, fertile White Legorn chicken eggs were 
incubated in a forced-draft, humidified incubator at 38^0 for the required time. 
To remove embiyos from eggs, the egg was held with blunt end uppermost 
(where the airspace is located). This was swabbed with 70% alcohol and allowed 
to dry. The shell was cracked in a line around the airspace by tapping it with 
forceps after which this portion of the shell and the membrane lining the airspace 
was removed. The embryo together with its adherent membranes was removed 
with a pair of curved forceps.
The embryos were then washed in a Petri dish containing L15 medium 
and all membranes were removed with pairs of watchmaker's forceps. The 
embryos were transferred to a 60 mm Petri dish containing L15 medium. To 
facilitate visualisation of early ganglia within the partially dissected embryonic 
head the dissection was carried out on a black background with illumination from 
above. The contrast was further improved by placing a small volume of liquid 
between the Petri dish and the underlying black background. All dissections and 
preparation of neuronal cultures were carried out in the laminar flow hood using
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standard sterile procedures. For the final stages of dissection a stereo microscope 
with zoom lens was used. Using electrolytically sharpened tungsten needles, two 
transverse cuts were performed to isolate the pait of the developing head that 
contains the trigeminal, geniculate, vestibular, petrosal and jugular ganglia 
(Fig.2.1). The trigeminal, jugular and nodose ganglia were dissected from 
chicken embryos of, 5, 6, 8, 10 and 12 days incubation: stages 24, 29, 34, 36 and 
38, respectively (Hamburger and Hamilton, 1951). The trigeminal ganglion was 
sub-dissected (Davies and Lumsden, 1983) into its neural crest-derived 
dorsomedial pole (DMTG) and placode-derived ventrolateral pole (VLTG) (Fig 
2.2) (Davies, 1986). The placode-derived nodose ganglia were dissected from 
the neck by teasing the tissue apart with two fine forceps where the nodose 
ganglia were identified by the attached vagus nerve (Fig. 2.3).
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E10 Chick Embryo: Lateral Aspect
TMN
VA
[From Davies and Lindsay, 1985]
Figure 2.1. Schematic illustration of an ElO chick embryo showing the locations of populations 
of cranial sensory neurons. TMN; trigeminal mesencephalic nucleus; T: trigeminal ganglion; J: 
jugular ganglion; N: nodose ganglion; VA: vestibular acoustic ganglion; G: geniculate ganglion; 
P: petrosal ganglion.
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Figure 2.2. Subdissection of the trigeminal ganglion to obtain dorsomedial and ventrolateral 
neurons. The ophthalmic lobe (OL) is separated from the maxillomandibular lobe (MML) and 
then the dorsomedial (DM) and ventrolateral (VL) parts are subdissected (From Davies, 1988)
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Figure 2*3. Ventral aspect of the thoracic region of an E l0 chicken embryo after removal of the 
skin and exposure of the heart and great vessels. The connective tissue lying either side of the 
great vessels contains the two nodose ganglia (N) attached to the vagus nerve (Shown by 
interrupted lines (From Davies, 1995).
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ACulture Procedure
a) Dissociation of the tissue
The dissected ganglia were incubated in 0.1% trypsin (Worthington) in 
Ca2+- Mg2+ free Hanks balanced salt solution (HBSS) for 10 min for E5 and E6 
ganglia, 12 min for ElO ganglia and 20 min for E12 ganglia. After the 
trypsinization, most of the trypsin solution was removed with a Pasteur pipette 
and the remaining trypsin was blocked by addition of Ham's F 12 medium 
containing 10% heat-inactivated horse serum (HIHS). The tissue was 
mechanically dissociated by gentle trituration in a fked-polished Pasteur pipette.
b) Separation of neurons from non-neuronal cells
The neurones were separated from the non neuronal cells by differential 
sedimentation. This technique depends on differences in sedimentation rates of 
cells in liquid medium, larger cells sedimenting faster than smaller cells. Thus, 
neurones sediment more quickly than non-neuronal cells. This technique is 
applicable to all populations of neurones in the peripheral nervous system and it 
is very efficient (Davies, 1986). However, it is only effective after stages when 
there is a clear difference in size between neurons and non-neuronal cells exists. 
In the present study, this technique was used for E8 and older ganglia. About 
60% of the neurones from the starting tissue were recovered uncontaminated by 
non neuronal cells and the neuronal viability was very high. An autoclaved 
dropping funnel was filled with 60 ml of Ham's F14 medium plus 10% of HIHS 
and was placed on an anti-vibration table in a cooling incubator at 2°C overnight
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before the dissections were carried out. The dissociated cell suspension (about 2 
ml using HBBS or PBS) was layered on the medium inside the dropping funnel. 
After one hour, fractions of about 5 ml were collected. To determine which 
fractions contain only neurones, 0.5 ml samples of these fractions were placed in 
a 24 multi-well plate and were examined with phase contrast microscopy.
c) Culture substrate
The pure neurone samples were plated in 35mm plastic Petri dishes 
previously coated with poly-omithine and laminin (Edgard etal, 1984). To coat 
the dishes, 1 ml of poly-omithine solution (0.5 mg/ml of poly-omithine in a 0.15 
M borate buffer, pH 8.7) was placed in each dish and left overnight at room 
temperature. The poly-omithine solution was aspirated the following morning 
and the dishes were washed three times with sterile water to remove any trace of 
borate buffer. The dishes were air dried in a laminar flow hood and 120|xl of 
laminin solution (20|xg/ml in PBS or Ham's F14) was placed in the centre of each 
dish and spread over about two-thirds of the dish surface using a plastic pipette 
tip. The dishes were then placed in a humidified culture incubator at 37 “C for at 
least 4h. After that time, the dishes were removed from the incubator and 
washed twice with culture medium (Ham's F14 plus 10% HIHS). Finally 1 ml of 
culture medium was placed in the dishes prior to the addition of 1ml of neuronal 
suspension. Pure neuronal suspensions from E8 and older ganglia and the 
dissociated cell suspensions from E5 or E6 ganglia (at which age differential 
sedimentation is not very effective in removing non-neuronal cells) were plated 
at very low density in 35 mm tissue culture dishes (250 to 500 per dish) To 
perform a dose response to neurotrophic factor, a suitable range of concentrations
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of this factor was set up in 1ml ofculture medium at double the required final 
concentrations. Subsequently 1 ml of cell suspension was added to the dishes.
d) Assessing survival
To assess neuronal survival, the number of attached neurons within a 
standard 12 X 12 mm grid placed under the centre of dishes was counted 6 hours 
after plating. The number of surviving, process-bearing neurons (the process 
being defined as an outgrowth three times longer than its cell body) was 
subsequently counted using the same standard grid 48 hours after plating. By 
that time almost all neurons had degenerated in control cultures (those containing 
no neurotrophic factor). The number of neurons surviving after 48 hours was 
expressed as a percentage of the initial number of neurons counted at 6 hours. In 
each experiment, control and neurotrophin-supplemented cultures were set up in 
triplicate. Each experiment was repeated at least twice. The same procedure was 
used to assess the proportion of neurons surviving in cultures set up in 4-well 
dishes, except that the entire surface of the wells was examined for neurons.
To ascertain wether the increased number of neurons observed in early 
ganglion cultures in the presence of neurotrophins was due to a direct survival 
response of neurons (as opposed to the differentiation of neuron progenitor cells 
present in these cultures), the fate of individual neurons in low density 
dissociated cultures was followed (Vogel and Davies, 1991). This was done by 
recording the location 6 hours after plating of unambiguously identifiable bipolai* 
neurons within a 9 x 9 mm grid scored on the under surface of poly- 
omithine/laminin-coated 60 mm culture dishes and monitoring at 12 hourly 
intervals until 48 hours if each of these neurons was surviving or had
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degenerated. To avoid any possible effects of neurotrophins on the size of the 
initial cohorts, these factors were added after the identification of cohorts at 12 
hours.
For experiments in which very high concentrations of neurotrophins were 
used, the neurons were grown in the 11 mm diameter wells of 4-well dishes 
(Greiner) that had been pre-coated with polyornithine and laminin. This 
permitted the use of only 100 jxl of culture medium in each well. Purified NGF 
(gift of W. Mobley) and purified recombinant BDNF and NT-3 (gifts of Gene 
Burton and John Winslow, Genentech Inc.) were added to these cultures either 
alone or in combination. In the 4 well dishes, the whole surface of each well was 
counted. All data are presented as mean ± SEM unless otherwise stated.
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2.3. RESULTS
Differences and developmental changes in the response of cranial sensory 
neurons to neurotrophins
By 48 hours incubation, the great majority and often all the neurons in 
control cultures of DMTG, jugular, VLTG and nodose neurons had degenerated 
(Fig.2.4). This permitted the survival response of these neurons to NGF, BDNF 
and NT-3 to be clearly observed at this time. The graphs in figure 2,5. show the 
magnitude and age-related changes in the survival-promoting effects of 
neurotrophins on these neurons from E6 to E12.
The bar charts in figure 2.6 compare the survival of neurons grown with 
each neurotrophin alone with the survival of neurons grown in the presence of 
different combinations of neurotrophins. Where two neurotrophins promote the 
survival of neurons in a given population, comparison of the numbers of neurons 
surviving in the presence of each neurotrophin alone with the number surviving 
in the presence of both neurotrophins will reveal whether the neurotrophins 
support the same or different subsets of neurons in the population.
(I) DMTG neurons
Figures 2.5 and 2.6 shows that the survival of the majority of DMTG 
neurons was promoted by NGF throughout the E6 to El 2 age range. In addition, 
at E6, almost as many neurons were supported by either BDNF or NT-3. This
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early response to BDNF and NT-3 was, however, short-lived. There was a 
marked fall in the number of neurons surviving in the presence of BDNF or NT-3 
between E6 and E8, and by E12 less than 5% of the neurons were supported by 
these factors, compared with over 60% supported by NGF.
200um
Figure 2.4. Phase contrast micrograph of ElO DMTG neurons after 48h in control culture (a) or 
in media supplemented with NGF (2ng/ml) (b).
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Figure 2.5. Age-related changes in the survival responses of cranial sensory neurons to 
neurotrophins. Graphs showing the percent survival of DMTG, Jugular, VLTG and Nodose 
neurons from E6 to E12 embryos after 48 hours incubation with 2ng/ml of NGF (circles), BDNF 
(squares) or NT3 (triangles). The mean +/- the standard error of the mean are shown (n=3). 
Stardard error of the mean is the standard deviation divided by the square root of n.
Control data for each type of neurons are presented in Figures 2.6-2.10.
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Additionally if E6 DMTG neurons were grown in the presence of NGF 
plus BDNF or NGF plus NT-3, there were very few additional surviving neurons 
compared with cultures containing NGF alone. (Fig 2.6) Likewise, there was 
negligible additional neuronal survival in cultures containing BDNF plus NT-3 
compared with cultures containing either of these neurotrophins alone. These 
results indicate that there are not separate subpopulations of neurons that respond 
each neurotrophin at E6, rather, the majority of E6 neurons respond to all three 
neurotrophins.
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Figure 2.6. Survival responses of DMTG neurons to neurotrophins alone and in combination. 
Bar chart showing the percent survival of DMTG neurons from E6 (black bars), E8 (light hatched 
bars), ElO (stippled bars) and E12 (dark hatched bars) embryos after 48h incubation with 2ng/ml 
of NGF, BDNF, NT3, NGF+BDNF, NGF+NT3 or BDNF+NT3. The mean ±  the standard error are shown (n=3).
76
(ii) Jugular neurons
As with DMTG neurons, the survival of the majority of jugular neurons 
was promoted by NGF at all ages. Jugular neurons also showed a marked, 
transitory survival response to BDNF and NT-3 at E6. The number of neurons 
surviving in the presence of BDNF or NT-3 decreased markedly at later ages, 
reaching 10% or less by ElO (Fig. 2.7).
There was negligible additional neuronal survival in E6 cultures 
containing NGF plus BDNF or NGF plus NT-3 compared with cultures 
containing NGF alone, indicating that at this early stage the majority of neurons 
supported by NGF also respond to BDNF and NT-3. Likewise, there was 
negligible additional neuronal survival in E6 cultures containing BDNF plus NT- 
3 compared with cultures containing either neurotrophin alone (Fig. 2.7).
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Figure 2.7. Survival responses of chicken Jugular neurons to neurotrophins alone and in 
combination. Bar chart showing the percent of survival of Jugular neurons from E6 (stippled 
bars) and E12 (dark hatched bars) embryos after 48 hours of incubation with 2ng/ml of NGF, 
BDNF, NT3, NGF+BDNF or BDNF+NT3. The mean ± the standard errors are shown (n=3).
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(iii) VLTG neurons
At all ages, the survival of VLTG neurons was supported by BDNF. This 
response to BDNF increased from E6 to E8, after which it remained in the region 
of 70 to 80% survival. In marked contrast to the early response of DMTG and 
jugular neurons to all three neurotrophins, only a small percentage of VLTG 
neurons were supported by NGF or NT-3 (less than 10% at any age) and there 
were no age-related changes in this response (Fig.2.5). The percentage survival 
of VLTG neurons in the presence of BDNF was not significantly changed by the 
addition of either NGF or NT-3 to the culture medium (Fig. 2.8).
Because many VLTG neurons are generated before DMTG neurons 
(D'Amico-Martel and Noden, 1980), it is possible that VLTG neurons may have 
passed through a period of responsiveness to multiple neurotrophins before E6, 
the age at which DMTG neurons respond to NGF, BDNF and NT-3. To exclude 
this possibility, VLTG neurons were cultured with different neurotrophins at E5 
(Fig. 2.9). After 48 hours incubation 9.0 ± 0.8% of the neurons were surviving in 
control cultures and there were no significant differences in the number of 
neurons surviving in the presence of either NGF (8.5 ±  0%) or NT-3 (13.0 + 
5.9%). There was, however, a clear survival response to BDNF (63.4 ± 2.5%). 
Thus, in contrast to early DMTG neurons, VLTG neurons at an equivalent early 
stage in their development do not exhibit responsiveness to multiple 
neurotrophins.
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Figure 2.8. Survival responses of VLTG neurons to neurotrophins alone and in combination Bar
chart showing the percent survival of VLTG neurons from E6 (black bars). E8 (light hatched
bars), ElO (stippled bars) and E l2 (dark hatched bars) embryos after 48 hours incubation with
2ng/ml of NGF. BDNF. NT3. NGF+BDNF. NGF+NT3 or BDNF+NT3. The mean ±  (he standard error are shown (n=3)
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Figure 2.9. Survival responses of E5 VLTG neurons to neurotrophins alone and in combination. 
Bar chart showing the percent survival after 48h in culture. C: control; N: NGF 2ng/ml; B; BDNF 
2ng/ml; 3: NT3 2ng/ml; N+B: NGF+BDNF; B+3: BDNF+NT3; N+3: NGF+NT3. The mean ± 
standard error are shown (n=3).
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(iv) Nodose neurons
Throughout the period studied, the survival of nodose neurons was 
supported by BDNF and NT-3. Of the two, BDNF was more effective (60% to 
over 80% of the neurons surviving with this factor compared with 20 to 40% 
with NT-3). At all ages, the numbers of neurons surviving in the presence of 
NGF was not significantly greater than the numbers of neurons in control 
cultures (Fig.2.10). Almost all neurons survived in the presence of both BDNF 
and NT-3 (Fig. 2.10), indicating that the nodose ganglion comprises two partially 
overlapping populations of BDNF-responsive and NT-3-responsive neurons. 
These neurons are responsive to BDNF and NT3 even earlier in development, E5 
(Fig 2.11). The survival response to NT3 decreases from E5 to E6.
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Figure 2.10. Survival responses of nodose neurons to neurotrophins alone and in combination. 
Bar charts showing the percent survival of Nodose neurons from E6 (black bars), E8 (light 
hatched bars), ElO (stippled bars) and E l2 (dark hatched bars) embryos after 48 hours incubation 
with 2 ng/ml of NGF, BDNF, NT3, NGF+BDNF, NGF+NT3 or BDNF+NT3. The mean ± the 
standard error are shown (n=3).
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Figure 2.11. Survival responses of E5 Nodose Neurons to neurotrophins alone (at 2ng/ml) and in 
combination. Bar chart showing the percent survival in culture after 48h. N+B: NGF + BDNF; 
B+3: BDNF + NTS; N+3: NGF + NTS. The mean ± standard errors are shown (n=3).
BDNF and NT-3 exert a direct survival response from early DMTG and 
jugular neurons
Because the neural crest-derived DMTG and jugular neurons are born 
between E4 and E6 in vivo (D'Amico-Martel, 1982), cell cultures set up at E6 
may contain neuron progenitor cells that are capable of differentiating into 
neurons in vitro (Rohrer et aL, 1985). Thus, it was important to ascertain if the 
increase in the number of neurons in these cultures in the presence of BDNF or 
NT-3 was due to a survival response of differentiated neurons or was due to 
enhanced proliferation or differentiation of progenitor cells. This is especially 
pertinent because BDNF may direct pluripotent neural crest cells to differentiate 
along the sensory neuron lineage (Sieber-Blum, 1991) and NT-3 increases the 
proliferation of neural crest cells (Kalcheim et aL, 1992) and enhances the 
proliferation or differentiation of dorsal root ganglion neuron progenitor cells 
(Wright era/., 1992).
Figure 2.12. shows the percent survival after 48 hours incubation in 
cohorts of E6 DMTG neurons identified 6 hours after plating. The majority of 
neurons in these cohorts were still surviving in the presence of either BDNF or 
NT-3, whereas only 10% were alive in control cultures. Moreover, the 
percentage survival in control and neurotrophin-supplemented neuronal cohorts 
was very similar to the overall percentage survival in E6 DMTG cultures in 
which the fate of individual neurons was not serially monitored (Fig.2.6). These 
results demonstrate that the effect of BDNF and NT-3 on the number of neurons 
in E6 DMTG cultures is due mainly, if not exclusively, to enhanced survival. A
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smaller number of cohort experiments carried out with E6 jugular neurons gave 
similar results (data not shown).
c
ok amG.
§0 "
20 “
NT- 3BDNFC o n t r o l
Figure 2.12. BDNF and NT3 exert a direct survival-promoting effect on E6 DMTG neurons. Bar 
chart of the percent survival after 48 hours incubation of cohorts of E6 DMTG neurons identified 
6 hours after plating. Cohorts were grown either without neurotrophins (control) or were 
supplemented with 2 ng/ml of BDNF or NT3 at 6 hours. The mean +/- the standard error are 
shown (n=3).
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Dose responses of DMTG neurons to neurotrophins shift to higher 
concentrations with age
The loss of the early survival response of DMTG and jugular neurons to 
BDNF and NT-3 could be due either to increasing numbers of the neurons 
becoming completely unresponsive to these neurotrophins with age or to a 
marked shift in the dose response of neurons in the population as a whole. To 
distinguish between these possibilities, B6 to E12 DMTG neurons were grown 
with BDNF or NT-3 over a broad range of concentrations up to 5 ng/ml (which is 
over 4 orders of magnitude higher than the saturating concentration of these 
neurotrophins for nodose and VLTG neurons, data not shown). For comparison, 
dose responses of DMTG neurons to NGF were also carried out at these ages.
Figure 2.13. shows the dose responses of E6, E8, ElO and E12 DMTG 
neurons to NGF, BDNF and NT-3. At E6, the majority of DMTG neurons were 
supported by saturating concentrations of each neurotrophin, and the 
concentrations of each neurotrophin that promoted half-maximal survival were 
similar (3.8, 4.7 and 12.7 pg/ml for NGF, BDNF and NT-3, respectively). By 
E8, however, the BDNF and NT-3 dose-responses showed a marked shift to 
higher concentrations. Although the majority of neurons were still promoted by 
the highest concentration of BDNF and NT-3 used (5 }Xg/ml), the concentrations 
of BDNF and NT-3 that promoted half-maximal survival had increased by 4 
orders of magnitude by E8 (to 98 and 124 ng/ml for BDNF and NT-3, 
respectively). There appeared to be further shifts in the BDNF and NT-3 dose 
responses to higher concentrations at ElO and E12 (seen most clearly in the case
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of NT-3). However, because maximal neuronal survival was not reached at the 
highest concentration used (5 pg/ml), the half-maximally effective concentrations 
cannot be reliably calculated at these ages.
There was also a shift in the NGF dose response to higher concentrations 
between E6 and E8. However, in contrast to the very large shifts in the BDNF 
and NT-3 dose responses during this period, the half-maximally effective NGF 
concentration increased by only one order of magnitude from 3.8 to 28 pg/ml. In 
contrast to the continued shifts in the BDNF and NT-3 dose responses at later 
ages, the NGF dose responses were similar at E8, ElO and E12 and there was no 
significant difference in the half-maximally effective NGF concentrations at 
these ages.
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Figure 2.13. Dose responses of DMTG neurons to neurotrophins.
Graphs showing the percent survival of DMTG neurons from E6 (filled circles), E8 (open 
circles), ElO (filled squares), and E12 (open squares) embryos after 48 hours incubation with 
NGF, BDNF or NTS at concentrations ranging from O.lp^ml to 5pg/ml. The mean +/- the 
standard error from typical experiments are shown.
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2.4. DISCUSSION
The experiments outlined in this chapter suggest that NGF promotes the 
survival of DMTG and jugular neurons and BDNF promotes the survival of 
VLTG and nodose neurons grown in low-density cultures that are virtually free 
of non-neuronal cells. These data are in agreement with results of previous in 
vitro studies of the effects of NGF and BDNF on the survival of mid-embryonic 
cranial sensory neurons (Davies and Lindsay, 1985; Lindsay and Rohrer, 1985; 
Lindsay et a l, 1985; Davies et a l, 1986b; Davies et a l, 1986a), In addition, by 
studying neurons at earlier developmental stages, it was shown that the survival 
of NGF-dependent DMTG and jugular neurons is transiently supported by BDNF 
and NT-3. Because there was negligible additional survival in E6 DMTG and 
jugular cultures grown with combinations of NGF, BDNF and NT-3, most of 
these neurons responded to all three factors during this early stage of their 
development. By monitoring the survival of individual E6 DMTG neurons 
between 6 and 48 hours in vitro, it was shown that BDNF and NT-3 exert a 
direct, through transient, survival-promoting action on NGF-dependent sensory 
neurons at an early stage in their development.
Previous work on the NGF-dependent trigeminal ganglion neurons of the 
mouse embryo has shown that the transient survival-promoting effects of BDNF 
and NT-3 on these neurons is largely over by the time the number of neurons in 
the trigeminal ganglion begins to decline as a result of naturally occurring 
neuronal death (Buchman and Davies, 1993). Although there are no available 
data on the timing of neuronal death in the chicken trigeminal ganglion, a 
developmental study of neuronal death in the sensory ganglia of cranial nerves
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DC and X in chicken embryos (Hiscock and Straznicky, 1986) has shown that the 
total number of neurons in the jugular ganglion peaks at E8 and decreases by half 
over the next five days of development. Thus, for at least chicken jugular 
ganglion neurons, the timing of the early survival response to BDNF and NT-3 
appears to be similar to that observed for mouse trigeminal ganglion neurons in 
that it is largely over by the time neurons numbers begin to fall as a result of cell 
death.
In vitro studies of developing dorsal root ganglion (DRG) neurons have 
shown that NGF and BDNF supported the survival of distinct subsets of neurons 
at E l2, whereas at E6 more than half of the neurons were supported by either 
factor alone (Lindsay et aL, 1985; Acheson et al., 1987), indicating that there is 
some overlap between NGF-responsive and BDNF-responsive neurons during 
the early stages of DRG development. In a detailed in vitro study of the survival 
requirements of DRG neurons from the earliest stages of their development 
(Ernsberger and Rohrer, 1988), it was shown that after an initial phase of 
neurotrophin independence, the survival of all neurons was promoted by either 
NGF or BDNF and that a proportion of the neurons subsequently lost 
responsiveness to BDNF. The current observations of early DMTG and jugular 
neurons are consistent with the early response of NGF-dependent neurons to 
BDNF and the subsequent loss of BDNF responsiveness. In addition, it was 
shown that NGF-dependent neurons are also transiently supported by NT-3 early 
in their development. Furthermore, by studying several different populations of 
cranial sensory neurons, it was demonstrated that the broad neurotrophin 
responsiveness of NGF-dependent neurons at early developmental stages does 
not extend to other populations of developing sensory neurons. VLTG neurons 
are supported by BDNF throughout their early development, but show virtually 
no response to either NGF or NT-3. Nodose neurons respond to BDNF and NT-
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3 from an early developmental stage, but show negligible response to NGF at any 
stage in their development. Thus, responsiveness to multiple neurotrophins is not 
a ubiquitous feature of the early stages of neuronal development, but among 
sensoiy neurons appears to be restricted to those that depend on NGF for survival 
during the phase of naturally occurring cell death.
In accordance with these observations, it has been shown that sympathetic 
neurons depend on NGF for survival by the time they innervate their targets 
(Cohen, 1960; Levi-Montalcini and Booker, 1960), but not earlier during 
development (Coughlin and Collins, 1985; Ernsberger et al, 1989; Birren et al, 
1993). These neurons, however, respond transiently to NT3 (Birren et al, 1993 ; 
DiCicco-Bloom et al, 1993, Barde , 1995) produced within the ganglion 
(Schechtersson and Bothwell, 1992) before the neurons become dependent on 
target-derived NGF.
The current studies show that the loss of the response of the NGF- 
dependent DMTG neurons to BDNF and NT-3 during development is associated 
with marked shifts in the BDNF and NT-3 dose responses to higher 
concentrations. Between E6 and E8 there is a shift of over four orders of 
magnitude in the BDNF and NT-3 dose responses and further increases are 
apparent at later stages. The marked shifts in the BDNF and NT-3 dose 
responses may be due to reduced levels of expression of TrkB and TrkC in 
DMTG neurons with development or to the increasing expression of truncated 
TrkB and TrkC isoforms that may act as dominant-negative receptors (ling etaL,
1992). Interestingly, there is a smaller shift of one order of magnitude in the 
NGF dose response of DMTG neurons to higher NGF concentrations between E6 
and E8. A similar shift in the NGF dose response is observed in mouse 
trigeminal neurons during a roughly equivalent stage of development between
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E12 and E15 (Buchman and Davies, 1993). Curiously, the mean level of TrkA 
mRNA increases in trigeminal neurons over this period of development (Wyatt 
and Davies, 1993) and there is no evidence for the existence of a TrkA isoform 
lacking the tyrosine kinase domain in developing trigeminal neurons (Rosenthal 
and Davies, personal communication). This developmental shift in the NGF dose 
response is also not dependent on the expression gp75 because it is still observed 
in developing trigeminal neurons obtained from mouse embryos that have a null 
mutation of the gp75 gene (Davies et al, 1993).
93
Chapter 3
TIMING OF NEURONAL DEATH IN TrkA, TrkB and TrkC MUTANT 
MOUSE EMBRYOS DEMONSTRATES NEUROTROPHIN SWITCHING 
IN DEVELOPING TRIGEMINAL NEURONS .
3.1. INTRODUCTION
Developing sensory neurons survive in culture independently of 
neurotrophins during the stage when their axons are growing to their targets 
(Davies and Lumsden, 1984; Ernsberger and Rohrer, 1988; Vogel and Davies,
1991). The in vitro survival of many populations of cranial sensory neurons is 
initially promoted by BDNF or NT3 (Vogel and Davies, 1991; Buchman and 
Davies, 1993). Whereas several populations of cranial sensory neurons retain 
dependence on these neurotrophins in culture throughout the phase of naturally 
occurring neuronal death (Chapter 2 of this thesis; Davies et a l, 1986a, 1986b; 
Hohn et a l, 1990), other populations switch dependence to NGF during the early 
stages of target field innervation ( Chapter 2 of this thesis; Buchman and Davies,
1993)
The m vitro switch from BDNF/NT3 dependence to NGF dependence 
has been studied most extensively in the trigeminal ganglion neurons of the 
mouse embryo (Buchman and Davies, 1993; Paul and Davies, 1995), but also 
occurs in cultured jugular ganglion neurons (Davies et a l, 1993a). When grown 
at low density in defined medium, ElO mouse trigeminal neurons, which have
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not yet innervated their peripheral targets, die between 24 and 48 hours in the 
absence of neurotrophins. The death of these early neurons is prevented by 
BDNF or NT3 but not by NGF. NGF promotes the survival of a small 
proportion of E ll  neurons and virtually all E12 neurons for 48 hours in culture. 
Concomitant with the acquisition of the NGF survival response, the survival 
responses to BDNF and NT3 are lost. In E13 cultures, less than 10% of the 
neurons are supported for 48 hours by BDNF, and the survival response to NT3 
falls to a similar level in E14 cultures. It is not known, however, if this apparent 
switch in the survival response of developing trigeminal neurons from 
BDNF/NT3 to NGF observed in culture takes place in vivo during normal 
development. Moreover, because the in vitro assessment of the effects of 
neurotrophins on developing neurons involves incubation periods of 48 hours or 
more, it is difficult to relate the timing of in vitro switching to the developmental 
stage of the neurons in vivo.
Analyses of mice that have targeted null mutations in the neurotrophin 
genes (Crowley et ah, 1994; Emfors et aL, 1994a, 1994b; Faiinas et aL, 1994; 
Jones et al., 1994; Conover et al, 1995; Liu et al., 1995) and tik genes (Klein et 
al., 1993, 1994; Smeyne et aL, 1994) have been extiemely useful in assessing the 
physiological relevance of earlier in vitro studies of the effects of neurotrophins 
on neuronal survival and in extending our understanding of the functions of 
neurotrophins in neuronal development (See Table 3.1)
95
Mutation
Phenotype
Behavioural PNS
(Neuron Loss)
CNS
(Neuron Loss)
gp75
NGF
viable and fertile Sympathetic ganglia, no 
loss; smaller DRG
viable by birth; reduced 
responses to painful 
stimuli; death within a 
month
SCO, 99%
DRG, 70-80%
Trigeminal ganglion, 70% 
Nodose, no loss of neurons
Motor neurons, no 
loss
Basal forebrain, 
cholinergic 
neurons; normal 
differentiation and 
reduced ChAT 
immunoreactivity 
Reduced axonal 
branching.________
TrIcA viable at birth, death 
within a month; no 
orientation in response to 
vibrissal stimulation. Basic 
motor functions normal
Trigeminal ganglia, 
70-90%;
DRG, 70-90%
SCO severe loss.
Decrease in AChE 
in ch olinergic  
fibbers
BDNF Some survival for few 
weeks. Head turning, 
spinning in week 2
SCO, no loss 
DRG, 30-50%
Vestibular, >80%
Nodose, 45-65% 
Trigeminal ganglion, 25- 
55%
Motor neurons, no 
loss
96
NT4 long-lived; no obvious 
neurological defects
Trigeminal ganglion, no 
loss
Vestibular ganglion, no 
loss
Nodose' some loss 
Petrosal, some loss_______
Motor neurons, no 
loss
TrkB
NT3
TrkC
A bsence o f  feeding  
activity, most die in 48h 
after birth
Trigeminal ganglia, 
DRG
Nodose, substantial loss.
Motor neurons, 
35%
Strik ingly  abnormal 
movements and postures; 
loss of proprioception, 
most die shortly after birth.
SCO, 55%
DRG, 55%
Nodose, 50%
Trigeminal ganglion, 65% 
Cochlear, 85%
Motoneurons, no 
loss
Loss o f spinal 
proprioceptive 
afferents and their 
peripheral sense 
organs (muscle 
spindles and Golgi 
tendon organs)
Abnormal movements and 
posture; death within a 
month
DRG, 20% Motoneurons, 30%
Table 3.1. Phenotypes of Neurotrophin and Trks (-/-) Mutant Mice.Adaptede from Snider, 1994.
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ASeveral studies of mutant mice suggest that BDNF and NT3 play a role in 
trigeminal ganglion development. By birth and the postnatal period there are 
marked reductions in the neuronal complement of the trigeminal ganglia of 
BDNF~^~ (Emfors et ah, 1994a; Jones et al, 1994), TrkB~^~ (Klein et a l, 1993) 
and NT3~^~ mice (Ernfors et al, 1994b). However, because trigeminal ganglia 
were not studied at intervals throughout embryonic development, it is not known 
at which stage of development BDNF and NT3 aie required for neuron survival 
or whether they influence the neuronal complement of the trigeminal ganglion by 
promoting precursor cell proliferation and/or differentiation. The latter 
possibilities are raised by the finding that BDNF directs pluripotent neural crest 
cells to differentiate in vitro along the sensory neuron lineage (Sieber-Blum,
1991) and that NT3 is a mitogen for cultured neural crest cells (Kalcheim et aL,
1992) and enhances the proliferation or differentiation of sensory neuron 
progenitor cells in culture (Wright et aL, 1992). Although many foetal trigeminal 
neurons are supported by NGF in vitro (Buchman and Davies, 1993), the 
dependence of trigeminal neurons in vivo has not been formally demonstrated 
and the relationship between the stage at which the neurons are critically 
dependent on NGF in vivo and the timing of naturally occurring neuronal death 
in the ganglion is not known.
To resolve the above issues, I have quantified the extent of neuronal death 
in the trigeminal ganglia of trkA~^~, TrkB~^~, TrkC~^~ and wild type mice at 
closely staged intervals throughout embryonic development. My results 
demonstrate that neurotrophin switching takes place during embryogenesis and 
have clarified the role of Trk receptor tyrosine kinases in sensory neuronal
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development by providing precise data on the timing of neuronal dependence on 
Trk signalling in vivo.
3.2. MATERIALS AND METHODS
Animals
Embryos were obtained from overnight matings of (i) TrkA^^~ mice, (ii) 
TrkB’^ ^" and (iii) TrkC^^~ mice. Pregnant females were killed by cervical 
dislocation at the required stage of gestation and the precise stage of 
development of the embryos was determined by the criteria of Theiler (Theiler, 
1972). The genotypes of the embryos were determined by a PCR-based 
technique using DNA isolated from embryonic tissues (Schimmang et al., 1995). 
DNA extracted from a small sample of the embryo tissue was amplified by PCR 
using specific primers.
Quantification of numbers of pyknotic nuclei in the trigeminal ganglion
Embryos were fixed by immersion in 4% paraformaldehyde in O.IM 
phosphate buffer pH 7.3. The brain was removed from E14 and older embryos to 
allow proper fixation of the trigeminal ganglia. After fixation for at least a week, 
the embryos were dehydrated and embedded in paraffin wax. E15 and older 
embryos were first decalcified with IM EDTA. Coronal sections of the head 
were cut at 8 (xm. These were mounted on gelatinised slides and were stained 
with cresyl fast violet.
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To evaluate the extent of cell death, all pyknotic nuclei were counted at 
400X magnification in every fourth section along the entire rostrocaudal extent 
of the trigeminal ganglia of El 1 to E19 embryos. Estimates of the total number 
of pyknotic nuclei in each ganglion were obtained by multiplying the sum of 
these counts by four. At each age, between four and ten ganglia of the following 
genotypes were studied: trkA'^^ mice, TrkB~^~, TrkC~^~ and wild type. In all 
cases, the sections were coded prior to counting to avoid any observer bias.
Quantification of total numbers of neurons in the trigeminal ganglion
To estimate the total number of neurons in the trigeminal ganglia of 
selected embryos, the profiles of every 10th coronal section of the ganglion were 
made using a drawing tube at lOOX magnification. The cross-sectional area of 
each counted section was measured using an Image Processing and Analysis 
Program (NIH Image). The average density of neurons was quantified in each of 
these sections at 1,000X magnification using a 0.0 Imm^ grid. Neurons were 
identified by virtue of the Nissl substance and their large, round, pale-stained 
nuclei (Konigsmark, 1970). The total number of neurons in each section was 
calculated from the section area and average neuron density in each section. The 
total number of neurons in the ganglion was estimated by adding these numbers 
and multiplying by 10, Correction for split nucleoli was not made as these do not 
appreciably affect the neuronal estimate (Jones, 1937). The estimates of the total 
number of neurons in the trigeminal ganglia of normal embryos in the present 
study are very similar to those previously obtained (Davies and Lumsden, 1984) 
by counting neuronal nuclei and correcting for split nucleoli by the method of 
Abercrombie (Abercrombie, 1946).
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Immunohistochemistry
To identify the proportion of neurons undergoing cell death in the early 
trigeminal ganglia of wild type and TrkB~^ ~ embryos, 8jim frozen sections were 
doubled labelled for neuron-specific markers (peripherin or 160 kDa 
neurofilament protein) and 3’ DNA ends generated by DNA fragmentation in 
apoptotic cells. Sections were incubated with either rabbit anti-peripherin 
antibody (Chemicon) diluted 1:300 in phosphate-buffered saline containing 0.1% 
Triton and 1% goat serum for 12 hours or mouse anti-160 kDa monoclonal 
antibody (Sigma) diluted 1:200 in phosphate-buffered saline containing 0.3% 
Triton and 1% horse serum for 48 hours. These primary antibodies were 
localised by an immunoperoxidase technique using a bio tiny lated secondary 
antibody and an avidin/biotinylated horse radish peroxidase macromolecular 
complex (Vectastain ABC Kit, Vector Laboratories). This was followed by in- 
situ DNA end-labelling with fluorescein-nucleotides (ApopTag Direct Kit, 
Oncor). The sections were examined and photographed using a Axioskop 
microscope. Cells undergoing apoptosis were recognised by an intensely 
fluorescent nucleus. Apoptotic cells were classified as neurons if a peroxidase- 
labeUed rim of cytoplasm was clearly visible.
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3.3. RESULTS
Developmental dianges in the number of pyknotic nuclei
Pyknotic nuclei in developing trigeminal ganglia were recognised as one 
or more very darkly stained spherical structures contained within a clearly visible 
membrane (Fig.3.1). The great majority of these pyknotic nuclei were observed 
in large degenerating cells, suggesting that these were neurons (Oppenheim, 
1991). In late foetal ganglia, a very small number of pyknotic nuclei were also 
observed in very small cells that were of a similar size to satellite cells, 
suggesting that a minority of the supporting cells undergo cell death in the 
ganglion. These latter pyknotic cells were not counted.
(i). Wild type embryos
In wild type embryos, pyknotic nuclei were observed as early as E ll. 
The number increased steadily by five-fold to reach a peak at E14 after which 
there was a decrease to a negligible number by the end of foetal development at 
E19 (Fig 3. 1).
1 0 2
Figure 3.1. Bright field view of a wild type E17 trigeminal ganglion showing the typical 
appearance of a pyknotic nucleus. A darkly stained spherical structure (arrow) is seen enclosed 
within a membrane. Magnification = X 1,2(X)
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(ü). TrkA embryos
The number of pyknotic nuclei in the trigeminal ganglion of trkA'f- 
embryos was very similar to that of wild type embryos at E ll  and El 2 (Fig. 3.2). 
In contrast to wild type embryos, there was a marked increase in the number of 
pyknotic nuclei between E12 and E13. At E l3 and E 14 the number of pyknotic 
nuclei in the trigeminal ganglia of trkA'^~ embryos was approximately three-fold 
greater than in ganglia of wild type embryos. After E l4 there was a marked fall 
in the number of pyknotic nuclei to less than in wild type ganglia at E15. The 
number of pyknotic nuclei fell further to the same negligible level by just before 
birth (E l9) as in wild type embryos. There was no obvious difference in the 
appearance of individual pyknotic nuclei in the trigeminal ganglia of trkA~^ ~ 
embryos and wild type embryos at equivalent stages of development.
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Figure 3% Graph comparing the number pyknotic nuclei in the trigeminal ganglia of wild type
and trkA’ ' embryos from El 1 to E19. Hie data were obtained from 4 to 10 ganglia of wild type
embryos and from 4 to 6 ganglia of trkA’ ’^ embryos at each age. The means and standard errors are shown.
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(iii)o TrkB”l~ embryos
The number of pyknotic nuclei in the trigeminal ganglion of TrkB~^~ 
embryos was substantially higher than that of wild type embryos at E ll  and E12 
(Fig.3.3). There were over four-fold more pyknotic nuclei at E l 1 and over three­
fold more pyknotic nuclei at E l2. From a clear peak in the number of pyknotic 
nuclei in TrkB~l~ ganglia at E12 there was a marked fall to less than in wild type 
ganglia at E13. At E15 and later ages, the number of pyknotic nuclei in TrkB~^ ~ 
ganglia was similar to that in wild type ganglia. There was no obvious difference 
in the appeai'ance of pyknotic nuclei in the trigeminal ganglia of TrkB~ ’^ embryos 
and wild type embryos at equivalent stages of development.
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Figure 3 Graph comparing the number pyknotic nuclei in the trigeminal ganglia of wild type 
and TrkB~^ ~ embryos from E ll  to E19. Hie data were obtained from 4 to 10 ganglia of wild type 
embryos and from 4 to 6 ganglia of TrkB'^~ embryos at each age. Hie means and standard errors 
are shown.
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(iv). TrkC“l° embryos
There was a small increase in the number of pyknotic nuclei in the early 
trigeminal ganglia of TrkC~^~ embryos (Fig.3.4). The number of pyknotic 
neurons was just over a two-fold greater than in wild type ganglia at E ll ,  and 
was 1.5-fold greater at E12. Although these increases in pyknotic nuclei in 
TrkC~^~ ganglia were far less than in TrkB'^' ganglia, they were nonetheless 
statistically significant (t-tests: E ll, p < 0.001; E12, p <0.02). At E13 and later 
ages there were similar numbers of pyknotic nuclei in TrkC~^" and wild type 
ganglia. As in trkA'f" and TrkB~/~ ganglia, there were no obvious differences in 
the appearance of pyknotic nuclei in the trigeminal ganglia of TrkC'^~ embiyos 
and wild type embiyos at equivalent stages of development.
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Figure 3.4. Graph comparing the number pyknotic nuclei in the trigeminal ganglia of wild type 
and TrkC'^' embryos from E ll  to E19. The data were obtained from 4 to 10 ganglia of wild type 
embryos and from 4 to 8 ganglia of TrkC~f~ embryos at each age except for E18 where 2 TrkC"!' 
ganglia were studied . The means and standard errors are shown.
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Differences in the neuronal complement of the trigeminal ganglion of wild 
type and mutant embryos at key stages of development
To ascertain the consequences of the differences in the number of dying 
cells in the trigeminal ganglia of wild type and mutant embryos at different 
stages of development, the total number of neurons in the ganglion was estimated 
at several key stages (Fig.3.5). At E13, when the total number of neurons in the 
trigeminal ganglion reaches a peak during normal development (Davies and 
Lumsden, 1984), there were no statistically significant differences in the total 
numbers of neurons in the trigeminal ganglia of wild type, trkA~^~ and TrkC~^~ 
embryos (t-tests; p > 0.1). In contrast, there was a 42%, statistically significant 
reduction in the number of neurons in the ganglia of TrkB'^~ embryos at this 
stage of development (t-test: p < 0.001). At E15, shortly after the number of 
neurons in the trigeminal ganglion begins to decline in normal development 
(Davies and Lumsden, 1984), there was a marked, 64%, statistically significant 
reduction in the number of neurons in trkA~^ ~ ganglia compared with wild type 
ganglia (t-test: p < 0.001). The number of neurons in E15 TrkB~^ ~ ganglia was 
significantly reduced by 33% compared with wild type ganglia (t-test, p < 0.01). 
By E l7, close to the end of the phase of naturally occurring neuronal death, the 
reduction in the number of neurons in trkA~^~ ganglia had further increased to 
69% compared with wild type ganglia. The number of neurons in E17 TrkB~^ ~ 
ganglia was still significantly reduced by 33% compared with wild type ganglia 
(t-test, p < 0.0005). By E17, however, there was a 22% reduction in the number 
of neurons in the ganglia of TrkC~^ ~ embryos compared with wild type embryos 
that was just within the limits of significance (t-test, p < 0.05).
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Figure 3.5. Bar chart of the total numbers of neurons in the trigeminal ganglia of wild type, trkA'
TrkB'^', and TrkO^' embryos at E13, E15 and El 7. Four ganglia of each kind were studied at
each age except at E15 where TrkC^' ganglia were not studied. The means and standard errors 
are shown.
I l l
The majority of cells dying in early TrkB^f" ganglia are neurons
To determine if the increased cell death in early TrkB~^~ trigeminal 
ganglia was due to increased loss of neurons, sections of TrkB~^~ and wild type 
embryos were double labelled for neuron markers and apoptotic nuclei at the 
peak of cell death in TrkB'^~ trigeminal ganglia at E12. Apoptotic cells were 
recognised by intense nuclear fluorescence following in-situ DNA end-labelling 
with fluorescein-nucleotides. Neurons were positively identified by cytoplasmic 
staining for either 160 kDa neurofilament protein or peripherin using an 
immunoperoxidase technique. All of the apoptotic cells in several sections of 
each ganglion were scored as either neurons or other cells. An apoptotic cell was 
scored as a neuron if the fluorescent nuclear staining was clearly and 
unambiguously contained within a distinct rim of peroxidase-labelled cytoplasm 
(Fig.3.6). There was no significant difference between the proportion of 
apoptotic cells positively identified as neurons by neurofilament staining in E12 
wild type embryos (67.3 ± 3.6%, n = 3 ganglia from different embryos) and E12 
TrkB"^~ embryos (69.0 ± 1.9%, n = 3). Likewise, there was no significant 
difference between the proportion of apoptotic cells positively identified as 
neurons by peripherin staining in E12 wild type embryos (70.0 ± 3.7%, n = 3) 
and E12 TrkB~^~ embryos (71.6 ± 5.6%, n = 3). These results suggest that the 
majority of dying cells in early wild type and TrkB~^ ~ trigeminal ganglia aie 
neurons. However, because of the strict criteria for classifying apoptotic cells as 
neurons, the actual proportion of dying cells that are neurons is likely to be even 
greater than our estimates suggest. Figures 3.7a and 3.7b illustrate the large
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difference in the numbers of apoptotic cells in wild type and TrkB~^~ ganglia at
E12.a
Figure 3.6. Matching bright field (a) and fluorescence (b) photomicrogr^hs of a section through 
the trigeminal ganglion of an E l2 TrkB" '^ embryo. In the plane of focus, two neurons are clearly 
identified by cytoplasmic staining for peripherin (a). One of these has fluorescent staining for 3' 
DNA ends in the nucleus characteristic of cells in the early stages of apoptosis (arrow, b). A 
nearby circle of fluorescent staining is present in a cell that was not stained with peripherin. 
Scale bar = 20pm.
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Figure 3.7. Photomicrographs of sections of the equivalent regions of El 2 trigeminal ganglia of 
wild type (a) and TrkB'^' (b) embryos labelled with fluorescent nucleotides for 3' DNA ends 
generated by DNA fragmentation in apoptotic cells. An increased number of labelled cells is 
clearly evident in b. Scale bar = 100pm.
114
3.4. DISCUSSION
Several of my findings suggest that many trigeminal neurons require 
functional TrkB receptors for survival at an early stage in their development. 
First, the number of pyknotic nuclei in E ll  and E12 ganglia was substantially 
greater in TrkB~^~ embryos compared with wild type embryos. Second, the 
majority of cells dying in early TrkB~^ ~ ganglia were positively identified as 
neurons. Third, the total number of neurons in the trigeminal ganglia of TrkB~^ ~ 
embryos was substantially reduced at E13 compared with wild type neurons. 
TrkB is the preferred receptor for two neurotrophins, BDNF (Glass et al,, 1991; 
Klein et al., 1991b; Soppet et al., 1991; Squinto et al., 1991) and NT4 
(Berkemeier et a l, 1991; Ip et al., 1992; Klein et al., 1992). Previous in vitro 
studies have shown that both BDNF and NT4 promote the survival of the 
majority of embryonic mouse trigeminal ganglion neurons at an early stage in 
their development and that the majority of neurons lose responsiveness to these 
factors by E13 (Buchman and Davies, 1993; Davies et al., 1993a; Paul and 
Davies, 1995). The finding that postnatal BDNF~^~ mice (Ernfors et al., 1994a; 
Jones et a i, 1994), but not NT4~^~ mice (Conover et al., 1995; Liu et a i, 1995), 
have marked reductions of the numbers of neurons in the trigeminal ganglion, 
suggests that BDNF, not NT4, is the physiologically important ligand for 
developing trigeminal ganglion neurons. However, because NT3 can also 
promote the survival of embryonic trigeminal neurons by signalling via TrkB 
(Davies et al, 1995), I cannot exclude the possibility that NT3 acting via TrkB is 
also important for the early suiwival of trigeminal neurons in vivo.
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Although studies of postnatal BDNF~^~ mice (Ernfors et a l, 1994a; Jones 
et a l, 1994) and TrkB~^~ mice (Klein et a l, 1993) have shown that BDNF is 
important for the development of a proportion of trigeminal ganglion neurons, 
because the trigeminal ganglia of these animals were not studied throughout 
erabryogenesis, it could not be ascertained at which stage of development BDNF 
is crucial. I have shown that BDNF is required at a very early stage of neuronal 
development and provide formal genetic proof for the proposal based on in vitro 
studies (Buchman and Davies, 1993; Paul and Davies, 1995) that many 
trigeminal neurons depend on BDNF or NT4 for survival at this stage.
Whereas the peak of cell death in the trigeminal ganglia of TrkB'^~ 
embryos occurs earlier than in wild type embryos, Schimmang and colleagues 
(1995) have shown that the increased loss of neurons that occurs in the vestibular 
ganglia of TrkB'^~ embryos occurs during the same time frame as in wild type 
embiyos. However, unlike trigeminal neurons which lose dependence on BDNF 
early in their development, vestibular neurons remain dependent on BDNF for 
survival in vitro throughout the peak period of naturally occurring neuronal death 
(Davies et a l, 1986b) and do not acquire survival dependence on NGF (Davies 
and Lindsay, 1985). Thus, it is not unexpected that the accelerated death of 
TrkB-deficient vestibular neurons should occur over the same period of 
development as these neurons normally die when competing for a limiting supply 
of BDNF in vivo.
This study has shown that trigeminal neurons depend on functional TrkA 
receptors for survival at a later stage of development than their dependence on 
TrkB signalling. At E ll  and E12, when there are substantially more dying cells 
in the trigeminal ganglia of TrkB~f~ embryos than wild type embryos, there are
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normal numbers of dying cells in the trigeminal ganglia of trkA~^~ embiyos. 
Accordingly, at E13, there is no significant difference between the total number 
of neurons in the trigeminal ganglia of trkA~^ ~ and wild type embryos, whereas 
there is a marked reduction in the neuronal complement in the ganglion of TrkB~ 
embryos by this stage. At E13 and E l4, there aie substantially higher numbers 
of dying neurons in the trigeminal ganglion of trkA~l~ embryos than wild type 
embryos, and by E l5 there is a marked reduction in the neuronal complement of 
the trkA~^~ ganglion. The later onset of survival dependence of trigeminal 
neurons on TrkA signalling in vivo is consistent with the later acquisition of the 
survival response of cultured trigeminal neurons to NGF (Buchman and Davies,
1993), the prefen*ed TrkA ligand (Hempstead et al., 1991; Kaplan et al., 1991; 
Klein et al., 1991a). My findings therefore provide genetic evidence for the 
switch in survival dependence of early trigeminal ganglion neurons from TrkB to 
TrkA ligands..
The switch in survival dependence of early trigeminal ganglion neurons 
from BDNF to NGF is consistent with the timing and sequence of expression of 
the respective neurotrophin and trk genes. BDNF mRNA is expressed in the 
presumptive maxillary tenitory of the trigeminal ganglion as early as E9.5, 
before the anival of the earliest trigeminal axons, and reaches a peak of 
expression at E12 (Buchman and Davies, 1993). BDNF  mRNA is also 
expressed in the hindbrain from as early as E9.5, although its level remains low 
and there is no peak in the expression early in development (Buchman and 
Davies, 1993). NGF mRNA and protein are detected in the maxillary process 
with the arrival of the earliest axons at El 1 (Davies et al., 1987) and peaks at 
E13 (Buchman et al., 1994). Transcripts encoding a TrkB protein that possesses 
a catalytic kinase domain are detected in embryonic mouse trigeminal ganglia as 
early as ElO and fall after E12 when transcripts for TrkB variants that lack a
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kinase domain predominate (Ninkina et aL, 1996). The levels of transcripts for 
TrkA and gp75, a neurotrophin receptor that enhances the survival response of 
trigeminal neurons to NGF (Davies et al., 1993b), increase markedly in 
trigeminal neurons after E l2 (Wyatt and Davies, 1993) coincident with the 
acquisition of NGF dependence of trigeminal neurons in vivo.
Estimates of the number of neurons in the trigeminal ganglion towards 
the end of the phase of naturally occuiiing neuronal death at E17 indicate that 
during embryonic development TrkA signalling is required for the survival of 
more trigeminal neurons than TrkB signalling. This in turn suggests that not all 
trigeminal neurons depend on BDNF for survival before becoming NGF 
dependent. Because my data suggest that TrkB signalling is important for the 
survival of many neurons during the early stages of trigeminal ganglion 
development (at E ll  and E12), it is possible that only early-born trigeminal 
neurons are dependent sequentially on BDNF and NGF for survival. Although 
detailed information on the time-course of neuronal differentiation in the mouse 
trigeminal ganglion is not available, the demonstration that the number of 
trigeminal neurons increases in the ganglion to E13 (Davies and Lumsden, 1984) 
and that new axons are recraited to the trigeminal nerve up to this time (Davies, 
1987) suggests that trigeminal neurons aie bom until at least E l3. The transient 
dependence of early-bom trigeminal neurons on BDNF has been proposed to 
sustain the survival of many of these neurons until the majority of later-born 
neurons have extended axons to their targets so that most neurons would compete 
for target-derived NGF during the same period of development (Davies, 1994b).
Although I have observed a small, statistically significant increase in the 
number of pyknotic nuclei in the trigeminal ganglia of TrkC-/- embryos at El 1 
and E12, there was no significant reduction in the total number of neurons in the
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trigeminal ganglia of TrkC^~ embiyos at E l3. This is surprising given the early 
survival response of cultured trigeminal neurons to NT3 (Buchman and Davies, 
1993; Paul and Davies, 1995) and the expression of TrkC mRNA by many 
neurons in the early trigeminal ganglia of the rat embryo (Ernfors et a l, 1992). 
Furthermore, there is a 61 to 64% reduction in the number of neurons in the 
trigeminal ganglia of postnatal NT3~^ ~ mice (Ernfors et a l, 1994b; Faiinas et al,
1994), and recent analysis of the trigeminal ganglion of NT3~^~ embiyos suggests 
that NT3 acts early in trigeminal ganglion development to promote the survival 
of proliferating trigeminal neuron precursor cells (ElShamy and Ernfors, 1996b), 
These findings suggest that whereas NT3 plays an important role in the early 
development of the trigeminal ganglion, TrkC tyrosine kinase receptor does not 
play a major role in mediating the effects of NT3 at this stage.
Although there was no significant reduction in the neuronal complement 
of the TrkC~^~ ganglion at E13, I observed a small, statistically significant 
reduction in the number of neurons in the trigeminal ganglion of E17 TrkC"/" 
embryos compared with wild type, suggesting that a small proportion of foetal 
trigeminal neurons depends on TrkC signalling for survival. It is known that a 
small proportion of neurons are supported in cultures of late foetal trigeminal 
cultures by low concentrations of NT3 and that these neurons are larger than 
those that are supported by NGF (Davies et a l, 1993b; Davies et a l,  1995). 
Thus, it is possible that this small, distinctive subset of neurons is lost in the 
TrkC~l~ ganglion.
Previous studies have also revealed differences between the phenotypes 
of TrkC~^~ and NT3~^~ mice. There is a 55 to 78% reduction in the number of 
neurons in the lumbai* DRG of NT3~^" neonates (Ernfors et a l, 1994b; Farinas et 
al, 1994) compared with only a 17 to 19% reduction in the lumbar DRG of tt'kC~
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neonates (Klein et al., 1994; Minichiello et a l, 1995). Likewise, the neuronal 
complement of the spiral ganglion of NT3~^~ neonates is reduced by 85 to 87% 
(Farinas et a l, 1994; Ernfors et a l, 1995) compared with a 51% reduction in 
trkC~^ ~ neonates (Schimmang et al, 1995). These differences aie likely to be due 
to the ability of NT3 to signal via TrkA and TrkB in embryonic sensory neurons 
(Davies et a l, 1995). NT3 is able to promote the in vitro survival of the majority 
of trigeminal and nodose neurons obtained from E14 trkC~^~ embryos but not 
from embiyos that also lack functional TrkA or TrkB receptors. Interestingly, the 
ability of NT3 to signal via TrkA and TrkB in sensory neurons decreases during 
development, becoming negligible by E18 (Davies et a l, 1995). Thus, it is 
possible that NT3 promotes the survival of trigeminal neuron progenitor cells by 
acting at least in part via non-preferred ti'k mceptor tyrosine kinases.
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Chapter 4
HIGH SPECIFICITY OF NEUROTROPHINS IN THE EMBRYONIC 
CHICKEN TRIGEMINAL SYSTEM
4.1. INTRODUCTION
Equilibrium binding studies have shown that neurotrophin-responsive 
neurons possess two classes of receptors: a common low-affinity receptor that 
binds NGF, BDNF and NT3 with similar Kd in the range of 0.8 x 10‘^M to 1.7 x 
10"^M and specific high-affinity receptors have Kds in the region of 2 x 10" 
(Sutter et al., 1979; Rodriguez-Tebar and Barde, 1988; Rodriguez-Tebar et al., 
1990, 1992). Two kinds of cell surface receptors have been described: the 
common-low affinity receptor gp75 (Chao, 1994) and members of the Trk family 
of receptor tyrosine kinases which bind neurotrophins with higher affinity 
(Barbacid, 1994; Klein, 1994).
In vitro studies of neurons obtained from mice with a null mutation in the 
gp75 gene (Lee et al., 1992) have demonstrated that gp75 is not essential for 
neurotrophin signal tiansduction but that it enhances the sensitivity of embryonic 
sensory and postnatal sympathetic neurons to NGF (Davies et al., 1993; Lee et 
al., 1994). Trk receptor tyrosine kinases are essential for neurotrophin signal 
transduction (Barbacid, 1994; Klein, 1994) and initiate a cascade of protein 
phosphorylations in cells following ligand binding (Kaplan and Stephens, 1994).
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Expression studies in cell lines have shown that TrkA is the receptor for NGF 
(Kaplan et al., 1991; Klein et al, 1991), TrkB is the receptor for BDNF and NT4 
(Berkemeier gf aL, 1991; Glass gf aL, 1991; Klein etal., 1991, 1992; Soppet 
a l, 1991; Squinto et a l, 1991; Ip et a l, 1992) and TrkC is the receptor for NT3 
(Lamballe et a l,  1991). In addition to these preferred receptor/ligand 
interactions, studies of Trk receptor tyrosine kinases expressed in fibroblasts 
have shown that NT3 is also able to signal through TrkA and TrkB (Lamballe et 
a l, 1991; Soppet et a l, 1991; Squinto et a l, 1991) and that NT4/5 is able to 
signal through TrkA (Berkemeier et a l, 1991). Likewise, NT3 can signal via 
TrkA and TrkB in developing sensory neurons (Davies et al, 1995).
In contrast to the cross-activation of high-affinity neurotrophin receptors 
by non-prefeiTed ligands in fibroblasts, binding and cross-activation are only 
observed with much higher concentrations of non-preferred ligands in neuronal 
cell lines and neurons. For example, whereas the BDNF and NT4/5 dose- 
responses of TrkB-expressing PC 12 cells and TrkB-expressing fibroblasts are 
similar, 100-fold higher concentrations of NT3 are required to elicit responses 
from TrkB-expressing PC12 cells compared with TrkB -expressing fibroblasts (Ip 
et a l, 1993). Likewise, a 10-fold higher concentration of NT3 is required to 
prevent BDNF binding to TrkB-expressing sensory neurons than to a TrkB- 
expressing kidney cell line (Dechant et a l, 1993a). Despite the higher ligand 
specificity of Trk receptor tyrosine kinases in neuronal cell lines and neurons, 
neurotrophins can be displaced from their respective high-affinity receptors on 
neurons by vei*y high concentrations of heterologous neurotrophin ligands. The 
binding of NGF and BDNF to their respective high-affinity receptors on 
sympathetic and dorsal root ganglion (DRG) neurons is reduced to 50% by 13- 
fold and 36-fold molar excesses of NT3, respectively (Dechant et a l, 1993a, 
1993b). 1,000-fold excesses of NGF and BDNF are required to cause a 50%
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reduction in the binding of each other to their respective high-affinity receptors 
on DRG neurons (Rodriguez-Tebar et al., 1990), The binding of NT3 to its high- 
affinity receptor on sympathetic and dorsal root ganglion (DRG) neurons is 
reduced to 50% by 1,300-fold and 2,100-fold molar excesses of NGF and BDNF, 
respectively (Rodriguez-Tebar et al., 1992). Very high concentrations of 
neurotrophins can also exert functional responses from neurons expressing 
heterologous high-affinity neurotrophin receptors. For example, NGF at a 
concentration of 5 p,g/ml is able to promote the sui*vival of the BDNF-dependent 
nodose ganglion neurons of the E6  chicken embryo (Rodriguez-Tebar et al., 
1990). At concentrations of NT3 sufficient to completely saturate high-affinity 
BDNF receptors on E8 nodose ganglion neurons (20 ji.g/ml), the survival- 
promoting effects of saturating concentrations of BDNF were completely 
blocked (Dechant et at., 1993a). These studies show that very high 
concentrations of neurotrophins can exert either agonist or antagonist effects on 
heterologous high-affinity neurotrophin receptors.
Although the concentrations of neurotrophins used in the above studies 
aie greater than the anticipated physiological range, these studies provide clear 
illustrations of the differing specificities of neurotrophin receptors in different 
cellular environments and give an indication of the capacity of different neurons 
to distinguish between neurotrophins. The aim of the current study was to extend 
this experimental analysis to the well-characterised neuronal populations of 
chicken embryo trigeminal system which have different and distinctive 
neurotrophin survival requirements during the mid-embryonic period of 
development. In particular, I wished to ascertain whether the agonist and 
antagonist actions of high concentrations of neurotrophins observed for 
previously studied neurons can be generalised to other populations of neurons. 
Previous work has shown that the proprioceptive neurons of the trigeminal
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mesencephalic nucleus (TMN) are supported by physiological concentrations of 
BDNF (Davies et aL, 1986a) and NT3 (Hohn et a i, 1990) but not by NGF 
(Davies et aL, 1987). The small-diameter neurons of the dorsomedial pole of the 
trigeminal ganglion (DMTG) consist predominantly of NGF-dependent neurons 
and very few BDNF-dependent neurons, whereas the large-diameter cutaneous 
sensory neurons of the ventrolateral pole of the trigeminal ganglion (VLTG) 
consist predominantly of B DNF - dependent neurons and very few NGF- 
dependent neurons (Davies et aL, 1986b). My studies of these neurons have 
revealed no significant agonist or antagonist effects of veiy high concentrations 
of neurotrophins acting on heterologous neurotrophin receptors, demonstrating 
that the specificity of neurotrophins for these neurons is far higher than shown 
previously for other neurons.
4.2. METHODS
The tissue culture procedures used in these experiments were exactly the 
same as the ones described in Chapter 2 . The neurons used in this study were 
from the ventrolateral portion of the tiigeminal ganglia (VLTG), the dorsomedial 
portion of the tiigeminal ganglia (DMTG), which were previously described in 
details in Chapter 2 and the trigeminal mesencephalic nucleus (TMN). The TMN 
neurons are primary sensory neurons derived from the neural crest and are 
located in the midbrain (Fig.4.1).
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Non neuronal cells were removed from the dissociated suspension of cells 
by differential sedimentation (as described in Chapter 2). The column fractions 
containing the neurons were centrifuged at 2000g for 5 min and the neurons were 
plated in the 11mm diameter wells of four-well culture dishes that had been 
coated with polyornithine and laminin. The cells were cultured in 100 jil of 
Ham's F14 medium supplemented with 10% HIHS, penicillin (60 mg/1), 
streptomycin (100 mg/1) and 24 mM NaHCOg with or without neurotrophins. 
The pure neuronal suspension was plated in 4 well dishes to make feasible the 
use of high concentrations of neurotrophins. In the case of treatment with two 
neurotrophins, they were added at the same time; at the plating time.
The suiwival was assayed as described in Chapter 2.
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Figure 4.1. Drawings of the dissection of a chicken TMN from an E12 embryo. (A) Dorsal aspect 
of the brain showing the location of the two coronal incisions (interrupted lines) for isolating the 
midbrain. (B) caudal aspect of the isolated midbrain showing the location of the two parasagital 
incisions for removing the roof of cerebral aqueduct after careful striping of the overlaying pia 
matter. (C) Dorsal aspect of the cerebral aqueduct showing the location of the incisions for 
cutting out the median part of the TMN. Tectal vesicle (TV), tectal comissure (TC), posterior 
comissure (PC), cerebral aqueduct (CA); (D) Rostral (R), Medial (M) and Caudal (C) TMN. 
From Davies, 1988.
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4.3. RESULTS
TMN neurons
All TMN neurons died in control cultures by 48 hours incubation. At this 
time, the survival of almost 80% of the neurons was promoted by saturating 
levels of BDNF (2 ng/ral) and very high concentrations of BDNF (5 jig/ml) 
promoted the survival of similar numbers of neurons (Fig. 4.2). In contrast, 
neither 2 ng/ml nor 5 |ig/ml of NGF, which is over 6  orders of magnitude greater 
than the half-maxim ally effective concentration (EC5 0 ) of NGF acting on E6  
DMTG neurons (Chapter 2 of this thesis), promoted the survival of TMN 
neurons. NGF at 25 Hg/ml also failed to promote the suiwival of TMN neurons. 
These results indicate that NGF at very high concentrations does not act as an 
agonist at the BDNF receptor expressed in TMN neurons.
To investigate whether NGF at very high concentrations could act as an 
antagonist at the BDNF receptor in TMN neurons, these neurons were grown 
with saturating and subsaturating levels of BDNF plus 5 [Xg/ml of NGF, Figure 
4.3 shows that the dose responses of TMN neurons to BDNF were very similar in 
the presence and absence of NGF. These results indicate that very high 
concentrations of NGF do not antagonise the action of BDNF on TMN neurons.
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50 um
Figure 4.2. Phase contrast micrograph of two ElO trigeminal mesencephalic neurons after 48 h 
in culture in medium supplemented with BDNF (5|igAnl)
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Figure 4 3 . Bar chart of the percent survival of ElO TMN neurons in control cultures and 
cultures containing either NGF or BDNF at concentrations of 2 ng/ml and 5 pg/ml. The mean 
and standard error are shown.
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Figure 4.4. Graph of the percent survival of ElO TMN neurons grown with BDNF at 
concentrations ranging from 3.2 pg/ml to 2 ng/ml either alone or with NGF at a concentration of 
5 ng/ml at each BDNF concentration. The mean and standard error are shown.
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VLTG neurons
Like TMN neurons, all VLTG neurons died in control cultures by 48 
hours incubation and almost 80% were supported by BDNF (Fig.4.5). Previous 
work has shown that VLTG neurons include a minor subset of NGF-responsive 
neurons in addition to BDNF-responsive neurons (Davies et aL, 1986b). In the 
current study, 5% of the VLTG neurons were supported by 2 ng/ml NGF, and 
increasing the NGF concentration to 5 |ig/ml caused only a further 10% increase 
in the number of surviving neurons. Eight percent of VLTG neurons were 
supported by 2 ng/ml of NT3. Increasing the NT3 concentration to 5 |xg/ml 
caused only a small additional increase (to 14%) in the number of surviving 
neurons. These data indicate that neither NGF nor NT3 at very high 
concentrations act as an agonists at the BDNF receptor expressed on the majority 
of VLTG neurons.
To investigate whether NT3 at very high concentrations could act as an 
antagonist at the BDNF receptor in VLTG neurons, these neurons were grown 
with saturating and subsaturating levels of BDNF plus 5 }ig/ml of NT3. Figure 
4.6 shows that the dose responses of VLTG neurons to BDNF were very similar 
in the presence and absence of NT3. These results indicate that very high 
concentrations of NT3 do not antagonise the action of BDNF on the great 
majority of VLTG neurons.
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Figure 4.5. Bar chart of the percent survival of ElO VLTG neurons in control cultures and 
cultures containing NGF, BDNF or NT3 at concentrations of 2 ng/ml and 5 pg/ml. The mean and 
standard error are shown.
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Figure 4.6. Graph of the percent survival of ElO VLTG neurons grown with BDNF at 
concentrations ranging from 3.2 pgAnl to 2 ng/ml either alone or with NTS at a concentration of 5 
jig/ml at each BDNF concentration. The mean and standard error are shown.
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DMTG neurons
The great majority of DMTG neurons died in contiol cultures by 48 hours 
incubation and 75% of the neurons were supported by 2 ng/ml of NGF (Fig. 4.7). 
Previous work has shown that DMTG neurons include a minor subset of BDNF- 
responsive neurons in addition to the major set of NGF-responsive neurons 
(Davies et al., 1986b). Figure 4.7 shows that almost 15% of the DMTG neurons 
were supported by 2 ng/ml BDNF. Increasing the BDNF concentration to 5 
|LLg/ml did not further enhance the survival of DMTG neurons but caused a small 
decrease in the number of suiwiving neurons. These data clearly indicate that 
BDNF at very high concentrations does not act as an agonist at the NGF receptor 
expressed on the majority of DMTG neurons. NT3 at a concennation of 2 ng/ml 
promoted the survival of 7% of the DMTG neurons, but increasing its 
concentration caused a greater than 4-fold increase in the number of surviving 
neurons to over 30%. Thus, it is possible that very high concentrations of NT3 
could promote neuronal survival by acting on the NGF receptor in an appreciable 
proportion of DMTG neurons.
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Figure 4.7. Bar chart of the percent survival of ElO DMTG neurons in control cultures and 
cultures containing NGF, BDNF or NT3 at concentrations of 2 ng/ml and 5 |ig/ml. The mean and 
standard error are shown (n=3).
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4.4. DISCUSSION
I have shown that neurotrophins exhibit a very high degree of specificity 
in the embryonic chicken trigeminal system. Whereas previous work has shown 
that a high concentration of NGF (5 |ig/ml) can promote the survival of the 
BDNF-dependent neurons of the E6  nodose ganglion (Rodriguez-Tebar et aL, 
1990), I have demonstrated that the same high concentration of NGF has no 
effect on the survival of BDNF-dependent ElO TMN neurons. Moreover, 5 
jj-g/ml of NGF has no effect on the dose response of TMN neui'ons to BDNF even 
at BDNF concentrations that are over 1.5 million-fold lower (3.2 pg/ml). 
Likewise, 5 [Xg/ml of NGF has negligible effect on the survival of the BDNF- 
dependent VLTG neurons. In the converse experiment, I have shown that a high 
concentration of BDNF (5 |ig/ml) has no effect on the survival of NGF- 
dependent ElO DMTG neurons. Thus, in the trigeminal system I find no 
evidence for agonist effects of NGF and BDNF acting at heterologous receptors 
at concentrations that are 6  orders of magnitude (Chapter 2 of this Thesis) greater 
than the EC5 0  for the prefeixed neurotrophin.
In contrast to the antagonist effects of high concentrations of NTS on the 
response of E8 nodose neurons to saturating levels of BDNF (Dechant et a i, 
1993a), I did not observe any antagonistic action of high concentrations of NT3 
on the response of ElO VLTG neurons to saturating or subsaturating levels of 
BDNF. The EC5 0  for BDNF acting on these neurons was unaffected by the 
presence of high concentrations of NT3. Taken together, these findings clearly 
demonstrate that some populations of neurons are able to discriminate between
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neurotrophins to a fai* greater extent than was previously appreciated. The only 
exception in the avian trigeminal system is the response of DMTG neurons to 
NT3, which is negligible with 2 ng/ml NT3 but increases to almost half of the 
number of neurons surviving with NGF with 5 pg/ml NT3. Previous in vitro 
studies of embryonic chicken DMTG neurons have shown that these neurons 
respond to low concentrations of NT3 at E6 and that the NT3 dose response 
shifts to higher NT3 concentrations with age (Chapter 2 of this Thesis). Thus, 
the response of DMTG neurons to NT3 at E12 essentially represents the tail-end 
of this response. Whether this response is mediated by very low, residual levels 
of TrkC expression at this stage or whether it is mediated via TrkA is not known.
What is the explanation of the differing abilities of neurons to 
discriminate between neurotrophins? The demonstiation that cross-activation of 
Trk receptor tyrosine kinases by heterologous neurotiophins is more restricted in 
neuronal cell lines than in fibroblast cell lines (Ip et aL, 1993), suggests that the 
molecular environment of the cell in which these receptors is expressed affects 
their ability to discriminate between neurotrophins. With regard to NT3 
discrimination, there is some evidence to suggest that gp75 may be involved. 
gp75 is expressed in PCI2 cells but not fibroblasts (Ip et aL, 1993) and 
expression of a truncated gp75 receptor in PC 12 cells results in decreased 
expression of wild type gp75 and increased neurite outgrowth in response to NT- 
3 (Benedetti et aL, 1993). Function-perturbing antibodies to gp75 also potentiate 
the response of PC 12 to NT3 (Clary and Reichardt, 1994). Moreover, 
sympathetic neurons from postnatal mice with a null mutation in the gp75 gene 
aie more sensitive to NT3 than sympathetic neurons from wild type animals (Lee 
et aL, 1994). Thus, direct or indirect interactions between Trk receptor tyrosine 
kinases and other co-expressed molecules may enhance the ability of Trk 
receptor tyrosine kinases to discriminate between neurotrophins. The differing
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abilities of various kinds of neurons to discriminate between neurotrophins could 
perhaps be due to differences levels of expression of these putative molecules. 
Alternatively, there could be structural variations in the ligand binding domains 
of Trk receptor tyrosine kinases expressed in different neurons that are 
responsible for differences in ligand discrimination. For example, TrkA and 
TrkC isoforms have been described that differ in their extracellular domains 
(Barker et aL, 1993; Gamer and Large, 1994) and a TrkA isoform that contains 
an 18 bp exon in the extracellular domain shows significantly higher activation 
by NT3 in PC 12 cells compared with the isoform that lacks this exon (Clai*y and 
Reichai'dt, 1994).
Why do neurons differ in their capacity to discriminate between 
neurotrophins? The concentrations of neurotrophins used in this and other 
studies (Rodriguez-Tebar et aL, 1990; Dechant et aL, 1993a; Dechant et aL, 
1993b) to test the ability of neurons to discriminate between neurotrophins are 
likely to be much greater than those normally encountered by neurons in vivo. 
Yet, quite clear differences were observed in the ability of neurons to 
discriminate between neurotrophins. Although these differences are clear-cut at 
veiy high neurotrophin concentrations, lower concentrations of the heterologous 
neurotrophin might have important in vivo effects on neurons whose 
discrimination between neurotrophins is not as stringent as others. Perhaps some 
degree of overlapping neurotrophin responses is important for some developing 
neurons whereas absolute neurotrophin specificity is essential for others.
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Chapter 5
TRKC mRNA EXPRESSION IN CHICKEN CRANIAL SENSORY AND 
SYMPATHETIC GANGLIA DURING DEVELOPMENT.
5.1. INTRODUCTION
The data presented in Chapter 2 demonstrates that chick neural-crest 
derived neurons show a marked decrease in the response to NT3 and BDNF 
during development, whereas NGF responsiveness remains unchanged. 
Curiously, neuronal populations that are placode-derived and BDNF dependent 
such as nodose and VLTG, do not appear to be additionally NT3 or NGF 
responsive at eaiiier developmental stages.
Mouse trigeminal neurons growing at low density in vitro also display a 
transient survival response to NT3 and BDNF during the earliest stages of target 
field innervation, before the onset of natural neuronal death and NGF 
dependence. The responsiveness to BDNF and NT3 is predominantly lost later in 
development as these neurons become dependent on NGF, however, a small 
subset of trigeminal neurons remain responsive to NT3 in vitro (Buchman and 
Davies, 1993). The data presented in chapter 3 backs up the results of these in 
vitro studies. A null mutation of the TrkB gene results in an early peak of cell 
death, compared with wild-type animals, coinciding with the stage when 
trigeminal neurons are responsive to BDNF in vitro. In the absence of TrkA,
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mouse tiigeminal neurons undergo increased cell death between E l3 and E l4, a 
time when they are responsive to NGF in vitro (Chapter 3 of this thesis; Pihdn et 
al, 1996).
Evidence is beginning to accumulate to suggest that the ability of a 
neuronal population to respond to neurotiophins, at least in the case of BDNF 
and NGF, is regulated at the level of neurotrophin receptor expression. The 
acquisition of NGF dependence in mouse trigeminal neurons is accompanied by 
a marked up-regulation in the expression of TrkA mRNA (Wyatt and Davies, 
1993). Trigeminal neurons express very low levels of TrkB transcripts during 
the stage of neurotrophin independence. Between ElO and E l2, when trigeminal 
neurons respond to BDNF, there is high level expression of a 9Kb transcript 
encoding the full length catalytic isofoim of TrkB. The level of this transcript 
decreases after E l2 as trigeminal neurons lose responsiveness to BDNF. In 
addition, there is a concomitant increase in the expression of 8.2Kb and 2.5 Kb 
transcripts that code for TrkB variants lacking the tyrosine kinase domain 
(Ninkina et al, 1996). It has been proposed that truncated foims of TrkB may act 
in a dominant negative manner to quench TrkB signalling and BDNF 
responsiveness. The expression of mRNA encoding the full length TrkB isofomi 
also parallels the acquisition of BDNF responsiveness in chick vestibular and 
nodose neurons (Robinson and Davies, 1996).
Because Trk receptors (Klein et al, 1991; Radeke and Feinstein, 1991; 
Holtzman et al, 1992) and gp75 (DiStefano et al„ 1992; Chao, 1994) can each 
mediate biological activities independently, it is not clear whether their 
expression is temporally correlated in neurotrophin responsive cells. In 
motoneurons there is a correlation between the onset of TrkB, but not of the 
gp75, expression and BDNF sensitivity (McKay et al, 1996). While this does not
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mie out a role for gp75 in mediating the effects of BDNF, it does indicate that 
TrkB alone may be capable of mediating the survival effects of BDNF 
(Weskamp and Reichai'dt, 1991). This may be also true among sensory neurons 
since high levels of TrkB ai'e expressed by a sub-population of DRG neurons, 
(presumably by cells responsive to BDNF), yet these cells express vei*y little 
gp75 (Ernfors et al, 1988). In mouse tiigeminal and superior cervical ganglia, 
gp75 and TrkA mRNAs are co-expressed from the earliest ages in development 
(Wyatt and Davies, 1993), whereas in developing chick vestibular and nodose 
ganglia gp75 mRNA expression precedes that of TrkB mRNA (Robinson et al, 
1996). While gp75 may increase the affinity of Trk proteins for neurotrophins, 
the role of gp75 in the context of neurons in vivo remains unclear. One possible 
explanation to account for the observed switch of neurotrophin responsiveness in 
developing neurons is that variations in the ratios of the high and low affinity 
receptors could affect the ability of neurons to discriminate between 
neurotrophins. The low affinity neurotrophin receptor, gp75, has been shown to 
increase the affinity of TrkA expressing cell lines for NGF (Benedetti et al, 
1993).
Determining the role that changing neurotrophin receptor expression 
plays in regulating the transient NT-3 survival response in neural-crest derived 
neuronal populations is potentially problematic. Unlike NGF and BDNF which 
show good receptor specificity, NT-3 can mediate biological effects via TrkA 
and TrkB in addition to its preferred receptor, TrkC (Lamballe et al, 1991; 
Davies et al, 1995). Any, or all of these receptors may therefore play a role in 
mediating the transient NT-3 survival response in developing neural crest derived 
neurons. Rat sympathetic neurons, like neural crest derived sensory neurons, also 
show a brief early NT-3 survival response in culture before they become NGF 
dependent (Di Cicco-Bloom et al, 1993). The sequence of TrkC and TrkA
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receptor gene expression detected in sympathetic neurons in vivo parallels the 
progression from NT-3 to NGF responsiveness. TrkC mRNA is highly expressed 
in mouse E15.5 SCG neurons, but decreases more than ten-fold by post-natal day
1. There is a reciprocal pattern of expression for TrkA mRNA whereby initial 
low levels of expression are increased 40-fold by birth (Binen et al, 1993; 
DiCicco-Bloom et al, 1993;Verdi and Anderson, 1994). Thus, in the case of 
sympathetic neurons, stage-specific responsiveness to NT-3 may reflect 
developmentally regulated expression of TrkC. In accordance with the lack of 
response of sympathetic neurons to BDNF, TrkB transcripts are not detectable in 
sympathetic neurons at any developmental stage (Fagan et al, 1996).
In chick embiyos, TrkC mRNA is present in neuron progenitor cells in 
the nascent, tiigeminal ganglion at stage 13 (Williams et al, 1995). TrkB mRNA 
expression does not appeai* until stage 19, peaks at E9 and then falls shaiply to 
much lower levels by E l8. TrkA mRNA is the last receptor mRNA to appeal' at 
stage 21/22 (embryonic day 3.5). TrkC mRNA has been detected as eai'ly as E3 
in the avian neural tube and DRG (Pinco et al, 1993; Kahane and Kalcheim, 
1994; Zhang et al, 1994). In the early stages of development, TrkC transcripts are 
only present in neural crest cell populations that have neurogenic potential and 
subsequently by a sub-population of differentiated neurons (Henion et al, 1995). 
A detailed analysis of early quail DRGs indicates that TrkC expression is limited 
to neuroblasts, and not to other cell types (Zhang et al, 1994; Henion et al,
1995). The very early onset of TrkC mRNA expression, prior to the appearance 
of an NT-3 survival response in neural crest-derived sensory neurons, is 
consistent with the multiple roles that NT3 appeal's to play in neurogenesis. 
Experimental evidence suggests that NT-3 can act as a differentiation factor, 
promote the survival of proliferating sympathetic and sensory neuroblasts and 
induce terminal mitosis in sympathetic and sensory precursors (Kalcheim et al,
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A1992; Write etal, 1992; DiCicco-Bloom etal, 1993; Gaese etal, 1994; ElShamy 
and Ernfors, 1996 a, b; El Sharay et al, 1996; Verdi and Anderson, 1994; Ockel 
etal., 1996).
In an attempt to determine the role that TrkC plays in mediating the early 
transient NT-3 survival response of sympathetic and sensory neurons, I have 
assayed the levels of TrkC mRNA in developing chick sensory and sympathetic 
ganglia. TrkC mRNA levels were assayed using both a sensitive quantitative RT- 
PCR technique (Wyatt and Davies, 1993) and a less precise semi-quantitative 
RT-PCR assay. The results show that TrkC mRNA is highly expressed early in 
development in these ganglia, and that TrkC mRNA levels fall at later stages of 
development. I have also investigated the regulation of TrkC mRNA expression 
in low density cultures of E6 DMTG neurons which were cultured for 24 or 48 h 
in the presence of different neurotrophins. Using this approach I have found that 
NT3 upregulates TrkC mRNA expression in vitt'o.
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A5.2. METHODS
DISSECTION AND CELL CULTURE TECHNIQUES
The neurons used in this study were from the DMTG and the lumbosacral 
pai'avertebral sympathetic chain. All procedures were carried out using standard 
sterile technique in a laminar flow hood. The DMTG dissection has already been 
described in Chapter 2. The separation of the neurons by differential 
sedimentation and the culture procedures were also described in Chapter 2.
The sympathetic chain
The sympathetic chain was removed using a pair of watchmaker's forceps 
after removing the thoracic and abdominal viscera .The chain was removed from 
mid-thoracic to sacral regions and separated from connective tissue using 
sharpened tungsten needles (Fig 5.1). The dissociation procedure was the same as 
that described for the other neurons in the Methods Section of Chapter 2. The 
neurons from the sympathetic chain ganglia are quite small early in development 
therefore it was only possible to separate neuronal cells from non-neuronal cells 
by differential sedimentation from ElO onwards.
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Figure 5,1. Camera lucida drawing of the ventral aspect of the lumbosacral region of an ElO 
chick embryo after evisceration showing the location of the sympathetic ganglia (Adapted from 
Davies, 1988).DRG; dorsal root ganglia; SC: sympathetic chain; SP: spinal cord.
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MOLECULAR BIOLOGY TECHNIQUES
1. RNA Isolation and Purification
The acid guanidinium thiocyanate RNA extraction method described by 
Chomczynski and Sacchi, (1987) provides a pure preparation of undegraded 
RNA in high yield. It is particularly useful for processing large numbers of 
samples and for isolation of RNA from minute quantities of cells or tissue 
samples. Immediately after removal from the animal, tissue was minced on ice 
and homogenised at room temperature with 500 (il of solution D (4M 
guanidiniun thiocyanate, 25mM sodium citrate, pH 7.0, 0.5% sarcosyl and O.IM 
2-mercapto-ethanol) in an Eppendorf tube. The following were added 
sequentially to the homogenate; 1/10 volume of 2M sodium acetate, pH 4, the 
same volume of water saturated phenol and 2/10 volumes of chloroform-isoamyl 
alcohol mixture (24:1). The reagents were mixed thoroughly by inversion after 
each addition . The final suspension was shaken vigorously for 10 sec, cooled on 
ice for 15 min and microfuged at 14,000 ipm for 15 min at 4°C. Following 
removal of the upper aqueous phase to a fresh Eppendorf, RNA was precipitated 
by the addition of two volumes of absolute ethanol or 0.6 volumes of 
isopropanol. The precipitate was allowed to foim at -20°C overnight. RNA was 
then recovered by microfuging at 14,000 rpm for 20 min and the resulting pellet 
was washed thoroughly with 70% ethanol before being allowed to dry. After 
resuspending the RNA pellet in 50pl of a buffer containing; lOmM Tris, 10 mM, 
MgCl2 and 20mM vanadyl ribonucleoside, contaminating DNA was removed by 
incubation with 20-30 units of RNA-free DNasel, for 1 hour, at 37°C. After this 
treatment the RNA tubes were removed to a 'DNA free' clean room that was
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reserved for setting up PCR reactions. The RNA was further purified using the 
RNAID kit from BIO 101. In brief, three volumes of 3M NaC103 were added to 
the RNA followed by 5-20 \il of RNA binding matrix (the exact volume was 
dependent on the amount of starting tissue or cells). After thoroughly mixing, the 
slurry was incubated at room temperature for 10 min to allow the RNA to bind to 
the matrix. The matrix was sedimented by brief centrifugation and washed with 
500 jxl of RNAID wash solution. This wash procedure was repeated twice 
followed by a final sedimentation of the matrix and complete removal of the 
wash solution. The RNA was then eluted from the matrix material by 
resuspension in 10- 50 \Ll of pure water (the exact amount depending of the 
amount of starting tissue or cells), followed by heating at 60“C for 5 min. 
Following centrifugation for 1 min at full speed, the RNA solution was removed 
to a fresh Eppendorf tube and stored at -80°C until required.
2. Cloning the cDNA competitor templates by PCR
In order to mate the cRNA contr ol or competitor species used to calibrate 
the quantitative RT-PCR assay, it was first necessary to isolate a fragment of 
TrkC cDNA encoding part of the tyrosine kinase domain.
2.a) Primer selection and PCR reaction
TrkC cDNAs were isolated by PCR using first strand cDNA from E8
chick brain. The cDNA synthesis reaction consisted of:
20 |il of Gibco Superscript buffer 
lO jllofQ .lM D TT 
10 fil 5[iM dNTPs 
l|il 100 pM Randon Hexanucleotides
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2.5 pi RNA guard 
Ipl of RNA from E8 chicken brain 
55 pi H2O
After incubating this mixture for a few minutes at 37°C, Ipl of 
Superscript (Gibco) was added and incubation was continued for further 30 
minutes.
To clone a cDNA fragment conesponding to the chicken TrkC tyrosine 
kinase domain, primers in the tyrosine kinase domain were designed based on 
alignment studies between the three chicken Trks (Fig 5.2). The regions chosen 
for primers contained the most mismatches between TrkC and the other Trks. 
The primers proved to be very specific, since the amplification using these 
primers produced only one single band (Fig 5.3). These primers were: 
sense: 5’TCCGACAAGGTCACAACTG 3' 
antisense: 5' TTGGCAGCCCGCAAGGAT 3'
PCR cycling conditions were; 40 cycles consisting of 94°C for 45 
seconds, followed by 5TC  for 30 seconds followed by 72°C for 30 seconds.
The PCR reaction mixture consisted of:
lOpl of first strand chicken cDNA from whole brain at E8. 
IplofdNTP 5mM 
4pl lOX Taq Buffer 
Ipl of MgCl2 
Ipl Taq polymerase 
5pl of each primer at 15nM 
13plH20
The PCR products wei‘e nan out on a 1.5% low melting agarose mini gel 
and the DNA band of interest was removed from the gel with a sharp razor blade. 
The agarose slice containing TrkC DNA was melted in three volumes of STE and
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subjected to phenol chloroform extraction. Basically, the same volume of phenol 
was added and the aqueous phase and organic phases were thoroughly mixed. 
The two phases were separated by centrifuging for 10 min at 13000 ipm and the 
supernatant was transfeired to a fresh Eppendorf tube. This process was repeated 
twice and was followed by an extraction with a mixture containing equal 
volumes of phenol and chloroform. The DNA present in the supernatant was 
precipitated by the addition of 2 volumes of ethanol and 1/10 vol of 3M NaAc. 
The precipitation was earned out overnight. The following morning, DNA was 
recovered by centrifuging for 5 min at 13000 rpm and the resulting DNA pellet 
was washed twice with 70% ethanol. The dried DNA was resuspended in 30-50 
jil of H2O. The purified DNA was then ligated into pGEM-T vector (Promega) 
according the manufacturers recommendations. The ligation mixture was used 
directly to transform highly competent E. coli X I1 cells (Maniatis, 1989).
2.b) Introducing Plasmids into E. Coli
Competent cells (E. Coli XLl Blue MRF’) were kept at -70°C. They 
were removed from the freezer and defrosted on ice. The cells were kept on ice 
throughout the whole of this procedure. 10|il of the ligation mixture was added to 
lOOfXl of competent cells in an Eppendorf and the mixture was incubated on ice 
for 40 minutes.
The tube was then transferred to a water bath at 42^C for 2 minutes (heat 
shock). The cells were returned to ice and 10 volumes of LB-medium, without 
antibiotic, were added. The cells were incubated at 37®C for 40 minutes before 
they were plated onto petri dishes containing LB agar and lOOmg/ml Ampicillin. 
This media was selective for cells containing the plasmid as the vector carried an
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ampicillin resistance gene. In some cases X-Gal and IPTG were also used as 
selectors for positive colonies. After 16 - 20 hours at 37°C, colonies were picked 
and used to inoculate 3ml of LB medium containing ampicillin. These cultures 
were grown for 10-16 hours at 37®C for mini-prep plasmid DNA extraction.
2.c) Plasmid DNA isolation by alkaline lysis
Isolation of plasmid DNA was performed by alkaline lysis (Birnboim 
and Doly,1979 and Birnboim, 1983). 3ml overnight cultures of E. coli were used 
for mini preparations of DNA. 1.5 ml Eppendorf tubes were filled with the E. 
coli cell suspension and gently centrifuged (6000rpm, 2 - 4  °C) for 3 minutes. 
The supernatant was poured off and the tubes were drained on a tissue. The pellet 
was resuspended in 200pl of solution number I (50mM glucose, 25mM Tris/HCl 
pH 8.0, lOmM EDTA and lOmg/ml of lysosyme). The pellet was resuspended in 
the solution using a rotamix and then put on ice for 10 minutes, 400|il of solution 
number II (0.2M NaOH and 1% SDS) was added and the solution was mixed 
gently. Subsequently, 300jil of solution number III (5M potassium acetate pH 
4.8) was quickly added, the solution was mixed gently and then put on ice for 30 
- 60 mins. The tubes were removed from the ice and the cell debris was pelleted 
by centrifuging at maximum speed (13,000 rpm) for 10 minutes. After 
transfeiTing the supernatant to another set of tubes, 500|il of isopropanol was 
added and the solution was mixed and left at -20°C for 30 minutes. The samples 
were then centrifuged at maximum speed (13,000 rpm) for 10 minutes to pellet 
plasmid DNA. After this, the supernatant was tipped off and the pellet was 
washed with 70% ethanol, followed by centrifugation at 13,000 rpm for 5 
minutes. The ethanol was emptied off and the pellet was dried under vacuum for 
20 minutes. After resuspending the pellet in 50p,l of water, lOOjil of 7.5M
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ammonium acetate was added and the mixture was left at -20®C for 30 minutes. 
Following centrifugation at 13,000 rpm for 10 minutes at O^C, the supernatant 
was removed to a new tube and lOOjil of isopropanol was added. The solution 
was then left at -20^0 for 10 minutes before being centrifuged at 13,000 rpm for 
10 minutes. Finally, the supernatant was tipped off, and the pellet was washed 
with 70% ethanol before being dissolved in 20jil of deionised water. Plasmid 
DNA was stored at -20“C. This method produced a purified sample of plasmid 
DNA suitable for restriction endonuclease digestion and sequencing.
When it was necessary the DNA was further purified by ammonium 
acetate and polyethylene glycol (PEG) precipitation. Briefly, two volumes of 7.5 
M ammonium acetate were added to the DNA solution. After 10 min at -20"C, 
the precipitated RNA, proteins and polysaccharides were removed by 
centrifugation for 10 min at 4° C (13 000 rpm). The DNA was precipitated from 
the supernatant with 0.6 volumes of isopropanol and following centrifugation, 
dissolved in water. An equal volume of PEG-NaCl solution ( 5.6g of PEG 6000; 
7ml of NaCl2 5M; H2 O up to 50ml) was added to the DNA solution. After 30 
min on ice, precipitated linear DNA was removed by centrifugation. Another 
volume of PEG-NaCl solution was added to the supernatant and the mixture was 
left for another 30 min on ice. Supercoiled plasmid DNA precipitates at this 
concentration of PEG and can be obtained as a pellet after centrifugation for 10 
min at 4“C (13 000 rpm). After a few washes with 70% ETOH the pellet was 
dried and resuspended in an appropriate volume of water. This pure DNA 
solution can be stored at -20“C for a few months. The DNA prepared by this 
method is as pure as that obtained by caesium chloride (CsCl2) gradient. DNA 
purification by the CsCl2 method stai'ts by pelleting cells from a large volume of 
culture (1 litie or 500 ml), at 10 000 ipm, in a Soiwall GSA rotor . The pellet was 
resuspended in 6ml of solution I and the tubes placed on ice. 2 volumes (12 ml)
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of solution II, were added followed by gently mixing. Immediately, 9ml of 
solution III were added and the lysate was incubated on ice for 10 min. The 
lysate was cleared by spinning at lOOOOrpm for 10 min in a Sorvall SS-34 rotor 
or equivalent. 0.6 volumes of isopropanol were added to the supernatant and the 
plasmid DNA was pelleted by spinning at 10 000 rpm for 10 min. The pellets 
were then well drained and resuspended in 6 ml of H^O in which 7g of caesium 
chloride was dissolved. To facilitate the separation of plasmid and chromosomal 
DNA bands, lOOjil of lOmg/ml ethidium bromide was added. The tubes were 
then topped up with liquid paraffin, carefully balanced and spun in a Beckman 
70Ti rotor, at 48 000 rpm, for at least 16h. The plasmid DNA was harvested 
through the wall of the tube using a syringe and needle. Ethidium bromide was 
extracted from the DNA by mixing with CsCl-isopropanol several times, 
allowing the phases to separate, and removing the upper non-aqueous layer. The 
clear final aqueous layer was diluted 2-fold with H2O and the DNA was 
precipitated with 0.6 volumes of isopropanol. The DNA pellet was washed with 
70% ethanol and ah" dried before resuspending in H2O. The concentration of the 
purified DNA was measured using a spectophotometer.
2.d) Restriction Analysis
Restriction endonucleases cleave double stranded DNA at specific sites 
within or adjacent to specific recognition sequences. Restriction endonucleases 
cleave DNA into discrete fragments in a sequence dependent manner. Such 
cleavage is used to generate fragments of DNA that can be subcloned in 
appropriate vectors, to confirm the presence of ligated inserts, or to generate 
fragments to be used as labelled probes in Northern or Southern blotting. 
Restriction endonuclease cleavage is accomplished simply by incubating the 
enzyme(s) with the DNA under appropriate reaction conditions. The amounts of
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enzyme and DNA, the buffer and ionic concentiations, and the temperature and 
duration of reaction will vary depending upon the specific application. In 
principle lU of restriction endonuclease completely digests Ijig of purified DNA 
in 60 min using the producer's recommended assay conditions. However, crude 
DNA preparations often require more enzyme and/or more time for complete 
digestion. The volume of restriction endonuclease added should be less than 1/10 
the volume of the final reaction mixture, because glycerol in the enzyme storage 
buffer may interfere with the reaction.
2,e) Electrophoresis of DNA
Electrophoresis of DNA was usually carried out in a 1% agarose gel. 
300ml of agarose-water mixture was heated for 4 minutes in the microwave to 
dissolve the agarose. When the solution was clear, 6ml of 50X TAB buffer (1 x 
TAB is 0.04M Tris-acetate, ImM EDTA, pH 7.5) and I5pl of lOmg/ml Ethidium 
bromide were added. The gel solution was left to cool before pouiing it into a gel 
ti*ay whose ends had been sealed with masking tape. Any air bubbles that were 
present were flamed with a Bunsen burner before gently adding the comb. When 
the gel had set, a small amount of TAE buffer was poured around the comb and 
the comb was removed. The electrophoresis tank was filled with IX TAE buffer 
until it just covered the gel. 15|ll of marker ladder solution (BRL) was then added 
to the 1st and to the last slot on the gel and the DNA digests were then loaded 
into the intervening wells (the whole tube volume was loaded). Electrophoresis 
was started slowly (lOOv) but when the samples had run into the gel the voltage 
was turned up to 200v. DNA fragment bands were observed under U.V. light.
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2.f) Subdoning fragments of DNA
The pGEM T vector into which the PCR isolated TrkC cDNA was 
initially cloned did not contain an appropriate restriction site to allow 
linearization of plasmid DNA prior to the generation of sense cRNA transcript. 
For this reason the TrkC cDNA was subcloned into the Bluescript vector. The 
TrkC cDNA was excised from the pGEM T vector with the restriction enzymes 
Sad and SacH and ligated into Sad and Sadi digested Bluescript vector.
O.lng of vector DNA, 0.5ng of TrkC cDNA fragment (isolated from a 
LMP agarose gel) and 2|il of ligation buffer (0.5M Tris pH 7.4, O.IM MgCl2, 
O.IM dithiothreitol, lOmM spermidine, lOmM ATP and 1 mg/ml BSA) were 
added to an Eppendorf tube and the final volume was made up to 10 (il with 
water. l|il (5 units) of T4 DNA ligase was added and the mixture was left in a 
water bath at 15^C for 3 hours for the ligation reaction to proceed.
2.g) Sequencing DNA
DNA sequencing was used to check the identity of the TrkC cDNAs 
cloned by PCR and the accuracy of the "filling" in reaction used to construct the 
TrkC cDNA control. The sequencing method used was the chain-termination 
method (Sanger et al, 1977). The chain-termination method involves the 
synthesis of a DNA strand by a DNA polymerase in vitro using a single-stranded 
DNA or a denatured double-stranded DNA as template. DNA synthesis is 
primed by a synthetic oligonucleotide and is carried out in two steps. The first is 
the labelling step and the second is the chain-termination step using 
dideoxynucleosides. In the first step, the primer is extended using limiting
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concentrations of the deoxynucleoside triphosphates, including radioactively 
labelled dATP. This step continues until almost complete incorporation of 
labelled nucleotide into DNA chains which are distributed randomly in length 
from several nucleotides to hundreds of nucleotides. In the second step, the 
concentration of all the deoxynucleoside triphosphates is increased and a 
dideoxynucleoside triphosphate is added. Processive DNA synthesis occurs until 
all growing chains are terminated by a dideoxynucleoside. During this step, the 
chains aie extended on average by only several dozen nucleotides. The reactions 
are terminated by the addition of EDTA and form amide. The products of the 
reaction are denatured by heating and resolved by electrophoresis.
I) Dénaturation of plasmid DNA;
4 - 5 }ig of plasmid DNA was denatured with 0.2M NaOH and 2mM 
EDTA in a final volume of 20pl over 10 minutes. The solution was then 
neutralised by adding 6|il of 7.5M ammonium acetate. The denatured DNA was 
precipitated by adding 100|il of ethanol and placing at -20^0 for at least 1 hour.
n) The sequencing reactions.
The DNA sample was removed from -20°C and centrifuged at maximum 
speed (13,000 ipm) for 10 minutes. The pellet was washed with 70% Ethanol and 
then centiifuged for a further 2 minutes. Following this, the 70% ethanol was 
poured off and the pellet was dried under vacuum.
The labelling mixture was made up for 12 DNA templates as follows:
155
24.6|il of nucleotide mixture (7.5mM dGTP, 7.5mM dATP and 7.5mM 
dTTP);12.3|il of DTT 0.1M;3.5ml of a dCTP (lOmCi/ml; 3000Ci/mmol) and 
2.5jal of water.
The solution was vigorously mixed prior to use.
The twelve 0.5ml Eppendorf tubes containing dry pellets of denatured 
DNA templates were prepared for the annealing reaction as follows. 2jil of 
sequenase reaction buffer (USB kit) was added to the side of each tube. Next, 
2jil of the appropriate primer was added to the side of the tube near the reaction 
buffer and 6jil of water was then added to the base of the tube. The buffer and the 
primer were tapped down and the whole mixture was vortexed followed by a 
brief spin in a microfuge. The mixture was left in a water bath at 37 for 15 
minutes before being left on the bench for 2 minutes to cool down prior to the 
labelling reaction. Next, forty eight 0.5ml Eppendorf tubes were prepared for the 
termination reaction. The lids were cut off the tubes and 2.5ql of the appropriate 
teiinination solution (USB kit) was added to the side of the tube, i.e. 4 rows of 12 
tubes with each row containing one of the four dNTPs. The solutions were 
tapped down and the tubes were then placed in a 37 “C water bath.
2.5ql of Sequenase 2.0 enzyme (USB kit) was diluted with 22.5ql of 
enzyme dilution buffer (USB kit), then the stock was immediately returned to 
-20°C.
The next step in the sequencing protocol was the labelling reaction. 3.5|il 
of the labelling mixture were added to the side of each of the tubes containing the 
annealed primer/template mixtures. 2jli1  of the diluted enzyme was then added to 
the side of each tube then both labelling and enzyme mixtures were tapped down 
to the base of the tubes. After 2 minutes at room temperature 3,5 ql of each of the 
products of the labelling reactions were quickly added to each of the termination
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solutions. All of this should be done at speed. The termination reactions were 
then placed in a water bath (37°C) for 5 minutes. After 5 minutes, 3jj,l of stop 
solution was added (USB kit) to stop the reactions This was added to the side of 
the tubes then it was tapped down. The tubes were then placed in a water bath 
(90°C) for 20 minutes to concentrate the mixtures and denature the DNA. 
Finally, the tubes were removed and put on ice prior to electrophoresis.
m ) Preparing the glass plates for electrophoresis of sequencing products.
One plate was silanized using dimethyldichlorosilane solution. This was 
liberally spread over the surface of the plate and vigorously rubbed in. The plate 
was then washed down with industrial methylated spirits and left to dry.
5ml of ethanol, 15|ll of acetic acid and 15p.l of Bind silane were mixed 
vigorously, and a second glass plate was coated with this mixture. The plate was 
washed with industrial methylated spirits and left to dry.
IV) Pouring the acrylamide gel.
29.4g of urea was added to 4.2g of an aciylamide/bis mixture (19:1). This 
mixture was made up to a final volume of 63ml using deionised water. When 
the reagents were completely dissolved, a small amount of deionising resin 
(AG50X8 (BioRad)) was added and the solution was stirred for another 10 
minutes. 7ml of the lOX electrophoresis buffer (108g of Tris base (890mM), 55g 
of Boric acid (890mM), 40 ml of 0.5 M EDTA pH8 (20mM) and made up to an 
end volume of 11, optimum pH of 8.3) was added to the solution which was 
subsequently filtered. 0.055g of ammonium persulphate was added and the 
solution was put under vacuum for ten minutes. The solution was removed from
157
vacuum and 45jil of TEMED was added to initiate polymerisation. The gel 
solution was rapidly poured between the two glass plates that had been 
previously prepared as described above. Care was taken to avoid producing air 
bubbles when pouring the gel. A sharktooth comb (48 slots) was positioned 
upside down between the two glass plates to produce an 0.3cm deep grove and 
the glass plates were clipped tightly together using bulldog clips. After 
polymerisation was completed, the bulldog clips were replaced with two slide-on 
clips and the system was transferred into the electrophoresis tank taking care to 
avoid air bubbles between the bottom of the plates, the presence of such bubbles 
can interrupt the flow of current through the gel. A thermometer was attached to 
the outside of one glass plate to ensure that the electrophoresis ran at the 
optimum temperature of 55°c. The comb was removed and the groove was 
washed with buffer using a syringe and needle. The gel was pre-run until the 
temperature reached the optimum of 55”C, after which the cunent was turned off 
and the comb was used to pierce the surface of the groove by about 1mm to 
produce 48 slots for sample loading. The gel was then loaded.
V) Loading the geL
The slots were rinsed using a syringe of buffer to remove any 
unpolymerised material and urea that had diffused out of the gel. 1.5|il of each 
termination reaction was added to each slot. Each template was loaded in the 
order T,C,G,A for ease of reading after developing the autoradiograph. 12 
samples could be loaded at once and then the tank had to heat up to the optimum 
temperature before any more samples were loaded. The electrophoresis was run 
at 50W constant power for either 3 -4  hours for a long run or 2 hours 15 minutes 
for a short run.
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VI) Fixing the gel to the glass plate.
After electrophoresis had finished and the glass gel plates were separated, 
the gel stuck to the glass plate that had been pre-treated with Bind Silane. This 
glass plate was soaked in 10% Acetic acid until the marker dye was no longer 
visible. The glass plate was then baked in an oven (80°C) for 20 minutes. The 
glass plate was removed from the oven and allowed to cool down.
Vn) Loading the film.
The glass plate was taken to the dark room where a Kodak X-ray film 
was placed over it. Another glass plate was placed over the film and the two 
plates were clamped together using bulldog clips. The plates were wrapped in 
black plastic and a cloth, to keep the light out, and stored in a cupboard 
overnight. The film was then developed and read from the base upwards and the 
sequence noted.
3. Quantitative and Semi-Quantitative RT-PCR assay
Traditionally, levels of individual mRNAs have been analysed by 
procedures such as Northern blots, RNA dot/slot blots, nuclease protection and in 
situ hybridisation. Application of the polymerase chain reaction (PCR) technique 
provides another method of mRNA analysis. The PCR-based method has been 
variously termed; RNA-PCR, RT-PCR, RNA phenotyping and Message 
Amplification Phenotyping (MAPPing). The teim adopted by this study is RT-
159
PCR. RT-PCR has been shown to be thousands of times more sensitive than the 
traditional RNA blotting techniques. This exquisite sensitivity gives RT-PCR the 
ability to detect extremely raie mRNAs, in addition to mRNAs in small numbers 
of cells and cell specific mRNAs expressed in mixed-cell populations.
While RT-PCR is an extremely sensitive method of mRNA analysis, 
obtaining quantitative information with this technique can be very difficult. This 
is due primarily to the fact that there are two sequential enzymatic steps 
involved: the synthesis of DNA from the RNA template and the polymerase 
chain reaction. In practise, the exponential nature of the polymerase chain 
reaction and the practical aspects of performing PCR pose the most serious 
obstacles to obtaining quantitative information. With some adaptations, however, 
RT-PCR can yield accurate quantitative results.
Apart from the quantitative RT-PCR assay, I also performed semi- 
quantitative RT-PCR analysis in part of my studies. This approach is not so 
accurate and precise but gives an idea of the relative levels of expression of a 
target molecule in different samples.
The goal of quantitative PCR is to deduce, from the final amount of PCR 
product, either the initial number of target molecules (No) or the relative starting 
levels of target molecules among several samples. Several methods are 
commonly used to quantify PCR products. The most straight forward approach is 
to measure the incorporation of labelled nucleotides or primers into PCR 
products resolved by gel electrophoresis. Although direct, the use of labelled 
nucleotides in PCR can be problematic. For this reason, I decided to use 5' end- 
labelled PCR primers rather than labelled nucleotides.
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In this study a quantitative and a semi-quantitative reverse 
transcription/polymerase chain reaction (RT/PCR) technique has been employed 
to determine the developmental expression of TrkC mRNA in peripheral 
neurons. The quantitative RT-PCR technique is based on the co-reverse 
transcription and co-amplification of TrkC mRNA and a slightly larger, in vitro 
transcribed, TrkC RNA control (4bp were inserted between the PCR primer 
sites). The PCR products of the control and native cDNA templates were 
resolved on 7% non-denaturing polyacrylamide gels that were subsequently dried 
and autoradiographed. Reactions were set up such that the autoradiographic 
signals from the PCR products of the native and control cDNA templates were 
approximately equal. The autoradiographs were scanned with a Molecular 
Dynamics Personal Laser Densitometer and the intensity of the respective signals 
was ascertained using ImageQuant software (Molecular Dynamics). These values 
enabled the levels of TrkC mRNA in the initial total RNA to be calculated.
Total RNA (Chomczynsky and Sachi, 1987), spiked with known amounts 
of the appropriate control RNA, was reverse transcribed for 45 minutes at 37“C 
with Gibco BRL Superscript enzyme in a 10 p.1 reaction containing the 
manufactures's buffer supplemented with 0.5 mM dNTPs and 10 |iM random 
hexanucleotides. Each reverse transcription reaction was then gently mixed with 
40|il PCR solution comprising IX NBL Taq DNA polymerase buffer, 1 unit of 
NBL Taq DNA polymerase, 40 jil of 5' end labelled primers and 0.2 mM dNTPs.
In some instances, due to shortage of time, a semi quantitative technique 
was used. The quantitative RT-PCR reaction was time consuming because it 
required a number of preliminary reactions to determine the coiTect amount of 
control cRNA to use. The semi quantitative technique gives an idea about the 
comparative level of expression of TrkC mRNA throughout the developmental
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period of interest. It consists of amplifying the same amount of target cDNA with 
labelled primers for L27 and TrkC. The levels of TrkC were estimated by 
comparison with L27 levels amplified with the same amount of cDNA from the 
same samples. The products of these separate reaction were mn either together or 
separately in a 7% acrylamide gel and the bands scanned on a densitometer. 
Relative levels of TrkC mRNA were calculated by normalising TrkC cDNA 
signals against the amount of L27 mRNA in each cDNA sample.
The initial primers used for PCR were located in the extracellular domain 
of chicken TrkC. This domain shows the least conservation sequences between 
the three Trk receptors.
Following the cloning of various isoforms for TrkC (Williams et al, 
1993) it became evident that the primers within the extracellular domain were 
recognising various different isoforms of TrkC and not just the full length 
isoform. In a bid to design an assay specific for the full length TrkC isoform, I 
then decided to use primers at the 3' prime end of the TrkC cDNA which contains 
untranslated sequence. However, Okazawa et al (1993) showed by Northern 
Blotting analysis that a probe encompassing this region hybridises to various 
TrkC mRNAs from 9 kb to 0.4 kb. The bands smaller than 1.2 kb are incapable 
of encoding the full length and therefore represent truncated isoforms. 
Therefore, I finally decided to make a very accurate compar'ative analysis of the 
highly homologous tyrosine kinase domains of the three different Trks (TricA, 
TricB and TrkC) and design very specific primers in that region for TrkC. In this 
way I was certain of only amplifying full lenght TrkC. The primers used to 
amplify the full length form of chicken TrkC were:
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5’ CCAGCATATTAAGAGAAGA 3’ 
and
3' GGTCGTAAAACAGTAACC S’
They hybridise 116 bp apart (Fig 5.3).
In the case of the quantitative RT-PCR assay, chicken TrkC control 
cRNA transcripts synthesised from the chicken TrkC cDNA that has been cloned 
by PCR, were included in the initial RT reaction.
In order to compare the relative level of TrkC mRNA in developing 
sensory neurons at different ages, the level of the mRNA encoding the 
ubiquitous, constitutively expressed L27 ribosomal protein was also measured in 
all RNA samples.
The primers used for the quantification of L27 mRNA were:
(S’) S’ GGCTGTCATCGTGAACAT (3’) 
and
(3’) S’CTTCGCTATCTTCTTCTTGCC (S’)
These primers hybridise 127 bp apart in the chicken L27 sequence 
(Lebeau et al, 1991) and were radio labelled as described for TrkC primers. The 
level of L27 mRNA in the extracted RNA was quantified in some cases by co­
reverse transcribing cellular RNA with run-off cRNA transcripts synthesised 
from an L27 cDNA that has an additional 4bp inserted between the primer 
annealing sites. The results are expressed as the quotient of the amount of TrkC 
mRNA and the amount of L27 in RNA extracted from various populations of 
sensory neurons.
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3.1. Synthesis of RNA control templates for Quantitative RT-PCR
In order to make the controls in each group of experiments more accurate 
and reproducible within any particular study, all experiments within a group used 
the same batch of control RNA templates that were transcribed, purified and 
quantified in one procedure. The control cDNA template, used to produce the 
control cRNA for the TrkC RT-PCR assay, was made by cleaving the cloned
cDNA at a single internal Styl site, filling in the 5' overhangs with Klenow
fragment of DNA polymerasel and religating the resulting blunt ends.
Control RNA transcripts were transcribed in a 200|il reaction containing 
the following:
40 |il of 5X tianscription buffer (40mM Tris, pH 7.9; 6mM MgCl2; 2mM
speraiidine)
8 III of 10 mM ATP 
8 III of 10 mM UTP 
8 pi of 10 mM GTP 
8 pi of 10 mM CTP 
8 pi of 100 mM DTT 
5 pi of RNA guard (40U/ pi)
3 pi of Sp6 (or T7, or T3) RNA polymerase (16 U/pl)
5 pi of linearized DNA template (Ipg/pl)
107 pi of H20.
Following incubation at 37°C for one hour, a further 3 pi of polymerase 
were added and the reaction was allowed to proceed at 37°C for another hour. At 
this point ribonucleoside vanadyl complexes (VRC's) solution were added to a 
final concentration of 10 mM. Template DNA was removed by the addition of
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50 Units of RNase free DNase I (Pharmacia) followed by incubation at 37 °C for 
60 minutes. The DNase reaction was stopped by the addition of 600 pi of 3M 
NaClOs and 50 pi of RNaid matrix (from RNAid k it). After thorough mixing, 
the slurry was incubated at room temperature for 5 minutes to allow RNA to bind 
to the solid matrix. Following the sedimentation of the RNaid matrix by brief 
centrifugation, the aqueous phase was removed and discarded and the matrix 
containing the bound DNA was washed twice with ice cold RNaid wash solution. 
RNA was eluted from the matrix by adding an appropriate volume of water 
(depending on the starting amount of tissue or cells) and incubating at 60°C for 5 
minutes. Following a brief centrifugation to sediment the matrix, the RNA 
solution was removed to a fresh microfuge tube and placed on ice. An aliquot of 
the RNA solution was used to determine the RNA concentration 
spectrophotometrically, after which the RNA was diluted and precipitated by the 
addition of 0.1 volumes of 3M NaAc, 3 volumes of ETOH and E. coli tRNA 
such that the final mixture contains 1 ng of transcript RNA and 100 ng of E, coli 
tRNA per microlitre. Finally the ethanolic mixture was aliquoted into individual 
0.5 ml Eppendorf tubes in 50 pi aliquots (50 ng each). Ethanol precipitated 
transcripts were stored at -20°C until required.
3.2. Labelling primers
Primers were labelled with P on their 5‘ ends in a 40 pi reaction 
containing the following:
4pl of lOX T4 PNK buffer ( 0.5 M Tris, pH 6, lOOmM MgCl2. ImM spermidine,
50mM DTT, ImM EDTA)
Ipl of each primer (1-2 pg/pl)
30 pi of ^ 2p ATP (3000ci/mmol, 10 mci/ml )
4 pi of T4 polynucleotide kinase (10 units/ pi).
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Following thorough mixing, the labelling reaction was carried out at 37° 
C for 45 minutes. Primers were purified from the labelling reaction mix using the 
"MERMAID" oligonucleotide purification kit (BIO 101). Basically this 
purification involves three steps; Three volumes of the binding salt were added to 
the reaction mix followed by 50 pi of the oligonucleotide binding matrix. After 
thorough mixing, the slurry was left at room temperature for 10-15 minutes to 
allow the primers to bind to the matrix. Following the completion of primer 
binding, the matrix material was pelleted by brief centrifugation and the high salt 
solution removed with a pipette. The pellet was then washed twice with 500 pi of 
"MERMAID" wash solution before final centrifugation and removal of the last 
drops of the washing solution with a fine micropipette. The matrix pellet was 
then resuspended in 200 pi of water and the primers were eluted from it by 
incubating at 60°C for 5 minutes. Following sedimentation of the binding matrix 
by centrifugation, eluted primers were removed to a fresh Eppendorf tube and 
stored at -20“ C until required
3.3. Reverse Transcription
Reverse transcription reactions were carried out in a 'big scale' reaction. 
For the quantitative RT-PCR assay, the two different competitors control RNAs 
(TrkC and L27) appropriately diluted, plus the target RNA were transcribed 
together. For the semi-quantitative PCR analysis, PCR amplification using 
different primers (either TrkC or L27) was also performed on cDNA from the 
same reverse transcription reaction. Basically each reaction has 3 pi of total 
RNA (or more in case of absence of control RNAs), 1 pi of each of the control 
RNA, 15 pi of reverse transcription mix, 1 pi of Superscript Reverse
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Transcriptase (Gibco BRL). For negative controls RNA was replaced by 2pl of 
water. Reverse transcription mix was made as a master mix for each batch of 
reverse transcription reactions being carried out. The use of a master mix ensured 
uniformity of conditions in all reactions carried out using that mix. The total 
volume of the master mix that was made up for each set of reverse transcription 
reactions was given by: v (pî)- (n-fl) x 17 where n is the number of reactions 
being carried out (enough of the master mix was made up to be sufficient for 
(n+1) reactions to allow for inaccuracies in pipetting when aliquoting the master 
mix to each individual reaction tube). If the term (nfl) is replaced by the symbol
then the composition of the master mix is:
2 X (’*') pi of Gibco Superscript buffer 
1X(*) pi of O.IM DTT 
2X (*)plof5m M dN TP 
1 X (*) pi of 100 pM random hexanucleotides 
0.25 X (*) pi of RNA Guard 
Make up to volume (v) with water.
The actual reaction was done in 0.5 ml Eppendorf tubes where the 17 pi were
carefully pipetted followed by the addition of the RNA samples. The tubes were
then removed to the PCR machine which should be set at 37°C. After 2 minutes
of these tubes being at 37®C 0.5 pi (100 units) of Superscript was added to each
reaction and the reactants were carefully mixed by drawing backwards and
forwards through a micropipette tip. In the case of a reverse transcription minus
control. Superscript was not added to the reactions. Following a brief spin in a
microfuge, the Eppendorfs were transferred back to 37°C and incubated for 45
minutes. In some cases RNA secondary structure may result in poor yields of
certain cDNA species. If the proposed PCR template results in such cDNA
species, it will be necessary to remove secondary structure from the region of
RNA concerned, before adding the RNA to the reverse transcription reaction, by
heating to W C  for 5 minutes followed by quenching on ice.
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3.4. PCR assay
Following reverse transcription, reactions were centrifuged briefly to 
return the tube contents to the bottom of the tube. The products of the reverse 
reaction were prepared for amplification by the addition of 40 pi of PCR mix. 
PCR mix was a master mix that contained all the additional components required 
for the PCR amplification, including the thermostable Taq polymerase. The total 
volume of the PCR master mix required was calculated in a similar way to the 
reverse transcriptase master mix and was equal to (n-fl) X 40 pi where n was the 
number of PCR reactions being carried out.
The master mix, was composed of:
4X (nfl)pl of lOX PCR reaction buffer (from Promega)
IX (n-hl)pl of MgCh (25mM) 
lX (n+l)plof5m M  NTP's 
4X (nf l)pl of labelled primer mix 
0.3X (nfl) pi of Taq polymerase 
Made up to a volume V with H2O
The above PCR mix composition was ideal for amplification of the 
cDNA template when it was present at 5-100 fg in the reaction. With different 
target cDNA concentrations it was necessary to adjust the composition of the 
PCR mix slightly to achieve optimal results.
Following addition of the PCR master mix to the products of the reverse 
transcription reaction, the two solutions were mixed and overlaid with 40pl of
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mineral oil. The reactions were then transferred to the heating block of a PCR 
machine where they were subjected to a number of cycles of denaturing, 
annealing and synthesis.
The exact parameters set for denaturing, annealing and synthesis, in terms 
of temperature, time and numbers of cycles, were dependent on the nature and 
concentration of the cDNA template to be amplified and largely had to be 
determined empirically.
Cycling parameters used for the amplification of the 116 bp chicken TrkC 
cDNA fragment consisted of 27 cycles of 45 seconds at 94“C, 45 seconds at 
56“C, 1 minute at 72“C, followed by a final incubation at 72“C for 10 minutes to 
ensure all single stranded templates were converted to a double stranded form.
L27 cDNA was amplified by 18 cycles of 94“C for 1 min, 60“C for 45 sec 
and IT C  for 45 sec followed by a final elongation step of 10 min.
Following the completion of amplification, reactions were removed from 
the PCR room to a room set aside for the analysis of PCR products.
3.5. Electrophoresis of PCR products
The PCR products were separated by electrophoresis on non-denaturing 
polyacrylamide gels. Because the size difference between the two products was 
only about 4%, it was important to ascertain the optimum polyacrylamide 
concentration with regards to maximum separation of the products. This was 
determined empirically and it was found to be 7% of 19:1 acrylamide-bis. The
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vertical gel apparatus used was Gibco V-15.17 that produces gels of 20 cm X 25 
cm, 0.8 mm thick and can accept 20 samples (10 pi each). After siliconising one 
of the glass plates, the gel apparatus was assembled according to the 
manufactures instructions.
About 100 pi of ammonium persulfate was added to 30 ml of gel solution 
and the solution was degassed for 20 min. Before pouring the gel solution 
between the glass plates, 45 pi of TEMED was added to initiate the 
polymerization of the acrylamide. The polymerised gel was inserted into the gel 
apparatus and tlie buffer reservoir were filled with IX TBE. After flushing the 
wells of the gel with buffer to remove unpolymerised acrylamide, the samples 
were loaded into the wells and the gel was run at a constant 350V. To obtain 
maximum resolution of PCR products, they were run as close as possible to the 
end of the gel.
At the end of electrophoresis, the gel plates were carefully parted, leaving 
the gel attached to the non siliconised glass plate. The gel was then transferred to 
Whatman 3MM paper and subsequently dried for 30 min at 60° C on a slab gel 
dryer. After the gel was thoroughly dried, it was autoradiographed. The relative 
intensities of the autoradiographic signals of the control cRNA and mRNA RT- 
PCR products were ascertained using a Molecular Dynamics laser densitometer 
with Image Quant software.
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5.3. RESULTS 
Specificity of the primers
A fragment of chick TrkC cDNA corresponding to the tyrosine kinase 
domain was cloned by PCR. This unique band (Fig. 5.2) was cut out from the 
gel and the identity of the cloned cDNA was verified by sequencing.
To select appropriate primers, either for cloning TrkC or for the RT-PCR 
amplification that will only amplify TrkC and not the others members of the trk 
family, an alignment of the chicken TrkA, TrkB and TrkC sequences was done 
using GCG software (Fig.5.3), For the RT-PCR assay primers in the tyrosine 
kinase domain were used to ensure that only the full length catalytic isoform of 
the receptor was amplified. The identification of the region in the tyrosine kinase 
domain that contained most abundant mismatches between TrkC and the other 
Trks was done manually. Using the computer software, Amplify 2.1., I tested the 
assay primers chosen against other known nucleotide sequences. A preliminary 
test was made using chicken TrkA, TrkB and TrkC sequences and only one 
major and specific product originated from the TrkC sequence.
To allow the construction of a control cDNA species for the RT-PCR 
assay the cloned chicken TrkC insert was subcloned in pBluescript SK^ in the 
Sad and SacII sites, and the unique Styl site was filled in. The filling in reaction 
was checked by sequencing the modified TrkC DNA and then RNA was 
synthetised in vitro.
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For quantitative PCR analysis, target mRNA in total RNA from neuronal 
samples was co-reverse transcribed with a slightly larger control RNA (prepared 
from TrkC or L27 cDNAs) and the resulting cDNA's were co-amplified by PCR, 
as described in detail in the Methods section of this Chapter. Co-reverse 
transcription and co-amplification of target mRNA and a control RNA negates 
the effects that a number of variables can have on reaction efficiency and on the 
RT-PCR product yield. For the semi-quantitative PCR analysis, a large reverse 
transcription reaction was set up only for the target RNA. To determine the 
reliability of the quantitative RT-PCR technique, reactions were carried out using 
known quantities of target and control RNA transcripts. During the log-phase of 
the reaction, the ratio between the reaction products was identical to the initial 
ratio of target and control RNAs, regardless of the starting quantities of these 
RNAs (data not shown).
Examples of an autoradiograph showing the separate target and control 
RT-PCR products for the TrkC mRNA are given in Fig 5.4.
Figure 5.2. Photograph of an agarose mini gel in which the unique TrkC PCR product is 
resolved (A) 205bp band, (B) 1Kb ladder DNA.
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Figure 5.3. Alignment of nucleotide sequences encoding chicken TrkA, TrkB and TrkC. The thin 
external arrows below the nucleotide sequence (1461-1666) indicate position and orientation of primers 
used for PCR amplification for cloning of a TrkC fragment. The internal thin arrows below the 
sequence (1504-1620) indicate the primers used for quantitative and semi-quantitative RT-PCR 
amplification. The arrowheads denote the transmembrane domain.
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BFigure 5. 4. Reliability of the quantitative RT-PCR technique. The autoradiograph shows the 
product of RT-PCR amplified with TrkC-spccific primers. (A) Reaction containing total RNA 
from E8 DMTG neurons, (B) Reaction containing Ing of control template, (C) Reaction 
containing both sets of the respective amplification products.
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TrkC ïïiRNÂ expression in chicken brains.
A semi-quantitative RT-PCR assay was used to measure the levels of 
TrkC mRNA in total chick brain RNA during development fiom E6 to P3. Chick 
brain total RNA was reverse transcribed and an equal amount of the resulting 
cDNA was amplified either with PCR primers specific for the tyrosine kinase 
domain of TrkC or with primers specific for the L27 ribosomal protein. TrkC 
mRNA was abundantly expressed at E6. At this age an additional RT-PCR 
product of bigger size was detected (Fig 5.5.). The level of TrkC mRNA 
decreased dramatically in later stages of development (Fig. 5.6.).
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Figure 5.5. Autoradiograph showing full length TrkC mRNA expression in chick brains. PCR 
reaction using TrkC and L27 primers to amplify cDNA from chicken brains at different ages. 
The top band represents the RT-PCR products of TrkC mRNA (116 base pairs) and the bottom 
band represents the RT-PCZR product of L27 mRNA (127 base pairs)
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Figure S, 6. Expression of TrkC mRNA in chicken brains. The bars represent the relative level 
of TrkC mRNA at each age after normalising to the level of L27 mRNA. Mean ± range between 
2 values is shown.
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TrkC mRNA In DMTG neurons
Quantitative RT-PCR was used to measure full length TrkC mRNA levels 
in total RNA extracted from pure preparations of DMTG neurons obtained from 
E8, ElO, E12 and E14 chicken embryos. At E6 it is not possible to separate 
neuronal from non-neuronal cells via the differential sedimentation technique due 
to the smaller size of the neurons. Therefore, the sample analysed at E6 contains 
some RNA from non-neuronal cells as well. There is a high expression level of 
TrkC mRNA at E6. At this age an additional RT-PCR product of bigger size is 
produced with the primers used. Perhaps it represents an alternatively spliced 
isoform of TrkC. From E8 onwards the level of TrkC mRNA is lower compared 
with the level of expression at E6 (Fig. 5.7.). This result is in accordance with 
the decrease survival response for NT3 of DMTG neurons during development. 
However, full length TrkC mRNA can still be detected at later stages of 
development (El2-El4) when very few of DMTG neurons are responsive to NT3 
in culture (Chapter 2). Full length TrkC mRNA was also detected in non 
neuronal cells. The TrkC levels for purified neurons were expressed relative to 
mRNA levels for the ubiquitous and constitutively expressed L27 ribosomal 
protein, which were also determined by RT-PCR.
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Figure S. 7. Graph of the level of TrkC mRNA relative to L27 in chicken DMTG neurons during 
development. The means and standard errors of measurements from three sets of neurons. Mean 
± standard errors are shown (n=3).
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The regulatios of TrkC expression by neurotrophins
In Chapter 2 it was shown that DMTG neurons are responsive to NT3 
and BDNF in early stages of development (E6-E8) and become exclusively 
dependent on NGF in later stages of development (EIO onwards). To investigate 
the influence of neurotrophins on the regulation of TrkC mRNA expression, 
quantitative RT-PCR was used to measure the levels of TrkC transcripts in very 
low density cultures of E6 DMTG neurons growing with or without 
neurotrophins. The neurotrophins were added at the time of plating and the 
neurons were left to grow for 48h before RNA was extracted for RT-PCR assay. 
Figure 5.8. shows that NT3 at low concentration (2ng/ml) up-regulates the 
expression of TrkC mRNA. No correlation was found between increased 
concentration of NT3 and higher levels of TrkC mRNA. Also, no increase in 
TrkC mRNA levels above control cultures was found when NGF or BDNF were 
administered to these cultures either in low (2ng/ml) or high concentrations 
(5|ig/ml).
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Figure S. 8. Expression of TrkC mRNA in DMTG neurons in culture. RNA was extracted after 
48 hours o f cells being in culture in 35 mm dishes supplemented with different neurotrophins (N, 
NGF; B, BDNF; 3, NT3)at 2ng/ml (L ), lOng/ml (M) or 5|ig/ml (H). Mean ± standard errors are 
shown (n=3)
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TrkC mRNA expression In sympathetic ganglia
Chick sympathetic neurons from the sympathetic chain survive in culture 
for at least 48h without neurotrophic support (Emsberger and Rohrer, 1989). 
Later, at EIO, they become highly dependent on NGF for survival in vitro . 
Holtz et al (1992) have shown that these neurons do not express TrkA at E7 and 
the expression of TrkA coincides with the acquisition of NGF dependence by 
these neurons. An investigation of TrkC mRNA expression was carried out in 
sympathetic ganglia from E7 to E14. Non-quantitative analysis by RT-PCR 
shows that initial high levels of TrkC mRNA at E7-E8 are dramatically reduced 
by EIO (Fig. 5.9.). Surprisingly, the level of TrkC mRNA expression increases 
after EIO, a period when these neurons are not responsive to NT3 (Fig. 5.10.). 
This later increased expression of TrkC mRNA levels is in accordance with the 
expression of TrkC mRNA in rat adult sympathetic neurons (Freda-Miller 
personal communication). However, these neurons do not respond to NT3 at later 
stages of development (Dechant et al, 1993).
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Figure S. 9. Graph showing the relative levels of TrkC mRNA in chicken sympathetic neurons, 
during development. Mean ± range between two values is shown. The values shown at each age 
are normalised to the levels of L27 mRNA.
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5.4. DISCUSSION
The major aim of this study was to investigate the timing and regulation 
of TrkC mRNA expression in developing sensory and sympathetic neurons. TrkC 
mRNA levels were measured using both a semi-quantitative RT-PCR assay and 
also a quantitative RT-PCR assay that used a cRNA control template, added to 
the reverse transcription reaction, to calibrate the assay. Initially, primers in the 
extracellular domain of TrkC were used for amplifying TrkC cDNA in the RT- 
PCR assay. This region has the least homology between the three Trks («40%) 
and therefore facilitated the design of an RT-PCR assay that would detect TrkC 
mRNA but not TrkA or TrkB mRNAs. However, during the course of study 
various forms of chick TrkC were discovered by other groups, including an 
isoform that lacks the tyrosine kinase domain and therefore presumably is 
incapable of transducing a signal upon NT-3 binding (Gamer and Large, 1994; 
Okazawa et al., 1993). To date, the role that truncated isoforms of TrkC play in 
NT-3 signalling is largely unknown. However, the isolation of truncated TrkC 
isoforms both in mammals and in chicken seems to suggest that they serve some 
function. Clues to the functions of tmncated TrkC have been obtained from 
studies of the TrkB receptor that also exists as a truncated isoform lacking the 
tyrosine kinase domain (Klein et al, 1990). In mouse, the periventricular 
expression pattern of TrkB is compatible with the idea that the truncated form 
might function as a scavenger receptor or as a transporter. Alternatively, 
truncated forms of Trk receptors might act as competitors against the catalytic 
form in a similar manner to truncated forms of the epidermal growth factor 
receptor (EOF) (Redemann et al, 1992). Data from experiments with mouse 
trigeminal neurons supports this hypothesis. In these neurons, expression of full
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length catalytic TrkB alone confers a survival response to BDNF, whereas co­
expression of truncated TrkB substantially reduces the BDNF survival response 
but has no effect on the NGF survival response. This suggests that BDNF 
responsiveness in developing sensory neurons is modulated by the relative levels 
of catalytic and truncated TrkB (Ninkina et al, 1996), In accordance with this 
hypothesis truncated and catalytic full length isoforms of TrkB appear to be co­
expressed in the same neurons in the mouse CNS (Axmanini et al, 1995).
Since the role of truncated TrkC receptors has yet to be fully 
characterised, I decided to restrict my studies of TrkC mRNA expression to 
mRNA that encodes the full length isoform of the receptor. For this reason I 
designed an RT-PCR assay that amplified a region of TrkC cDNA within the 
cytoplasmic kinase domain. The kinase domain is extremely well conserved 
between the different Trk receptors, both at the amino acid and the nucleotide 
level. For this reason, it was necessary to perform a sequence alignment between 
the different Trk receptors in the kinase domain and choose PCR primers in 
regions that showed the least homology between TrkC and the other Trk 
receptors
Timing of expression of TrkC mRNA
Quantitative RT-PCR has shown that full length TrkC mRNA is 
expressed at high levels at early stages in DMTG neurons and that the level of 
expression decreases at later ages. The decrease in TrkC mRNA expression that 
occurs as DMTG neurons mature is reflected by a the loss in responsiveness of 
DMTG neurons to NT-3 in culture (see Chapter 2) suggesting that the timing of 
NT3 responsiveness is controlled by the expression of its receptor. The same 
developmental correlation between neurotrophin responsiveness and
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neurotrophin receptor mRNA expression was observed in sympathetic neurons, 
from the paravertebral sympathetic chain. Although immature E7 chicken 
sympathetic neurons proliferate and survive in culture for several days 
independently of neurotrophic factors (Emsberger et al, 1989), NT-3 promotes 
their long term survival in culture. However, NT-3 does not promote the survival 
of El I sympathetic neurons in-vitro (Dechant et al, 1993). In accordance with 
this, I have shown tliat full length TrkC mRNA is expressed at high levels in E7 
sympathetic ganglia but is reduced 5-fold by EIO. Interestingly, TrkC mRNA 
levels appear to increase some 4-fold between EIO and E14 so that by E14 they 
are almost as high as at E7. Sympathetic neurons do not show a survival response 
to NT-3 during the period EIO to E 14. This observation contradicts previously 
published data showing that in rat sympathetic ganglia at E14.5, a developmental 
period equivalent to E7 in chick sympathetic ganglia, TrkC mRNA is expressed 
at high levels but levels are reduced markedly after E17.5 and TrkC mRNA is not 
detectable in sympathetic ganglia at birth using in-situ hybridisation (Birren et al, 
1993). A reciprocal pattern of TrkA mRNA expression is observed in rat 
sympathetic ganglia. TrkA mRNA is not expressed in E14.5 sympathetic ganglia, 
first appears at low levels at E l6.5 and is readily detectable by E17.5 (Birren et 
al, 1993). The timing of neurotrophin receptor expression is in accordance with 
the neurotrophin responsiveness of developing rat sympathetic neurons. At early 
developmental stages, rat sympathetic neurons respond to NT-3, but not NGF, 
with increased survival. However, later in development, when TrkC mRNA 
levels are low and TrkA mRNA levels are high, sympathetic neurons respond to 
NGF and not NT-3 (Birren and Anderson, 1993; DiCicco-Bloom etal, 1993). It 
has been suggested that the switch in neurotrophin receptor expression that 
occurs in developing rat sympathetic ganglia is mediated in part by NT-3 
produced by non-neuronal cells surrounding sympathetic ganglia (Verdi and 
Anderson, 1994; Verdi et al, 1996), However, a second study failed to identify a
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role for NT-3 in regulating TrkA expression in developing sympathetic neurons 
(Wyatt and Davies, 1995). Although a study using iodinated NT-3 to detect high 
affinity NT-3 binding sites in developing chick sympathetic neurons has 
concluded that TrkC receptors were expressed at high level by E ll neurons, a 
time when these neurons no longer respond to NT-3 by increased survival, the 
methodology used does not distinguish between full length catalytically active 
TrkC receptors and the shorter truncated isoform. My data are therefore novel in 
that they comprise first demonstration of full length TrkC expression in 
sympathetic ganglia at a time when sympathetic neurons no longer respond to 
NT-3 by increased survival. Recently, another group have reported detecting 
TrkC mRNA expression up to E15.5 in chicken sympathetic ganglia (Holst and 
Rohrer unpublished observations). Further studies are needed to ensure that the 
high level TrkC mRNA expression detected in E12 and E14 sympathetic neurons 
is restricted to neurons and does not reflect expression of TrkC mRNA by non­
neuronal cells that are increasing in number in sympathetic ganglia at this time. If 
this is indeed the case it would signal another role for NT-3 in chick sympathetic 
neurons apart from promotion of survival. For example, NT-3 may play a role in 
regulating catecholamine or neuropeptide synthesis or in promoting target 
innervation.
By treating fertilised quail eggs with an anti-NT3 antibody, Gaese et al
(1994) demonstrated that NT3 is needed in vivo if the full complement of nodose 
and DRG neurons to be reached in these ganglia. More recent work involving 
transgenic mice has demonstrated that in the absence of NT-3 there is a marked 
reduction in the number of proliferating precursors in immature trigeminal, 
dorsal root and sympathetic ganglia that reflects increased death of neuroblasts 
rather than a reduction in the rate of neuroblast division (ElSharay and Emfors, 
1996 (a) and 1996 (b); ElShamy et al, 1996). This in vivo data is in agreement
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with in vitro data showing that NT-3 supports the long term survival of 
proliferating sympathetic neuroblasts from rat (Birren and Anderson, 1993; 
DiCicco-Bloom et al, 1993). Proliferating neuronal precursors do not have access 
to target field neurotrophic factors but rather appear to obtain NT-3 locally. In the 
case of sympathetic ganglia, the source of NT-3 for proliferating neuroblasts 
would appear to be non-neuronal cells surrounding the sympathetic ganglia 
(Verdi et al, 1996). In the case of sensory neuroblasts, it appears as if cells within 
the developing ganglia itself provide NT-3 (ElShamy and Emfors, 1996b). It is 
not clear whether neurons, neuronal precursors or non-neuronal cells within early 
sensory ganglia synthesise NT-3. If the former is the case then it calls into 
question the supposition that neurons are independent of neurotrophic factors 
during the period that they grow towards their targets (Vogel and Davies, 1991).
TrkC may mediate the other roles that NT-3 plays during the early stages 
of neural development. For example NT-3 has been shown to accelerate 
maturation of sensory neurons and increase differentiation of motor neurons 
(Wright et aL, 1992; Averbuch-Heller et al, 1994). Data from experiments with 
the PC 12 cell line support the idea that NT-3 may play a role in regulating some 
aspect of neuronal differentiation (Valenzuela et al, 1993). In addition, in-ovo 
administration of NT-3 during a specific time window in the development of 
chick appears to result in the cessation of division of sensory neuron precursors 
(Ockel et aL, 1996). Similarly, the administration of high levels of NT-3 to 
proliferating sympathetic precursors in vitro has been reported to result in exit 
form the cell cycle (Verdi and Anderson, 1994).TrkC transcripts appear to be 
expressed very early in neuronal development by subsets of premigratory and 
early migrating neural crest cells that migrate exclusively on the medial pathway 
(Henion et al, 1995). This suggests that NT-3 may play a role in controlling 
neural crest-cell migration.
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Regulation of the expression of TrkC
I have shown that NT-3 can up-regulate the mRNA for its preferred 
receptor, TrkC, in E6 DMTG neurons grown in low density cultures. Although 
regulation of TrkC mRNA by NT-3 does not appear to be dose dependent, it is 
possible that the lowest concentration of NT-3 (2ng/ml) that I used in my study 
represents a saturating level. Further experiments would be needed to determine 
whether this is the case. The regulation of neurotrophin receptor mRNAs by 
neurotrophins provides a mechanism by which the response of particular neurons 
to neurotrophins can be coordinated both spatially and temporally with the onset 
of neurotrophin expression in peripheral and central targets and to the arrival of 
fibres in their targets. This phenomenon is not new and has been well established 
in vitro, although the role that neurotrophins play in regulating the expression of 
their receptors in vivo is not yet clear. For example, up-regulation of mRNAs for 
both the low and high affinity NGF receptors in mouse trigeminal sensory 
neurons occurs in parallel with an increase in NGF levels in the principal 
peripheral targets of these neurons (Wyatt and Davies, 1993). The expression of 
mRNA for the low affinity neurotrophin receptor, gp75, is regulated in vitro by 
BDNF and NGF (Wyatt and Davies, 1993). However, gp75 mRNA shows a 
normal pattern of expression in the developing trigeminal neurons in the absence 
of a functional NGF gene suggesting that NGF does not play a role in regulating 
gp75 mRNA expression in sensory neurons in vivo (Davies et al., 1995). 
Although NGF appears to regulate expression of the mRNA for its high affinity 
receptor TrkA in basal forebrain cholinergic neurons and in PC 12 cells 
(Holtzman et al, 1992; Meakin et al, 1992), it does not appear to do so either in 
cultured sympathetic neurons or in sensory neurons both in vitro and in vivo
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(Wyatt and Davies, 1995: Wyatt and Davies, 1993; Davies et al, 1995). BDNF 
has recently been shown to regulate the expression of the mRNA for its high 
affinity receptor, TrkB in cultured nodose ganglion neurons from chick 
(Robinson et al, 1996), however analysis of TrkB mRNA expression in embryos 
that contain a null mutation in the BDNF gene will be required to establish 
whether BDNF regulates the expression of TrkB mRNA during in vivo 
development. Similarly, a study of NT-3 null mutant embryos will determine the 
role that NT-3 play in regulating the expression of its receptor during 
development. In addition, further studies analysing the expression of mRNAs 
encoding different isoforms of the TrkC receptor, both in NT-3 knockout 
embryos and in culture, will determine whether NT-3 is involved in regulating 
the splicing of the TrkC message and hence in determining the ratio of full 
length, truncated and kinase insert isoforms.
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CONCLUSIONS
Taken together, the data presented in this thesis provide evidence for 
changes in the responses of developing neural crest derived, neurons but not 
placode derived neurons to neurotrophins.
The chicken tissue culture studies presented in Chapter 2 showed that 
DMTG and jugulai* neurons are responsive to BDNF, NT3 and NGF in early 
stages of development. Subsequently these neurons lose their responsiveness to 
BDNF and NT3, becoming responsive only to NGF. It is unlikely that the eaily 
survival responses of neural crest derived neurons to BDNF and NT3 play a 
direct role in regulating the final number of neurons that survive in these ganglia 
because the responses aie laigely over by the time naturally occuning neuronal 
cell death begins. It is possible, however, that the function of these early survival 
responses to BDNF and NT3 may be to sustain the survival of the neurons whose 
axons reach the target field during the early stages of its innervation. If, in the 
absence of eaily BDNF and NT3 survival responses, the supply of NGF from the 
target field was limiting from the eaiiiest stages of target field innervation, it is 
possible that too many neurons would be eliminated before the capacity of the 
growing tar get field has increased to support the required number of neurons. It 
may also be an advantage for most of the neurons that innervate a given tai’get 
field to compete for survival at the same time.
It is also shown that subsets of trigeminal neurons discriminate 
between neurotrophins at very high concentrations during the period of cell
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death, indicating that neuroti'ophin responses can be far more highly specific than 
previously thought.
The examination of the timing of neuronal death in mouse trigeminal 
ganglia of mice lacking each of the three trk receptors by quantification of 
normal neurons and pyknotic nuclei from E ll  to E17 provided convincing 
supporting evidence in vivo for the in vitro results showing that neural crest 
derived neurons undergo a switch in their neurotrophin requirement: early in 
their development they require signalling through TrkB and later these neurons 
i-equire signalling through TrkA.
In order to investigate if the loss of the early response of chicken 
trigeminal neurons to NT3 and BDNF is related to their high affinity receptor 
expression pattern, quantitative and semi-quantitative PCR assays were 
developed to investigate the timing and regulation of expression of TrkC mRNA 
in chicken trigeminal and sympathetic neurons during development. It was 
observed that there is a high level of TrkC mRNA in early trigeminal neurons 
which accords with the early survival response of these neurons to NT3. This 
suggests that the timing of NT3 responsiveness is controlled by the expression of 
its receptor. The detection of an extra TrkC mRNA ti'anscript using tyrosine 
kinase primers is an interesting finding. It may represent a novel truncated 
isofoim of TrkC, a possibility which I am currently investigating. The abrupt 
decrease in the levels of expression of TrkC mRNA at E8 could be due to a 
transcription of different isoforms of this receptor mRNA instead of the full 
length form which is known to be the functional one. It is also important to note 
that the E6 DMTG sample in which TrkC mRNA was investigated comprises a 
mixed population of neuronal and non-neuronal cells. Therefore the decreased 
levels of expression could simply reflect the expression of TrkC mRNA only in 
neuronal cells. The expression and regulation of TrkB mRNA is also under 
investigation.
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It is important to note that this phenomenon of switching neurotiophin 
responsiveness, although not universal to all types of neurons, is highly 
conserved between lower (chicken) and higher (mouse) vertebrate neurons of the 
same origin (neural crest derived neurons), reinforcing the general significance of 
this phenomenon in neural development.
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Appendix
Media for Tissue Culture
L15
This medium is used for dissecting. It is air buffered.
To one litre of medium (made up with double distilled H20)add*. 
100 mg Streptomycin 
60 mg Penicillin 
Adjust to pH 7.3 with HCl or NaOH 
Millipore filter using 0.22-pm sterile bells.
HAM'S F12
F-12 medium (HAM), carbonate-free, supplemented with L-glutamine. This 
medium is used for microinjection (do noj add NaHCOs), or rinsing cells and 
dishes.
GibcoBRL Cat. No. 21700-026 (1 L unit, powder)
To one litre of medium (made up with double distilled H2 O) add:
100 mg Streptomycin 
60 mg Penicillin 
Adjust to pH 7.3 with HCl or NaOH
Add heat inactivated horse serum (GibcoBRL) to 10% (defrost in a waterbath at 
37T).
Filter sterilize after adding serum (if serum is required).
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HAM'S F-14
The F-14 medium is a carbonate-based medium, it is normally used to grow the 
neurons. It is made up as a lOx concentrate.
The diluted solution is kept not longer than a week at 4°C 
Imperial Cat. No. 3-791-35 (5 L unit, powder, with L-glutamine, without 
NaHCOs).
This is a special formulation for neuronal cell culture
To a 500 ml (lOX concentrated stock) add; |
500 mg streptomycin i
300 mg penicillin
Store in 50 ml aliquots (lOx) at-40°C |
To make Ix defrost 50 ml lOx aliquot in 3TC  waterbath 
450 ml ddH20 
add 1 g NaHCOs
pH to sligthly acid (6.7) with a piece of dry-ice 
Filter 0.22-{im into a sterile bottle after serum addition.
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SATO STOCK
Note In some formulations, SATO is supplemented with insulin and transferin. 
These two components are omitted here because of their possible effects on cell 
differentiation, survival and growth (mitogen).
To make up a 222ml stock, add:
Pathocyte-4-BSA (ICN Biomedicals Cat. No. 810101) 100 ml
Putrescine (Sigma P-7505 (1 g))(160 mg / 100 ml ddH20) 100 ml
Progesterone (Sigma P-6149 (1 mg)(l mg / 1.6 ml EtOH) 1 ml
L-Thyroxine (Sigma T-0397 (4 mg))(4 mg / 10ml EtOH) 10ml
Sodium selenite (Sigma S-9133 (1 mg))(l mg / 2.6 ml PBS) 1 ml
Tri-iodo-thyronine (Sigma T-6397 (100 mg))(16.8 mg / 50 ml EtOH) 10ml
Mix and aliquot above ingredients in 11.1 ml aliquots, store at -40°C 
When preparing the final medium:
Put a 0.22-pm filter -f 20 ml syringe on top of a 500 ml F-14 bottle 
Add 11.1 ml SATO STOCK to 488.9 ml
5 ml of 200 mM Glutamine (Gibco Cat. No. 25030-024)
Filter using a filter unit with filling bell (Sigma F-9013), 0.22-pm sterile,
pH to 7.3
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Solutions
HBSS
Hanks’ balanced salts without calcium and magnesium (GibcoBRL Cat. No, 
14170-070, 100 ml/bottle).
This medium (serum-free and carbonate-free) is used to coat the plastic dishes 
with laminin, to trypsinize and triturate the ganglia, and to load the cell 
suspension on the dropping funnel.
QJLMJPM
0.1 M phosphate buffered saline. Dissolve 10 tablets (Oxoid, code BR14a) in 1 
litre ddH20. Autoclave at 115“C for 10 minutes.
To convert to full Dulbecco phosphate saline add 0.5 ml mineral salt solution 
(code SR39) to the autoclaved solution, pH 7.3 (approx.).
5 M K O H
140 g KOH pellets in 500 ml ddH20. This solution is used for making tungsten 
wire needles.
TUNGSTEN NEEDLES
Tungsten needdles, which are required to complete the dissections, are made 
from 0.5 mm diameter tungsten wire. The wire is cut into 3 to 5 cm lengths using 
a grind wheel. The 1cm end is bent at an angle of about 60“ and this end is 
immersed with the bent portion near horizontal in 0.5M KOH. Then, a current of 
3 to 12 V AC is passed through to the wire and a second electrode (copper or
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Steel rod) immersed in the solution. The tungsten is etched away over several 
minutes forming a taper from the bend to the tip of the needle. The needles 
should be washed in water to remove any alkali. For dissection, the needles are 
conveniently held in chuck-grip platinum wire holders.
Trypsin
Use Worthington trypsin, add 50 mg to 5 ml of Ca/Mg free PBS (GibcoBRL). 
Filter sterilise in laminar flow hood. Aliquot 100 pi into 0.5 ml eppendorf tubes. 
Used to dissociate neuronal cells.
Laminin
Stored in 20 pi aliquots at 1 mg/ml then diluted to 20 pg/ml in PBS, F14 or 
HBSS.
4% Paraformaldehyde
40 g/1 in PBS. Heat in a water bath until temperature reaches 66“C, then add 
NaOH until all of the paraformaldehyde dissolves. Filter with 0.22-pm filter and 
50 ml syringe. (Important! Paraformaldehyde may be carcinogenic, use gloves 
and avoid breathing dust)
Borate BujRTer fO.lSM)
4.6g boric acid (Sigma) in 500ml distilled water. pH to 8.4 with 5M NaOH. This 
buffer is used to dissolve the poly ornithine.
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Poïvornithin
0.5 mg/ml in 0 .15M Boric Acid pH 8.4. Filter sterilised, stored at 4“C and used 
within one week.
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